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Abstract 
The description of this thesis is divided into three chapters following the 
chronological events of my research development. 
In chapter one, a series of new 1,4-anthracenediones were synthesized via 
functionalizations of the methyl side chain of 6-methyl-1,4-anthracenedione. The new 
1,4-anthracenediones were found to exhibit potent cytotoxic activities against human 
L1210 leukemic and HL-60 cell lines. A key intermediate, 6-bromomethyl-1,4-
anthracenedione (1.44), was first synthesized through a sequence of reactions including a 
double Friedel-Crafts reaction, reductive quinone formation, and selective benzylic 
bromination. The bromide (1.44) was further converted to other 1,4-anthracenediones via 
hydrolysis, subsequent oxidation, and  reductive amination or nucleophilic substitution. 
Chapter two deals with a continuous research project aiming at macropolycyclic 
cyclodecitycene or [10]beltene derivative using Diels-Alder reaction as the key strategy 
for cyclization. A tetraene, (4aR,5R,7S,7aS,11aR,12R,14S,14aR)-5,7,12,14-tetrahydroxy-
2,3,9,10-tetramethylene-1,4,4a,5,6,7,7a,8,11,11a,12,13,14,14a-tetradecahydro-6,13-o-
benzenopentacene (2.51), was synthesized by following previous work from this 
laboratory. Unfortunately, the Diels-Alder reaction of tetraene 2.51 with triptycene 
bisquinone showed predominantly polymerization over intramolecular cyclization. The 
use of double activated quinone such as 1,4,5,8-naphthodiquinone (2.64) and 1,2,4,5-
tetraethoxycarbonyl-1,4-benzoquinone (2.70) as dienophiles gave monoadducts 2.67 and 
2.71 respectively. However, they both failed to cyclize under high dilution conditions at 
elevated temperature, which may be rationalized by chair conformations adopted in six-
membered rings causing unfavorable twist for intramolecular cylization. Further study 
showed tetraene 2.51 underwent an unexpected furan ring forming reaction. 
In chapter three, an unprecedented substituted cyclododeciptycene, 
2,4,6,8,10,12,14,16,18,20,22,24-dodecahydro-9,11,21,23-tetramethoxy-(2,14:4,16:6,18:8, 
20:10,22:12,24)-hexa(o-benzeno)-[12]cyclacene-1,3,5,7,13,14,17,19-octaone (3.138), 
was successfully synthesized based on a successful intramolecular Diels-Alder reaction, 
 which was developed from the above [10]beltene project and previously reported 
literature work. A series of all cis-iptycenequinones were synthesized as bisdienophile 
building blocks from a sequence of Diels-Alder reactions, separation of individual Diels-
Alder adducts, enolization, and oxidative demethoxylation. It was found that each Diels-
Alder adduct isomer shows distinguish 1HNMR signals inherent to its structure. The 
characteristic 1HNMR signals allow the identification of the structures of 
iptycenequinones derived from the above reactions. A bisdimethoxyanthracene, 
6,8,15,17-tetramethoxy-7,16-dihydro-7,16-(o-benzeno)heptacene (3.56), was synthesized 
as bisdiene building block, which reacted with cis,cis-heptiptycene tetraquinone (3.23).  
The cycloadduct was transformed to cyclododeciptycene 3.138, whose structure was 
firmly established by a single-crystal X-ray analysis. 
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CHAPTER 1 - Synthesis of new 1,4-anthracenedione analogs for  
their study of anticancer activities 
1.1 Introduction 
Cancer is still one of main killers of human beings in the 21st century. Development of 
new, more potent anticancer drugs remains a major challenge.1  New leading compounds have 
been discovered either by screening new natural products or known synthetic compounds. In our 
lab, after screening anticancer activity of a number of intermediates towards the synthesis of 
functionized beltenes (See Chapter 2), we found 1,4-anthracenedione and triptycenebisquinone 
have potent anticancer activities as leading compounds. Synthetic efforts towards their analogs 
aiming at better anticancer activity were undertaken in our lab. My project mainly involved the 
synthesis of new 1,4-anthracenedione analogs via functionalization of the methyl side chain of 6-
methyl-1,4-anthracenedione. 
1.2 Background 
1.2.1 Quinone-containing anticancer drugs 
Quinones widely exist in biological systems and they are essential to many life processes 
including biological redox process.2 Many naturally existing quinones have potent anticancer 
activity such as doxonubicin and mitomycin C, and have been used in clinical therapy for more 
than twenty years.1 Quinone-containing anticancer drugs fall into the following categories 
based on their structural characteristics and rationalization of their antitumor activity.  
1.2.1.1 Mitomycin C and related quinone-containing alkylating agents3 
This category includes mitomycin C, porfiromycin, diaziquone, carbazilquinone, 
triaziquone, and EO9 etc. (Figure 1.1) They contain a special alkylating group in their structure 
along with a quinone moiety. The activity of alkylating groups is triggered by enzymatic 
reduction of the quinone moiety in vivo to form covalent linkages with cellular components 
including proteins, membranes, and DNAs, which accounts for their antitumor activities.3 
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Quinone rings may also contribute to their cytotoxicity through formation of reactive oxygen 
species during redox cycling.  
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Figure 1.1 Mitomycin C and related quinone-containing alkylating agents. 
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Scheme 1.14 Proposed mechanism for the antitumor activity of mitomycin C. (Taken from 
reference 4 without permission) 
For example, mitomycin C, which has been used clinically for more than 30 years,5 can 
be activated by intracellular flavin reductases in either a one- or two-eletron reduction pathway 
(Scheme 1.1). The one-electron pathway forms a semiquinone radical anion (1.7), which 
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transfers an electron to molecular oxygen and produces a superoxide radical anion under aerobic 
conditions. While in hypoxic conditions, mitomycin is further reduced to its phenol form (1.8) in 
two-electron reduction pathway. The methoxide substituent is then eliminated, which further 
triggers opening of the aziridine ring which forms a highly reactive species termed mitosene. 
Mitosene attacks DNA to form crosslinks between C1 and C10 carbon atoms and causes cell 
damage.4 This latter pathway is more powerful against cancer cells. Therefore, mitomycin C and 
related quinone-containing alkylating agents are often used to treat oxygen-deficient solid tumors.   
1.2.1.2 Daunorubicin and related anthracycline DNA intercalating agents 
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Figure 1.2 Daunorubicin and related anthracycline DNA intercalating agents. 
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This family of antitumor antibiotics includes daunorubicin, doxorubicin (adriamycin), 
idarubicin, epirubicin, aclacinomycin, and nogalamycin (Figure 1.2). These are dierent from the 
first category because anthracyclines intercalate to molecular DNA and inhibit DNA replication 
process.6 Their structure consists of a flat anthraquinone backbone and a sugar residue with 
various purposes. In the case of daunorubicin (1.9), the duanosamine residue forms hydrogen 
bonds towards the minor groove of a DNA molecule. Meanwhile, electron-deficient 
anthracenequinone ring inserts itself into electron-rich purine-pyrimidine bases (Figure 1.3), 
causing a distorted DNA helix, which interferes normal binding activities of DNA polymerases, 
RNA polymerases, topoisomerases, and other related enzymes required for DNA replication and 
RNA synthesis.7,8  Clinically, anthracyclines are used to treat a wide range of cancers, including 
leukemias, lymphomas, breast, uterine, ovarian, and lung cancers.  
 
Figure 1.38 The crystal structure of d(CGATCG) complexed  
with daunorobicin (pdb code: 1DA0)    
Mitoxantrone  (1.15), AQ4N (1.16), and dynemicin A (1.17) have an similar 
anthraquinone backbone as anthracyclines mentioned above. Their cytotoxicity is also related to 
their intercalation with DNA. Different from reversible binding of daunorubicin and doxorubicin, 
mitoxantrone intercalates DNA and cut off DNA, causing DNA aggregation and compaction.9 
AQ4N is structurally related to mitoxantrone but contains a bioreductive N-oxide group, acting 
as prodrug with increased antitumor activity against hypoxic cancer cells.10 Dynemicin A is also 
a reductively activitated antitumor agent. With its unique ten-membered enediyne moiety 
conjugated with anthraquinone moiety, it causes DNA cleavage via DNA backbone hydrogen 
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abstraction by a reactive benzenoid diradical formed through a series of reduction, epoxide 
opening, nucleophilic addition, and Bergman cycloaromatization steps. 11,12 (Scheme 1.2) 
1.17
1.18
1.191.20
1.21 1.22  
Scheme 1.2 Proposed mechanism for the antitumor activity of dynemicin A. (Taken from 
reference12 without permission)  
1.2.1.3 Geldanamycin and related benzoquinone ansamycin Hsp 90 inhibitors  
 The benzoquinone ansamycin, such as geldanamycin, herbimycin, and macbecin, belong 
to a family of antitumor antibiotics that were first isolated from actinomycete broth.13-15  They 
are characterized by a 20-membered macrocylic lactam ring incorporated with a benzophenone 
backbone inside it. First described as tyrosine kinase inhibitors, they are now more frequently 
associated with heat shock protein 90 (Hsp 90), a molecular chaperone involved in maintaining 
correct conformation and stability of its client proteins required for many key cellular functions 
such as cell growth, cell survival, apoptosis, angiogenesis, and oncogenesis. Geldanamycin binds 
with high affinity to the ATP binding pocket of Hsp 9016 (Figure 1.5). As a result, Hsp 90 loses 
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its ability to act as a chaperone, and the client proteins become misfolded and lose their functions, 
leading to cell death.17 To overcome its toxicity and lack of stability as a drug candidate,  a 
number of geldanamycin derivatives such as 17-AG,18 17-AAG,18 and 17-DMAG19 were 
developed.  
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Figure 1.4 Geldanamycin and related benzoquinone ansamycin Hsp 90 inhibitors. 
 
Figure 1.5 The crystal structure of the N-terminal domain of the yeast Hsp90 chaperone 
complexed with geldanamycin (pdb code:1A4H) 16 
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1.2.2 Nature existing 1,4-anthraquinones 
Anthracenequiones widely exist in nature mostly as 9, 10-anthraquinones. Very few 1,4-
anthraquinones separated from nature have been reported2 (Figure 1.6).  The first 1,4-
anthraquinones identified in nature were viocristin and isoviocristin isolated from mycelia of 
Aspergillus cristatu in 1980.20 Biological studies show they have antibiotic activity and 
inhibitory effect on protein, RNA, and DNA synthesis of Bacillus brevis cells.21, 22 Rrufoolivacin 
B was isolated from Cortinarium rufoolivaceus, which shows antiplasmodial activity against 
asexual erythrocytic stages of P. falciparum in vitro with IC50 = 1.67μg/ml.23 More recently 
discovered 1,4-anthracenediones in nature are presengulone and segulone.24 Both were isolated 
from Senna sophera, a medicinal plant used in India. Their biological activities have not yet been 
investigated. These natural existing compounds show some promise that new anticancer drugs 
based on 1,4-anthracenequinones may have potential to be as active as those 9, 10-
anthracenequinones mentioned above. 
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Figure 1.6 Nature existing 1,4-anthraquinones  
1.2.3 Previous studies in our lab 
Previous studies in our lab have found that 1,4-anthracenedione (1.35) showed potent 
anticancer activity towards L1210 leukemia and human HL-60 tumor cells with IC50 = 42.2 nM 
 8
and 140.7 nM, respectively, while quinizarine, a 9,10-anthracenedione derivative, was inactive 
up to 1.6 μM.25 To study whether other substituted 1,4-anthracenedione showed similar activities 
against cancer cells, several other 1,4-anthracenedione derivatives were synthesized as shown in 
Scheme 1.3. Their cytotoxicities against L1210 and HL-60 tumor cell lines in vitro were given in 
Table 1.1. The data clearly shows that substitution at A-ring decreased antitumor activity, while 
the substitution at C-ring remained significant antitumor activity for 1,4-anthracenediones.    
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Scheme 1.3 
Compound L1210, IC50 (nM) HL-60, IC50 (nM) 
1.34 Not active at 1.6 μM Not active at 1.6 μM 
1.35 42 ± 2 140 ± 7 
1.36 Not active at 640 nM Not active at 640 nM 
1.38 Not active at 256 nM Not active at 256 nM 
1.39 84 ± 6 243 ± 16 
1.40 Not active at 640 nM Not active at 640 nM 
1.42 Not tested Not active at 10 μM 
1.43 29 ± 1 87 ± 4 
Table 1.1 Cytotoxicities of previous synthetic 1,4-anthracenediones in vitro. 
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 However, low water solubility of these 1,4-anthracenediones may limit drug 
administration in animal studies and clinical trials. The purpose of this research project was to 
synthesize new 1,4-anthracenedione derivatives with better water solubility and also investigate 
their anticancer activities. The most active compound, 6-methyl-1,4-anthracenedione (1.43), was 
chosen for further side-chain modification at 6-methyl position while leaving BC-ring intact for 
anticancer activity.  
1.3 Synthetic efforts towards new 1,4-anthracenedione analogs 
1.3.1 Functional group transformation of 6-methyl-1,4-anthracenedione (1.43) 
The functionization of 6-methyl-1,4-anthracenedione (1.43) was started from bromination 
of the side methyl group. The standard free-radical benzylic bromination using NBS and benzoyl 
peroxide in refluxing tetrachloromethane failed to give the desired product. Several other 
conditions also failed.26 However, radical bromination using copper (II) bromide and t-butyl 
hydroperoxide as radical initiator in acetic anhydride at 80oC successfully gave 6-bromomethyl-
1,4-anthracenedione (1.44) in 75% yield together with overbrominated byproducts. Compound 
1.44 was the key intermediate to synthesize new 1,4-anthracenedione analogs. 
Hydrolysis of 1.44 with silver trifluoroacetate in aqueous dioxane at room temperature 
for two hours to give 92% yield of alcohol 1.45, which was easily oxidized with IBX (o-
iodoxybenzoic acid)27 in DMSO to give 62% yield of aldehyde 1.46 or with Jones reagent to 
give 82% yield of acid 1.47 (Scheme 1.4). 
Me
O
O
O
O
Br
CuBr2
t-BuOOH
Ac2O
80oC
1.43 1.44
CF3CO2Ag
O O: H2O = 4:1
O
O
HO
1.45
O
I
O
O
DMSO
IBX
O
O
H
O
1.46
Acetone
Jone's Agent
O
O
HO
OO
O
HO
1.45 1.47
OH
 
 
Scheme 1.4 
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1.3.2 Synthesis of water soluble analogs 
We have synthesized several 1,4-anthracenedione analogs with modification at the 6-
position. Nonetheless, in order to achieve better water-solubility, a more hydrophilic group such 
as a sugar or quinic acid group were attached to the molecule.  
An ester group can be formed from a bromide reacting with a silver salt of an acid. The 
quinic acid silver salt 1.48 was easily prepared by stirring silver oxide and quinic acid in ethanol 
at room temperature overnight. Reaction of bromide 1.44 with the silver salt of (-)-quinic acid 
(1.48) in dioxane afforded ester 1.49 in 46% yield. 
O
OAc
N
H
OAc
AcO
AcO
O
O1.52
NaBH3(CN)
HOAc, MeOH
HCl
O
OAc
N
H2
OAc
AcO
AcO
O
O1.53
Cl
CO2AgHO
OH
OH
HO
O
O
Br
1.441.48
+
Dioxane HO
OH
OH
HO
O
O
1.49
O
O
O
O
H
O
1.46
O
OAc
NH3Cl
OAc
AcOAcO
O
OAc
N
OAc
AcOAcO
O
O
+
1.50 1.51
Pyridine
4A molecular sieve
CH2Cl2
 
Scheme 1.5 
 Stepwise reductive amination of aldehyde was used to install an amino sugar group into 
the molecule. When aldehyde 1.46 reacted with 1,3,4,6-tetra-O-acetyl-β-D-glucosamine 
hydrochloride (1.50)28 in dichloromethane and pyridine, imine 1.51 was formed in 60% yield, 
which was reduced with sodium cyanoborohydride in acetic acid and methanol  to produce the 
amine 1.52 with protected sugar group. Attempts to remove the acetoxy protecting groups to give 
a water soluble analog under either basic or acidic conditions were unsuccessful.  However, the 
hydrochloric acid salt of the amine (1.53) is soluble in water. 
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1.3.3 Synthesis of a phosphate ester prodrug 
The biological study showed 6-hydroxymethyl-1,4-anthracenedione (1.45) has good 
anticancer activity (Table 1.2). A prodrug approach was used to convert it to a water-soluble 
phosphate 1.56, which would release the active quinone 1.45 by phosphatases in vivo. Treatment 
of bromide 1.44 with silver di-t-butyl phosphate 1.5429 in refluxing chloroform gave di-t-butyl 
phosphate 1.55 in 48% yield (Scheme 1.6), which was deprotected in 4M HCl in dioxane and 
neutralized with sodium carbonate to afford the water-soluble prodrug disodium phosphate 1.56.  
O
O
Br
1.44
O
O
1.55
P
O
t-BuO OAg
OBu-t
+
1.54
P
O
t-BuO O
OBu-t
CHCl3
O
O1.56
P
O
NaO O
ONa
1) HCl, Dioxane
2) Na2CO3
 
Scheme 1.6 
1.4 Anticancer activities and conclusions 
The biological activity of synthetic 1,4-anthracenedione was carried out in our 
collaborator Dr. Jean-Pierre Perchellet’s Lab.  IC50 values of new synthetic 1,4-anthracenediones 
against L1210 and HL-60 leukemic cells  at day 4 were summarized in Table 1.2. From both 
Table 1.1 and 1.2, the IC50 of various 1,4-anthracenediones are in a range of 26 to 462 nM for 
L1210 cells and 79 to 1260 nM for HL-60 cells with some exceptions. Unexpectedly, increased 
water-solubility correlated to decreased anti-cancer activities. This may be due to the increased 
difficulty to cross hydrophobic cell membranes for more water-soluble drugs. 1,4-
anthracenedione 1.44 and 1.45 have almost the same anticancer activity against L1210 cells as 
their mother compound 1.43. All three compounds show anticancer activities comparable to 
daunomycin, of which the IC50 value is 30 nM in similar conditions.30 However, their 
mechanism against cancer cells are somehow different from daunomycin. 1,4-Anthracenediones 
have broader spectrum of molecular targets in cells. They were found to block nucleoside 
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transportation, cause DNA fragmentation, and decrease the growth of L1210 leukemic cells.25, 31 
They were also found targeting cytochrome c, caspase-9, -3 and -8, poly(ADP-ribose) 
polymerase-1, and internucleosomal DNA in wild-type and MDR (multidrug-resistant) HL-60 
cells by a mechanism partially mediated by caspase-2 activation but not involving Fas 
signaling.32  Besides, they can trigger cytochrome c release without caspase activation. Most 
interestingly, they seem to target mitochondria directly to induce a rapid loss of mitochondrial 
membrane potential together with permeability transition pore opening under experimental 
conditions, which was not found in daunoymcin.33, 34 Their wide spectrum of molecular targets 
and activity against MDR tumor cells make them a potential new synthetic class of quinone-
containing-anticancer drugs in chemotherapy. 
Compound L1210, IC50 (nM) HL-60, IC50 (nM) 
1.44 26 ± 1 79 ± 3 
1.45 37 ± 2 125 ± 7 
1.46 462 ± 43 1260 ± 104 
1.47 Not active at 4.0 μM Not active at 256 nM 
1.49 Not tested 919 ± 78 
1.52 Not tested 254 ± 23 
1.53 Not tested 1980 ± 176 
1.55 Not tested 133 ± 9 
 
Table 1.2 Cytotoxicities of new synthetic 1,4-anthracenediones in vitro. 
 In conclusion, a series of new 1,4-anthracenediones were synthesized via 
functionalizations of side chain of 6-methyl-1,4-anthracenedione. They were found to exhibit 
potent cytotoxic activities against human L1210 leukemic and HL-60 cell lines. A key 
intermediate, 6-bromomethyl-1,4-anthracenedione (1.44), was first synthesized through a 
sequence of reactions including a double Friedel-Crafts reaction, reductive quinone formation, 
and selective benzylic bromination. The bromide 1.44 was further converted to other 1,4-
anthracenediones via hydrolysis, subsequent oxidation and  reductive amination or nucleophilic 
substitution. 
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1.5 Experimental Section 
General Methods: NMR spectra were obtained at a Varian Unity Plus (400 MHz) or Varian 
Gemini 2000 (200 MHz). FAB spectra were taken by using Xe beam (8 kV) and m-nitrobenzyl 
alcohol as matrix. Quinizarine, methylamine in THF (2 M solution),  4-methylphthalic anhydride, 
aluminum trichloride, and t-butyl hydroperoxide were commercially available. Davisil silica gel, 
grade 643 (200–425 mesh), was used for the flash column chromatographic separation.  
1.5.1 Synthesis of key intermediate 6-bromomethyl-1,4-anthracenedione 
O
O
Br
1.44  
1.5.1.1) 6-Methyl-1,4-dihydroxy-9,10-anthracenedione (1.42) 
To a melted (180 oC) mixture of 37.1 g (27.9 mmol) of aluminum trichloride and 7.25 g 
(12.4 mmol) of sodium chloride under argon was added a mixture of 5.00 g (30.8 mmol) of 4-
methylphthalic anhydride (1.41), 3.74 g (34.0 mmol) of hydroquinone, and 15.0 g (113 mmol) of 
aluminum trichloride in one portion. The mixture was stirred and heated at 220 oC for 2 h, cooled 
to room temperature, poured into 300 mL of ice water, and acidified with 12 N HCl. The 
precipitate was filtered, washed with water, and dried in a vacuum desiccator to give 6.28 g 
(80% yield) of 1.42:  mp 174~176 oC (lit35: 175~177 oC); 1H NMR (CDCl3, 400 MHz) δ 12.96, 
12.92 (2 s, 2 H), 8.25 (d, 1 H, J = 8.0), 8.15 (s, 1 H), 7.64 (d, 1 H, J = 8.0), 7.31 (s, 2 H), 2.56 (s, 
3H); 13C NMR (CDCl3, 50 MHz) δ 187.5, 187.1, 158.0, 157.9, 146.1, 135.6, 133.6, 131.4, 129.6, 
129.3, 127.6, 127.5, 113.1, 113.0, 22.2; MS (MALDI): m/z 255.40 (M+H)+. 
1.5.1.2) 6-Methyl-1,4-anthracenedione (1.43)  
To a suspension of 3.00 g (11.8 mmol) of 1.42 in 50 mL of methanol at 0 oC under argon, 
was added 1.80 g (47.6 mmol) of sodium borohydride in portions. The mixture was stirred at      
0 oC for 4 hours and acidified with 6 N HCl. The yellow precipitate was filtered, dried, and 
applied to flash column chromatograph (silica gel) using a mixture of hexane–ether–CH2Cl2 
(60:5:1) as an eluent to give 2.57 g (98% yield) of the title compound 1.43: mp 174~176 oC 
(lit36:182~183 oC);  1HNMR (CDCl3, 400 MHz) δ 8.59, 8.54 (2 s, 2 H), 7.97 (d, 1 H, J = 8.4 Hz), 
7.84 (bs, 1 H, J = 1.6), 7.53 (dd, 1 H, J1 = 8.4 Hz, J2 = 1.6 Hz), 7.06 (s, 2 H), 2.58 (s, 3 H); 13C 
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NMR (CDCl3, 50 MHz) δ 185.0, 184.9, 140.4, 140.3, 140.1, 135.3, 133.3, 132.2, 130.2, 129.4, 
128.9, 128.7, 128.4, 128.0, 22.2; MS (MALDI) m/z 223.11 (M+H)+. 
1.5.1.3) 6-Bromomethyl-1,4-anthracenedione (1.44)  
 To a solution of 0.70 g (3.2 mmol) of 1.43 and 1.0 g (4.5 mmol) of copper (II) dibromide 
in 14 mL of acetic anhydride at 60 oC under argon, was added 1.1 mL (5.0 mmol) of t-BuOOH 
(90%) dropwise through a dropping funnel. The solution was stirred at 80 oC for 2 h, cooled to 
room temperature, diluted with 200 mL of water, and extracted with methylene chloride (50 mL 
×3). The combined organic layer was washed with brine, dried over MgSO4, concentrated, and 
applied to column chromatograph on silica gel using a petrol ether-ethyl acetate (17:3) as an 
eluent to give 0.72 g (75% yield) of the title compound 1.44:  mp 183~184 oC; 1H NMR (CDCl3, 
400 MHz) δ 8.59 (s, 1 H), 8.58 (s, 1 H), 8.06 (d, J = 8.4 Hz, 1 H), 8.04 (d, J = 1.8 Hz, 1 H), 7.72 
(dd, J = 8.4, 1.8 Hz, 1 H), 7.08 (s, 2 H), 4.67 (s, 2H); 13C NMR (CDCl3, 100 MHz) δ 184.7 (2 C, 
C=O), 140.3, 140.2, 139.4, 135.0, 134.6, 131.2, 130.7, 129.9, 129.1 (2 C), 128.9, 128.7, 32.8. 
Anal. Calcd for C15H9BrO2·0.025H2O:  C, 58.37; H, 3.21. Found: C, 58.28; H, 2.92. 
1.5.2 Further function group transformation of 6-bromomethyl- 1,4-anthracenedione 
O
O
HO
1.45
O
O
H
O
1.46
O
O
HO
O
1.47  
1.5.2.1) 6-Hydroxymethyl-1,4-anthracenedione (1.45) 
 A mixture of 71 mg (0.24 mmol) of the bromide (1.44) and 59 mg (0.27 mmol) of silver 
trifluoroacetate in 2 mL of 1,4-dioxane–water (4:1) was stirred under argon at 25 oC for 2 hours, 
diluted with 10 mL of acetone, and filtered through Celite. The filtrate was concentrated and 
applied to flash column chromatograph (silica gel) using a mixture of hexane–ethyl acetate (1:1) 
as an eluent to give 52 mg (92% yield) of the title compound 1.45: mp 178~179 oC (crystallized 
from toluene); 1H NMR (CDCl3, 400 MHz)  δ 8.58 (s, 1 H), 8.56 (s, 1 H), 8.03 (d, J = 8.4 Hz, 1 
H), 8.02 (d, J = 1.4 Hz, 1 H), 7.68 (dd, J1 = 8.4, J2 = 1.4 Hz, 1 H), 7.06 (s, 2 H), 4.94 (s, 2 H); 13C 
NMR (CDCl3, 100 MHz) δ 184.9 (2 C, C=O), 142.9, 140.3, 140.2, 135.2, 134.5, 130.7, 129.3, 
128.9 (2 C), 128.4, 127.3, 125.5, 62.6. Anal. Calcd. For C15H10O3·0.02H2O: C, 74.14; H, 4.37. 
Found: C, 74.33; H, 4.50. 
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1.5.2.2) 6-Formyl-1,4-anthracenedione (1.46) 
To a 5 mL of IBX (1M DMSO solution) 27 was added 250 mg (1.05 mmol) of the alcohol 
1.45. The reaction mixture was stirred under argon at room temperature for 12 hours. The 
mixture was filtered. The filtrate was diluted with wather (100 mL) and extracted with methylene 
chloride (100 mL ×2). The combined organic layers were washed with water (100 mL), brine 
(100 mL), dried over anhydrous magnesium sulfate, filtered, concentrated, and applied to flash 
column chromatograph (silica gel) using a mixture of petrol ether–diethyl ether (2:1) as an eluent 
to give 154 mg (62% yield) of the title compound 1.46: mp 185~186 oC; 1H NMR (CDCl3, 400 
MHz) δ 10.25 (s, 1 H, CHO), 8.81 (s, 1 H), 8.69 (s, 1 H), 8.56 (d, J = 1.6 Hz, 1 H), 8.19 (d, J = 
8.0 Hz, 1 H), 8.17 (dd, J1 = 8.0 Hz, J2 = 1.6 Hz, 1 H), 7.14 (s, 2 H); 13C NMR (CDCl3, 50 MHz) 
δ 191.5 (CHO), 184.5 (2 C, C=O), 140.3 (2 C), 138.0, 136.7, 135.7, 134.6, 131.5, 130.7, 130.3, 
129.5, 128.8, 126.5; Anal. Calcd For C15H8O3: C, 76.27; H, 3.41. Found: C, 75.87; H, 3.74. 
1.5.2.3) 5,8-Dioxo-5,8-dihydroanthracene-2-carboxylic acid (1.47) 
To a solution of 119 mg (0.500 mmol) of the alcohol  in 10 mL of acetone under argon, 
was added a solution of 0.50 mL (1.4 mmol) of Jones reagent (preparation: 26.72 g of chromium 
trioxide was dissolved in 23 mL of concentrated H2SO4  and then diluted to  a volume of 100 
mL). The mixture was stirred at 25 oC for 3 h, and then filtered through Celite, concentrated to 
dryness. The residue was applied to flash column chromatograph (silica gel) using a mixture of 
diethyl ether–ethanol (9:1) as an eluent to give 103 mg (82% yield) of the title compound 1.47: 
1H NMR (DMSO-d6, 200 MHz) δ 8.91 (s, 1 H), 8.81 (s, 1 H), 8.69 (s, 1 H), 8.37 (d, J = 8.4 Hz, 1 
H), 8.17 (d, J = 8.4 Hz, 1 H), 7.20 (s, 2 H); 13C NMR (DMSO-d6, 50 MHz) δ 184.3, 184.1, 166.8, 
140.1, 140.0, 136.1, 133.6, 132.3, 131.3, 130.5, 129.7, 129.5, 128.8, 128.5, 127.7; Anal. Calcd 
For C15H8O4·0.03H2O: C, 69.35; H, 3.43. Found: C, 69.13; H, 3.75. 
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1.5.3 Synthesis of water soluble analogs 
HO
OH
OH
HO
O
O
1.49
O
O
O
OAc
N
OAc
AcOAcO
O
O
1.51
O
OAc
N
H
OAc
AcOAcO
O
O1.52  
1.5.3.1) 5,8-Dioxo-5,8-dihydro-2-anthracenylmethyl-(1R,3R,4R,5R)-1,3,4,5-tetrahydroxy-
cyclohexanecarboxylate (1.49) 
A mixture of 0.30 mmol of silver (-)quinate (1.48) [prepared from 0.10 g of (-)-quinic 
acid and 60 mg of Ag2O in 3mL of ethanol] in 1 mL of 1,4-dioxane was stirred under argon for 
24 hours. The reaction mixture was filtered through Celite, concentrated, and applied to column 
chromatograph (silica gel) using a mixture of ethyl acetate-methanol-water (100:16.5:13.5) as an 
eluent to give 32 mg (46% yield) of the title compound 1.49: [α]22D = -41.7o (c 0.005, MeOH); 
1H NMR (DMSO-d6, 400 MHz) δ 8.62 (s, 1 H), 8.58 (s, 1 H), 8.28 (d, J = 8.8 Hz, 1 H), 8.26 (d, J 
= 1.6 Hz, 1 H), 7.77 (dd, J = 8.8, 1.6 Hz, 1 H), 7.16 (s, 2 H), 5.61 (s, 1 H, OH), 5.29 (d, J = 13.2 
Hz, 1 H), 5.32 (d, J = 13.2 Hz, 1 H), 4.72 (d, J = 3.6 Hz, 1 H, OH), 4.56 (d, J = 4.4 Hz, 1 H, OH), 
4.51 (d, J = 6.4 Hz, 1 H, OH), 3.93 (m, 1 H), 3.81 (m, 1 H), 3.40 (m, 1 H), 2.10~1.70 (m, 4 H); 
13C NMR (DMSO-d6, 50 MHz) δ 184.4 (2 C, C=O), 173.4, 140.1 (2 C), 138.3, 134.1, 133.7, 
130.3, 129.0, 128.5, 128.2, 128.0 (2 C), 127.9, 73.8, 72.9, 67.5, 67.3, 65.0, 37.6 (2 C). Anal. 
Calcd For C22H20O8•0.02H2O: C, 62.81; H, 5.01. Found: C, 62.78; H, 4.84. 
1.5.3.2) N-[(1,4-Dioxo-1,4-dihydroanthracenyl)methylidene]-2-amino-2-deoxy-1,3,4,6-tetra-
O-acetyl-β-D-glucopyranose (1.51) 
A mixture of 21 mg (89 mmol) of the aldehyde 1.46, 33 mg (95 mmol) of 1,3,4,6-tetra-O-
acetyl-β-D-glucosamine hydrochloride (1.50) 28, 50 μL of pyridine, and 0.20 g of 4 Å molecular 
sieves in 3 mL of methylene chloride was stirred under argon at room temperature for 24 hours, 
filtered through Celite, and applied to column chromatograph (silica gel) using a mixture of 
hexane and diethyl ether (1:1) as an eluent to give 30 mg (60% yield) of the title compound 1.51: 
mp 192~193 oC; [a]22D = +125o (c 0.007, MeOH); 1H NMR (CDCl3, 400 MHz) δ 8.68 (s, 1 H), 
8.63 (s, 1 H), 8.45 (s, 1 H), 8.23 (s, 1 H, N=CH), 8.17 (d, J = 8.4 Hz, 1 H), 8.08 (d, J = 8.4 Hz, 1 
H), 7.10 (s, 2 H), 6.02 (d, J = 8 Hz, 1 H), 5.51 (t, J = 9.6 Hz, 1 H), 5.19 (t, J = 9.6 Hz, 1 H), 4.40 
(dd, J = 12, 4.4 Hz, 1 H), 4.16 (dd, J = 12, 2 Hz, 1 H), 4.02 (m, 1 H), 3.61 (dd, J = 9.6, 8.4 Hz, 1 
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H), 2.12 (s, 3 H), 2.05 (s, 3 H), 2.03 (s, 3 H), 1.89 (s, 3 H); 13C NMR (CDCl3, 100 MHz) δ 184.3, 
184.2, 170.6, 169.8, 169.5, 168.6, 163.9, 140.0, 139.9, 136.3, 136.1, 134.5, 132.3, 130.8, 129.4, 
129.2, 128.9, 128.5, 127.3, 92.9, 73.0 (2 C), 72.8, 67.9, 61.7, 20.7, 20.6, 20.5, 20.4. HRMS calcd. 
for C29H28NO11 (M+H) 566.1657, found 566.1430. 
1.5.3.3) N-[(1,4-Dioxo-1,4-dihydroanthracenyl)methyl]-2-amino-2-deoxy-1,3,4,6-tetra-O-
acetyl-β-D-glucopyranose (1.52)  
To a solution of 25 mg (44 mmol) of the imine 1.51 in 0.1 mL of acetic acid and 1 mL of 
methanol under argon, was added 11 mg (0.17 mmol) of sodium cyanoborohydride. The solution 
was stirred at 25 oC for 3 hours, diluted with 40 mL of water, and extracted twice with 20 mL of 
dichloromethane. The combined organic layers were washed with brine (40 mL), dried over 
anhydrous magnesium sulfate, filtered and concentrated. The residue was applied to column 
chromatograph (silica gel) using a mixture of hexane and ethyl acetate (1:1) as an eluent to give 
14 mg (55% yield) of the title compound 1.53: mp >120 oC (dec.); [a]22D = +175o (c 0.004, 
MeOH); 1HNMR (CDCl3, 400 MHz) δ 8.54 (s, 1 H), 8.52 (s, 1 H), 7.99 (d, J = 8 Hz, 1 H), 7.89 
(s, 1 H), 7.59 (d, J = 8 Hz, 1 H), 7.05 (s, 2 H), 5.69 (d, J = 8.8 Hz, 1 H), 5.06 (t, J = 9.6 Hz, 1 H), 
4.31 (dd, J = 12.4, 4 Hz, 1 H), 4.13 (m, 1 H), 4.10 (d, J = 14.4 Hz, 1 H, CH2N), 4.04 (d, J = 14.4 
Hz, 1 H, CH2N), 3.83 (m, 1 H), 3.00 (t, J = 8.8 Hz, 1 H), 2.07 (s, 3 H), 2.06 (s, 3 H), 2.05 (s, 3 H), 
2.04 (s, 3 H); 13CNMR (CDCl3, 100M Hz) δ 184.6, 184.5, 170.8, 170.5, 169.5, 169.0, 141.9, 
139.9, 139.8, 134.7, 134.0, 130.3, 130.0, 129.2, 128.5,128.4, 128.3, 128.2, 94.8, 73.8, 72.4, 68.1, 
61.6, 60.3, 51.7, 21.0, 20.8, 20.6, 20.5; HRMS calcd for C29H30NO11 (M+H) 568.1819, found 
568.1831. 
To a solution of 5.0 mg (8.8 mmol) of amine 1.52 in 1 mL of methanol, was added 35 mL 
(0.14 mmol) of HCl (4 M in dioxane). The solution was stirred for 10 min. and solvent was 
removed to give 5.3 mg (100% yield) of hydrochloric salt 1.53. 
1.5.4 Synthesis of a phosphate ester pro-drug 
O
O
1.55
P
O
t-BuO O
OBu-t
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1.5.4.1) (1,4-Dioxo-1,4-dihydroanthracenyl)methyl di-t-butylphosphate (1.55) 
A mixture of 0.10 g (0.33 mmol) of bromide 1.44 and 0.33 g (0.59 mmol) of silver di-t-
butyl phosphate (1.54)29 in 15 mL of chloroform was refluxed under argon for 6 hours, filtered 
through Celite, concentrated, and applied to column chromatograph (silica gel) using a gradient 
mixture of hexane and ethyl acetate (1:1) as an eluent to give 68 mg (48% yield) of the title 
compound 1.55: mp 126~128 oC; 1H NMR (CDCl3, 400 MHz) δ 8.61 (s, 2 H), 8.07 (d, J = 8.6 
Hz, 1 H), 8.05 (s, 1 H), 7.71 (d, J = 8.6 Hz, 1 H), 7.08 (s, 2 H), 5.22 (d, JHP = 7.4 Hz, 2 H, OCH2), 
1.51 (s, 18 H); 13C NMR (CDCl3, 50 MHz) δ 184.8 (2 C), 140.2 (2 C), 138.9, 138.7, 134.9, 134.6, 
130.6, 129.0 (2 C), 128.8 (2 C), 128.2, 83.1 (d, JCP = 7.2 Hz, 2 C), 67.8 (d, JCP = 5.7 Hz, OCH2), 
30.1 (d, JCP = 4.2 Hz, 6 C). Anal. Calcd For C23H27O6P•0.03H2O: C, 62.31; H, 6.46. Found: C, 
62.49; H, 6.06. 
1.5.4.2) Disodium (1,4-dioxo-1,4-dihydroanthracenyl)-methyl phosphate (1.56)  
To a solution of 20 mg (47 mmol) of phosphate 1.55 in 1 mL of 1,4-dioxane, was added  
0.12 mL (0.47 mmol) of 4 M HCl. The reaction mixture was stirred at room temperature for 1 
hour, and 78 mg (0.93 mmol) of NaHCO3 was added, and solvent was removed. To the solids, 2 
mL of ethanol was added, and resulting mixture was stirred for 5 min, filtered, and the filtrate 
was concentrated to give 14 mg (84% yield) of 1.56. 1H NMR (DMSO-d6, 400 MHz) δ 8.64 (s, 1 
H), 8.60 (s, 1 H), 8.30 (d, J = 8.4 Hz, 1 H), 8.24 (s, 1 H), 7.77 (d, J = 8.4 Hz, 1 H), 7.17 (s, 2 H), 
5.11 (d, JHP = 7.6 Hz, 2H, CH2P). 
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CHAPTER 2 -  Synthetic efforts toward a macropolycyclic 
[10]beltene derivative  
2.1 Introduction 
This project is part of ongoing research in our lab, which has been carried out by three 
previous students in our lab, Jinmei Fan,1 Dr. Xiaodong Huang,2 Dr. Neil Brown3 since 1996. 
The initial synthetic target was [12]beltene derivative 2.1, which could be retrosynthetically 
constructed from triptycene bisquinone (2.2) and 1,2,4,5-tetramethylene cyclohexane (2.3). Due 
to difficulty of synthesis and instability of the tetraene 2.3,4,5 we switched to [10]beltene 
derivative 2.4 for easier synthesis of diene building block 2.5. The target macropolycyclic [10] 
beltene 2.4 was expected to undergo self-assembly forming nanotube-like channels. 
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2.2 Background 
2.2.1 Structure of beltenes and related macropolycycles 
Many objects in the macro-world can find their topologically counterparts in micro-
molecular level.6  Belt-shaped macropolycycles are attractive because of their interesting 
molecular architecture and potential applications in supramolecular chemistry and material 
science.7  Vögtle first pointed out that belt-shaped macropolycycles with laterally fused six-
membered rings are interesting targets for synthesis.8  The term “beltenes” was first used by 
Alder and Sessions to describe the imaginary molecules 2.6 in Figure 2.2 as “lateral fusion of 
cyclohexa-1,4-diene rings and linkage into a macrocyclic belt-like assembly”.9  Beltene-related 
macropolycycles such as cyclacenes and collarenes (2.7 and 2.8 respectively) share similar 
carbon backbones with fully or partially aromatized rings around the macropolycycles.  Fully 
conjugated cyclacenes attract more attention both synthetically and theoretically as substructures 
of fullerenes and single-wall carbon nanotubes (Figure 2.3).10  They may also be possible 
precursors towards the rational synthesis of these new carbon allotropies.10  Despite several 
attempted synthetic endeavors, no beltene and cyclacene has been synthesized yet.  Only recently,  
has a new family of fully conjugated cyclophenacene derivatives been synthesized from C60 
fullerene.11-13   
 
               [n]Beltene                 [n]Cyclacene                  [2n]Collarene             
   
[10]Cyclophenacene “Vögtle Belt” 
                                             2.9                                            2.10 
Figure 2.2 Beltenes and their related macropolycycles 
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Figure 2.3 Single-wall carbon nanotubes and fullerenes with their belt-like 
substructures.10 (Taken from reference 10 without permission) 
2.2.2 Syntheses of Beltenes and their related macropolycycles 
Synthetically, most of the beltene derivatives were constructed by Diels-Alder reactions 
of rational designed dienes and dienophiles. Diels-Alder adducts were then further converted to 
their partially aromatized derivatives towards beltenes or cyclacenes. Other approaches such as  
dearomatization of specific regions of fullerenes11-13 or metal-templated synthesis14, 15 were also 
applied in some cases. 
2.2.2.1 Diels-Alder approach 
A sequence of Diels-Alder reactions is a powerful method to construct macropolycycles. 
At least two Diels-Alder reactions are required for cyclization. Adducts in the first Diels-Alder 
reaction are converted to an intermediate with right-oriented new diene and dienophile moieties 
to undergo a second intramolecular Diels-Alder reaction.  In Scheme 2.1, the diene of a 
thiophene dioxide reacted with a curved bisdienophile in the first Diels-Alder reaction to form 
endo- and exo-monoadduct. Both adducts would undergo in situ reverse chelotropic reaction to 
furnish a new diene moiety. However, only endo-isomer underwent a second Diels-Alder 
reaction to give [3]beltene derivative 2.11 since the new formed diene was close to the other 
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double bond, while in exo-adduct two Diels-Alder components were away from each other.16  In 
another example, a sequence of three Diels-Alder reactions was applied to give a [4]beltene 
derivative 2.12.17 
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Scheme 2.2 
Either the intermolecular Diels-Alder reaction of a bisdiene (AA-type, A: acceptor) with 
a bisdienophile (BB-type, B: donor) or dimerization of an AB-type monomer can be applied to 
construct larger beltene derivatives. Representative works have been done in three research 
groups: Cory’s group, Stoddart’s group, and Schlueter’s group. 
In Cory’s group, an AA-BB type intermolecular double Diels-Alder cyclization of the 
bisdiene 2.13 and bisquinone 2.14 was applied to construct [8]beltene derivative 2.15. The yield 
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was as high as 69% in refluxing dioxane. Derivatization of Diels-Alder adduct 2.15 led to 
hexaone 2.16. However, further efforts to make fully conjugated [8]beltene derivatives      
failed.18, 19 
A typical example of AB type Diels-Alder cyclization was the construction of a belt-like 
backbone of fullerene C84(D2) by Schlueter and coworkers.20  The dimerization of an AB type 
curved monomer exo-2.17 or endo-2.17 generated in situ from different isomers of 2.18 in the 
refluxing toluene gave the same cyclized dimer 2.19 in a yield of 45% and 25% respectively. The 
difference of yields could be rationalized by comparing the different orientation of monomers 
during cyclization. For the endo-2.17, cyclization underwent two sequential Diels-Alder 
reactions of the diene and dienophile moieties in exo-orientation. While in case of exo-2.17, two 
sequential Diels-Alder reactions are through endo-pathway, which is energetically more 
favorable.  
 
 
Figure 2.4 
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Stoddart’s synthesis of Kohnkene gave another elegant example of how controlled and 
predictable Diels-Alder reactions were used to construct a macropolycyclic ring. The 
bisdienenophile 2.20 and bisdiene 2.21 showed high face selectivity.  Their high selectivity is 
related to the relative electron densities of two faces inherent in their rigid structures.21 
Cycloaddition of 2.20 favors the exo-face with higher electron density. While in bisdiene 2.21, 
cycloaddition prefers from the endo-face with lower electron density.  If both faces of diene and 
dienophile are considered, only one major 1:1 adduct 2.22 is formed out of four possible isomers.  
Similarly, by changing the ratio of starting materials, 1:2 adduct 2.23 or 2:1 adduct 2.24 would 
be obtained as the major product.  The iterative DA reactions from different combination of 
intermediates in the same way finally gave the Kohnkene 2.25. 
 
Scheme 2.3 Construction of Kohnkene utilizing face-selectivity of 
dienophile 2.20 and diene 2.21 
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The transformation of Kohnkene 2.25 towards fully conjugated cyclacene and beltene 
through a sequence of reductive aromatization, dehydration, and reduction was stopped at 
[12]collarene 2.29 (Scheme 2.4).21   
 
Scheme 2.4 Transformation of Kohnkene 2.25 towards [12]beltene 2.30.21 (Taken from 
reference 21 without permission) 
2.2.2.2 Dearomatization of fullerene C60, a substructure-directed synthesis of [10]cyclophen-
acene derivatives  
In Nakamura group, several fully conjugated [10]cyclophenacene derivatives have been 
recently synthesized by dearomatizing  specific regions of C60, e.g. the north pole and south 
pole.11-13 When an organocopper reagent was used, fullerene C60, a 60 π conjugated system, was 
successfully converted to 50π system 2.32.  After protection of an acidic proton, a second 
organocopper addition reaction was applied to transfer 2.32 to a 40 π system 2.33. Then after 
deprotection, a hydrocarbon derivative of [10]cyclo-phenacene 2.35 was synthesized (Scheme 
2.5).11 Further structure modification led to a double-decker buckyferrocenes, in which 5-
membered ring in north pole and south pole were complexed with iron(II), while the 
cyclophenacene equator remained intact.13  Since [10]cyclophenacene is a substructure of C60, 
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this approach  is a “substructrue-directed synthesis” corresponding to a ‘substrate-directed 
synthesis”of Kohnkene named by Stoddart.21 
 
Scheme 2.5 Synthesis of a [10]cyclophenacene from C60. (Taken from reference 11 
without permission) 
2.2.2.3 Metal templated approach 
 
Scheme 2.6 Synthesis of a CpCo-complexed conjugated beltene.14  (Taken from 
reference 14 without permission) 
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Very recently, a new structure of fully conjugated beltenes has been synthesized by 
Gleiter and coworkers.14  The rigid cyclic diyne 2.36, when irradiated with 254 nm UV light, 
underwent trimerization in the presence of CpCo(CO)2 with a yield of 14%. The mechanism may 
be a first step dimerization of 2.36 giving a curved intermediate 2.37. When the third molecule of 
2.36 was added to 2.37, the newly formed CpCo group was installed on the exo-face because of 
steric hindrance of the endo-face. So the open-chain trimer 2.38 has more curved structure to 
allow two ends close enough for cyclization. Increasing the size of CpCo group by substitution 
on the Cp ring gave improved yields of cyclization up to 41%.14 
2.2.3 Potential applications of Beltenes and their related macropolycycles 
Beltenes and related macropolycyclic compounds contain unique belt-shaped topology. 
Their bent surface provides interesting system to study bending π orbitals.22 Moreover, the inner 
cavity with regularly oriented π orbitals in a circular pattern makes them new attracting hosts or 
receptors.23, 24 They also may be potential precursors for rational syntheses of carbon nanotubes 
or fullerenes.10  
2.2.3.1 Interesting systems for study behavior of bent p-orbitals. 
 
Figure 2.5 Conjugation in curved versus planar surfaces  (Taken from reference 10 
without permission) 
One distinguished structural feature of beltenes and related macropolycycles is that they 
contain p orbitals perpendicular to a curved surface, where conjugation and strain effect 
counteract with each other. Conjugation effect causes the molecule to adapt plane configuration 
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for maximum overlaps of orbitals, while the strain inherent in the molecule lowers the degree of 
conjugation by reducing overlaps. The interaction between the two effects varies from system to 
system. A study on a series of [n](2,7)pyrenophanes (Figure 2.6, the left structure) with a 
distorted pyrene ring showed that only a small amount of conjugation energy was lost over a 
wide range of bend.25  However, in a “picotube” molecule, strain greatly changes conjugation 
pattern. Although it may be looked upon as four anthracenes connected by single bonds, it is best 
described as double-bond-joined 1,4-cyclohexadiene.26 Thus, it would be interesting to study 
interaction between the two effects in [n]cyclacene for their tunable strain with different numbers 
of n. For beltene systems, double bonds are separated from each other and no normal conjugation 
is present, but columnar homoconjugation by through-space interactions of π–orbitals may apply 
to beltenes.  
 
Figure 2.6 A series of [n](2,7)pyrenophanes  with distorted pyrene ring synthesized by 
Bodwell and coworkers25, 27-29  and a picotube synthesized by Herges and coworkers.26 
2.2.3.2 Host-guest chemistry of beltenes. 
 
Figure 2.7 a) Binding energy ratios of various [n]beltene-cation complexes. b) Various 
cations captured by [n]beltenes ( Li+, Na+, K+, Rb+, and Cs+ are captured by [5], [6], [7], [8], and 
[9]beltene, respectively) 24  (Taken from reference 24 without permission) 
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When beltene structures were first proposed by Alder and Session,9 they were referred to 
as a potential cavity-based host. Based on MM2 calculation, [9]beltene is a good host for 
acetylene.  Other molecules may be also combined specifically in the cavity by suitable 
derivatization of beltenes.9 Since the exact structure of beltene has not been synthesized, the only 
way to study their potential property is by theoretical calculation.  
Recently, theoretical works done by Choi showed collarenes24 and beltenes38 may be 
good ionphores based on cation-π interaction. Beltenes have finer ion selectivity than 
collarenes.38 ( Figure 2.7 ) From the calculated ion binding energy,  it was shown that [5]beltene 
is specificly combined to Li+, [6]beltene to Na+, [7]beltene to K+, [8]beltene to Rb+, and 
[9]beltene to Cs+. 
2.2.3.3 As potential precursors for carbon nanotubes or fullerenes. 
Carbon nanotubes and fullerenes, since their discovery in the early 1990’s,30-32 have been 
an active research area, mainly due to their remarkable physical properties as new materials and 
molecular electronic devices. However, current arc-discharge methods or similar methods can 
not control the synthesis of these new carbon allotropies and greatly limit their application.33  
The rational synthesis of carbon nanotubes and fullerenes from smaller organic ring- or belt-like 
motifs may provide the alternative route to them.10 Pioneering work on the rational synthesis of 
C60 from polyarene has been achieved despite low yields.34, 35 Although synthesis of carbon 
nanotubes from beltenes and related macropolycylces has not been realized yet, it is likely to be 
achieved in future since many other tube-like structures have been assembled from belt-shaped 
macrocycles.7  
2.3 Synthetic studies towards a macropolycyclic [10]beltene derivative 
2.3.1 Previous work in our lab 
2.3.1.1 Synthesis of diene component dimethyl 1,3-butadiene-2,3-dicarboxylate (2.5). 
Dimethyl 1,3-butadiene-2,3-dicarboxylate (2.5) was used as a potential bisdiene 
components for synthesis of [10]beltene derivative 2.4. Two ester groups would later be 
transformed to a diene component for another Diels-Alder reaction.  It was synthesized in three 
steps either from commercially available 2,3-dimethylmaleic acid anhydride (2.40) or methyl 2-
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bromopropionate (2.43)3 as shown in Scheme 2.7. In route I,2 the acid anhydride 2.40 was first 
methylated in refluxing methanol with a catalytic amount of sulfuric acid to afford quantitative 
yield of 2,3-dimethylbutenedioic acid dimethyl ester 2.41a. A subsequent photo induced radical 
bromination using azo-bis isobutyronitrile (AIBN) as radical initiator and N-bromosuccinimide 
(NBS) in tetrachloro methane would afford a mixture of cis-/trans- dibromide 2.42a and 2.42b in 
a yield of 90%. Then the mixture of dibromide underwent reductive elimination with potassium 
iodide and sodium thiosulfate in refluxing acetone to give diene 2.5 in 83% yield. Route II was 
only different in the first step of making dimethyl ester.3 The two isomers of diester 2.41a and 
2.41b instead of one isomer in route I, was synthesized in 96% yield by copper mediated ester 
couplings with lithium diisopropylamide(LDA) in THF. The mixture of two diesters was then 
used for the bromidation and elimination to form diene 2.5. Route II was better for large scale 
synthesis since the starting material 2.40 used in route I is expensive.    
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Scheme 2.7 Synthesis of 1,3-butadiene-2,3-dicarboxylate (2.5) 
2.3.1.2 Synthesis of tetraol (2.48). 
 Synthesis of tetraol (2.48) was first accomplished by Xiaodong Huang in our lab starting 
from Diels-Alder reaction of triptycene bisquinone (2.2) and diene 2.5.2 The synthesis of 
triptycene bisquinone would be discussed later in Chapter 3. The Diels-Alder reaction with 
excess amount of diene 2.5 surprisingly gave only one diadduct in a yield of 87%, which was 
ascribed to a combination of steric effects and secondary orbital interactions (Reference3, Page 
92).  The explanation was not satisfactory, since the quinone ring is sterically not much 
difference compared with benzene ring. Besides, after the first equivalent of diene was added to 
triptycene bisquinone 2.2, there would certainly be an increase in the steric hindrance of endo-
face and reduce face-selectivity of a second diene molecule. How could the face-selectivity of 
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the second Diels-Alder reaction remain the same? The so-called through-bond homoconjugation 
between two quinone rings may be the predominant reason (Figure 3.7).  The p-orbitals of 
quinone rings on the endo-side of triptycene bisquinone 2.2 have more overlap than those on the 
exo-side. In other words, the two quinone rings are somehow “conjugated” in a curved surface 
with concave endo-face having more conjugation than convex exo-face. Since a quinone moiety 
is an electron withdrawing group, the endo-face is more electron-deficient than exo-face, thus a 
better dienophile. The structure of 2.44 was proved by X-ray crystallography.  
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Scheme 2.8 Synthesis of tetraol 2.48 
The next step was reducing ketones in Diels-Alder adducts 2.44 to tetraol 2.45 in 81% 
yield by treating with sodium borohydride and cerium chloride in methanol at 0oC. The hydride 
was added from less hindered exo-face. The hydroxyl groups in 2.45 had to be protected for 
further reduction of ester function group. Only two diagonal hydroxyl groups can be protected by 
bulky t-butyldimethylsilyl (TBDMS) group due to the crowd conclave face. The protected 
product 2.45 was isolated in 70% yield using TBDMSOTf as silylation reagent and triethyl 
amine as base in methylene chloride at 0oC. After protection, two consecutive reductions by 
magnesium in methanol and lithium aluminum hydride in THF finally gave the tetrol 2.48 in 
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78% yield of two steps. The structure of 2.48 was verified by X-ray crystallography. 
Interestingly, all the hydroxymethyl groups are pointing to the exo-face.  
2.3.1.3 Formation of tetraene (2.51) 
Synthesis of tetraene (2.51) was accomplished by Neil Brown, who continued on the 
beltene project starting from the tetraol 2.48.3 The previous study by Xiaodong found that the 
conversion of tetraol 2.48 either to tetrabromide and tetratosylate failed to give tetraene 2.50 due 
to terminal furan ring formation.2 Neil found that treatment of tetraol 2.51 with o-
nitrophenylselenocyanate and tri-n-butyl phosphine in anhydrous pyridine at 65oC for 3 hours 
would afford the tetraselenide 2.49 in almost quantitative yield.(reference3, page 99) However, 
the yield of selenization varied from batch to batch depending largely on condition of solvent 
and reagents. Then tetraselenide 2.49 was oxidized by m-chloroperoxybenzoic acid (mCPBA) to 
tetraselenoxide, which underwent elimination in situ to form tetraene 2.50 in a yield of 65%. 
Since the bulky t-butyldimethylsilyl (TBS) group may prevent final cyclization, it was removed 
by tetra-n-butyl ammonium fluoride (TBAF) to afford the tetraene 2.51 in 63% yield.  The 
crystal structure was later proved by X-ray when I took over the project.  
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Scheme 2.9 Synthesis of tetraene 2.51 
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2.3.1.4 Preliminary Diels-Alder reaction studies 
 After the synthesis of tetraene 2.50 and 2.51, Neil Brown explored the Diels-Alder 
reaction of them. The preliminary results showed there were mainly two problems associated 
with the Diels-Alder reaction in order to get cyclized Diels-Alder adduct. One was the 
competition of polymerization and intramolecular cyclization when tetraene (2.50 or 2.51) and 
triptycenebisquinone (2.2) were used in DA reaction, since NMR data of crude Diels-Alder 
reaction mixture showed unidentified broad peaks which indicated possible formation of 
oligomers or polymers. This problem could be solved by a stepwise strategy through a triene 
2.55, in which only one end can react with dienophile. Then the 1:1 adducts from Diels-Alder 
reaction were separated and further functional transformation was applied to convert the other 
end to diene. This detour would afford 1:1 adducts of tetraene with dienophile for further 
cyclization under high dilution condition (Scheme 2.12). 
 
Scheme 2.10 Synthesis of triene 2.55 
 The synthesis towards triene 2.55 was carried out by Neil Brown up to one isomer of 2.54. 
First protection of one hydroxyl group on 2.48 gave a mixture of two possible triols 2.52a and 
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2.53b in 26% yield together with over-protected diols and unreacted starting material 2.48. Then, 
selenization of triol 2.52 in similar conditions as that of tetraol 2.48 gave a mixture of two isomer 
2.53a and 2.53b in 62% yield, which was partially separable in column chromatography. The 
less polar spot is likely 2.53b due to the relative upshift of side-TBS group in 1HNMR. (In Neil’s 
thesis, the assignment of structure 2.53a and 2.53b to their NMR spectra may not be correct.) 
Further oxidation of a mixture of 2.53a and 2.53b afforded a mixture of 2.54a and 2.54b in a 
yield of 61% according to Neil’s thesis (reference,3 page 109). However, as was later found out, 
only the less polar isomer of 2.54 was actually separated by Neil Brown. The impurities inside 
the sample gave over-estimated yield. That might be the reason he thought there were two 
isomers inside it. Based on 1H NMR, the less polar isomer is most likely 2.54a and the more 
polar isomer is 2.54b since the side TBS group is more congested in 2.54a so that more Si-Me 
peaks are found in 1HNMR spectrum due to rotation restriction. The Diels-Alder reaction of the 
more polar isomer of 2.54 with triptycene bisquinone 2.2 did give 1:1 monoadducts, which was 
verified by both NMR and MS spectroscopy (reference,3 page 109). Since Diels-Alder reaction 
of dienophile triptycene bisquinone is endo-face selective while triene 2.55 is likely not, the 
observed two adducts were most likely exo-endo-adduct (2.56) and endo-endo-adduct (2.57).  
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Scheme 2.11 Possible adducts of triene 2.54a and triptycene bisquinone 2.2 
 Based on above preliminary data, Neil proposed a synthetic route to cyclized adduct 2.60 
(Scheme 2.12). The 1:1 adducts 2.58 would follow a sequence of selenization, oxidation, and 
elimination to generate the other diene moiety for cyclization. Apparently, the quinone moiety 
could not stand selenization condition due to 1.4-addition of phosphine to quinone rings, which 
makes this route difficult to realize unless there are extra steps of protection and deprotection of 
quinone rings. 
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 The other problem was the determination of steorochemsitry of Diels-Alder adducts. The 
successful cyclization depended on the closeness of diene and dienophile moiety. The exo-endo 
adduct 2.56 might undergo cyclization later after generation of a new diene, while endo-endo 
adduct could not because the two ends are opposite to each other. Thus the stereochemistry of 
Diels-Alder adducts is very important for cyclization. However, it could not be differentiated 
from 1H NMR spectra, which made the identification of those adducts becoming a difficult issue. 
For example, in a model reaction, when tetraene 2.51 was reacted with an excess amount of 1,4-
benzoquione, only “one” major diadduct was formed as indicated from one set of protons in 1H 
NMR spectrum. However, we can not tell from 1H NMR whether it is an endo-adduct and exo-
adduct. (reference,3 page 105) The only way to know whether the desired adduct was formed is 
through crystallography. A crystal needs to be prepared, which is not available in many cases.  
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Scheme 2.12 Proposed synthesis of cyclized adduct 2.60 (reference,3 page 111). 
2.3.1.5 Summary 
 After many years of continuous work, tetraene 2.51 was finally synthesized. The next job 
was to cyclize it with triptycene bisquinone or another dienophile to make cyclized beltene 
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derivatives. The major challenges included undetermined structures of Diels-Alder adducts, 
unfavorable oligomerization, and uncertain cyclization prospects.   
2.3.2 Continuous work towards a macropolycyclic [10]beltene derivative 
2.3.2.1 Unsuccessful installation of diene and dienophile in one molecule through triene 2.55   
 In previous work, a triene 2.55 was designed to achieve the installation of both diene and 
dienophile moiety in the same molecule. I started working on this project by following the route 
proposed in Scheme 2.12.  
The deprotection of TBDMS group was easily achieved by stirring a mixture of two 
isomers, 2.54a and 2.54b, with 3.6 equivalent of TBAF in THF at room temperature for 3 hours. 
The deprotected pentiol-triene 2.55 was obtained in 86% yield  
The attempted Diels-Alder reaction of deprotected triene 2.55 with triptycene bisquinone 
2.2 in refluxing 1,2-dichloroethane gave mainly unidentified polymer-like products together with 
1,4-anthracenedione and recovered starting material 2.2, which indicated decomposition or 
polymerization might happen under reaction conditions. A more reactive dienophile is needed to 
be found to react with triene 2.55 which took painfully nine steps to make from triptycene 
bisquinone 2.2. 
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Since both triptycene bisquinone 2.2 and triene 2.55 have unsymmetrical exo/endo-faces, 
problems arouse in identification and separation of different adducts. We resorted to symmetric 
planar bisquinone 2.64. In this case, the double-activited inner double bond reacts first with 
diene moiety and particular symmetry gave only one adduct even the diene moiety has two 
different faces. Also, the Diels-Alder reaction of 2.64 can happen at a much lower temperature 
because of its double-activitied nature. 
The 1,4,5,8-naphthodiquinone(NDQ) 2.64 was synthesized according to literature 
procedure.36 1.4-dimethoxybenzene was heated with 2.62 in melting salts AlCl3 and NaCl at 190 
oC to afford 5,8-dihydroxynaphthalene-1,4-dione 2.63 in 20% yield, which was further oxidized 
by ditrifluoroacetyl-iodobenzene to give NDQ 2.64 in 66% yield. 
Diels-Alder reaction of triene 2.55 and bisquinone 2.64 happened at room temperature in 
1,2-dichloroethane to give Diels-Alder adduct 2.65 in 82% yield. So far, we have bypassed the 
face-selectivity problem to afford only one adduct. However, the attempted selenization of 2.65 
failed to give expected monoselenide 2.66 for later elimination and generation a new diene 
moiety. The possible reason might be the incompatibility of cyclohex-2-ene-1,4-dione moiety in 
the reaction conditions. The synthetic route towards a possible cyclization precursor through 
triene 2.55 was finally abandoned.   
2.3.2.2 Successful installation of diene and dienophile in one molecule with failed cyclization   
 The successful synthesis of Diels-Alder adduct 2.65 made us believe that in similar 
conditions, tetraene 2.51 should form similar monoadduct 2.67 with double activated bisquinone 
2.64  by carefully controlling the ratio of starting materials.  
 When the tetraene 2.51 was stirred with 0.6 equivalent of the bisquinone 2.64 in 1,2-
dichloroethane, monoadduct 2.67 was obtained in 33% yield together with diadduct 2.68 and 
recovered tetraene. The monoadduct has diene moiety at one end and cyclohex-2-ene-1,4-dione 
moiety at the other end as the dienophile. The intramolecular cyclization would be expected to 
happen when heated in a high dilution condition at raised temperature.  
 However, when a solution of 0.001M of 2.67 was heated in refluxing benzene, no 
identifiable cyclized product 2.69 was separated. Even if the cyclization happened, the yield was 
too small to identify. One possible reason might be the dienophile in the 2.67 was not reactive 
enough for cyclization in low temperature, while raised temperature caused polymerization.  
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 We then resorted to a double-activated quinone 2.70. The quinone 2.70 contains two 
double-activated Diels-Alder reaction sites. The monoadduct 2.71 would expect to have a much 
more active dienophile moiety for intramolecular Diels-Alder cyclization even at room 
temperature (Scheme 2.15). 
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 However, only monoadduct 2.71 and diadduct 2.72 were separated when tetraene 2.51 
and dienophile 2.70 was stirred in 1,2-dichloroethane at room temperature. No cyclized product 
2.73 was separated. From 1H NMR, both 2.71 and 2.72 contain one set of peaks, which mean 
they most likely consisted of one compound. However, the actual endo- or exo- conformation 
was hard to determine. If only steric effects were considered, the less hindered exo-face of 
tetraene 2.51 was preferred in Diels-Alder reaction, so 2.71 was more likely exo-adduct, which 
could not be cyclized.  When compound 2.71 was slowly heated to a higher temperature from 50 
oC to 80 oC in benzene, an undetermined product was formed. The possibility of being 2.73 was 
excluded by MS spectrum. 
2.3.2.3 Isomerization of tetraene 2.51 
Frustrated by failure of cyclization by Diels-Alder reaction strategy, we started to look 
for other cyclization strategies.  When tetraene 2.51 was heated with 1st generation Grubb 
catalyst in refluxing 1,2-dichloroethane overnight, a small amount of 2.74 was separated. We 
later found that 2.74 was one major product (61%) when tetraene 2.51 was heated in 150oC alone. 
The structure was proved by X-ray crystallography. To our surprise, diagonal hydroxyl groups 
added to the nearest double bond to form furan rings.    
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Scheme 2.16 
2.3.2.4 Summary 
Although instability of tetraene 2.51 and unsuccessful cyclization by Diels-Alder reaction 
gave this project a dim prospect, a new chiral clip-shaped molecule 2.74 was synthesized.   
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2.4 Discussions and conclusion 
2.4.1 Requirement for successful cyclization 
Failed cyclization of tetraene 2.51 raised a question about what are important factors for 
successful cyclization by Diels-Alder reactions. A thorough literature research was done and a 
list of successful examples of AA-BB type cylization and AB type cylization are listed in Table 
2.1 and Table 2.2.  It seems that all successful cyclization of Diels-Alder reactions were based 
on rigid or slightly flexible Diels-Alder components with both reacting ends parallel or nearly 
parallel to each other. Apparently, this would help to bring the remaining diene and dienophile 
close to each other after first Diels-Alder reaction. On the contrary, the two diene components in 
the tetraene 2.51 are twisted in an angle because of preferred chair conformation of cyclohexane 
rings (Scheme 2.16). After the first Diels-Alder reaction, the attached quinone moiety extended 
from one diene end are actually even more far away from the other diene moiety.  
 DA precursors Product Reaction condition and yields
I 
n-C6H13
n-C6H13
n-C6H13
n-C6H13
O
O
O
O  
n-C6H13
n-C6H13
C6H13-n
C6H13-n
O O
O O
H
H
H
H
H
HH
H
Dioxane, reflux, (high 
dilution condition)  
Yield: 69% 19 
II 
O
O
O
O
O
O
 
O
O
O
O
O
O
 
Toluene, reflux, 7h, yield: 
69%21 
III O
O
O
O
O O  
O
O
O
O
O
O
 
CH2Cl2, PTFE high-pressure 
reaction vessel, 10kbars, 
200h, 55-60oC 
yield: 20%21 
IV 
O
O
O
O
O
O
O
 OO
O
O
O
O
O
 
Toluene, reflux, 12h 
Yield:78%21 
Table 2.1 Successful cyclization from AA-BB type Diels-Alder reactions in literature. 
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 DA precursors Product Reaction condition and yields 
I 
O
O
  
110oC, yield: 23% to 70% 
depending on  the 
concentration37, 38 
II O
O O O
O
O
O
O
O
 
1)Xylene, reflux, 48h, yield: 
3.6% 
2) CH2Cl2, PTFE high-pressure 
reaction vessel, 18kbars, 72h, 
50oC, yield: 48%21 
III 
 
O
O
R
R
 
O
O
O
O
R
R
R
R
1) Toluene, reflux, yield:25% 
2) Neat, 200oC, high-
vacuum(0.02mbar), 1h 
endo-syn: no cyclization 
product observed. 
endo-anti:  
yield 10%20 
IV 
O
O R
R
 
O
O
O
O
R
R
R
R
1) Toluene, reflux, 2d,  
exo-syn:  
yield:43% 
2) Neat, 200oC, high-vacuum 
(0.02mbar), 1h 
exo-syn:  
yield: 40%20 
V 
O
O
O
O  
Toluene, reflux, 60h, open-
chain and cyclized trimer 
together, 
yield: 6%39 
Table 2.2 Successful cyclization from AB type Diels-Alder reactions in literature. 
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An MM2 molecular modeling was done for exo-endo adduct of triptycene bisquinone 2.2 
with the tetraene 2.51 and the minimized energy conformations were shown in Figure 2.8. Since 
the calculated conformation for tetraene agreed pretty well with X-ray structure, (shown in 
Scheme 2.9) we believed structures calculated by this method are quite close to real ones. For 
exo-endo adduct 2.75 and its enolised derivative 2.76 which was once believed to have better 
orientation of diene moiety and quinone moiety for cyclization, the belt region is curled in a 
spiral fashion so that the diene moiety and quinone moiety are pointing away from each other. In 
order to bring two ends parallel to each other for Diels-Alder cylization, cyclohexane rings 
within 2.75 and 2.76 have to be all boat conformation, but this is both statistically unlikely and 
energetically unfavorable to occur. The conclusion drawn from molecular modeling was 
supported by experimental results that Diels-Alder reaction of 2.51 and 2.2 gave unidentified 
mixture oligmers and polymers, since monoadducts continued to react with starting materials in 
reaction conditions. It is also unlikely for twisted two ends of monoadduct 2.75 to undergo 
dimerization-cyclization for the same reason.  
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Figure 2.8 Molecular modeling (MM2) of minimized energy conformation for exo-endo-adduct 
of triptycene bisquinone (2.2) and tetraene 2.51. (The two ends were colored yellow for clarity.)  
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Similar MM2 molecular modeling study was done for monoadduct 2.67.  Again, the 
molecule encounters a problem of twisted diene and quinone moiety. Besides, the concave 
skeleton of 2.67 is two cyclohexane rings smaller than 2.75, which makes it less likely to bring 
the two ends close to each other to undergo intramolecular Diels-Alder reaction. The calculation 
matches with experimental findings in that the cyclized product was not detected. 
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Figure 2.9 Molecular modeling (MM2) of minimized energy conformation for monoadduct 2.67. 
(The two ends were colored yellow for clarity.) 
 In conclusion, three important requirements are learned from both unsuccessful ring 
closing reactions and molecular modeling analysis for the design of building blocks to construct 
a macropolycycle by Diels-Alder reactions. First, diene unit and/or dienophile need to parallel to 
each other in the building blocks. Second, it would be better for dienes and dienophiles to have 
right face-selectivity to minimize the number of possible Diels-Alder adducts (as in the case of 
Kohnkene). Otherwise, Diels-Alder adducts would be able to easily differentiate from each other 
(such as “inherent 1HNMR structural indicators” discussed in Chapter 3).   Third, for the final 
cyclization, the intramolecular diene and dienophile moieties should be close to each other and in 
correct alignment in space. Fulfilling the above three requirements, a functionized 
cyclododeciptycene was successfully synthesized in Chapter 3.    
2.4.2 Conformation communication inside tetraene 2.51  
 Conformation transduction or communication has been reported and studied for 
tetrasubstituted cis-decalins and perhydroanthracenes (Figure 2.10).40-44 When the conformation 
of one side of a molecule is changed upon a signal stimulus, conformation of the opposite side is 
changed accordingly. Unexpected intramoleucular furan formation of tetraene 2.51 in diagonal 
fashion leading to compound 2.74 led us wonder whether conformations in the two sides of 
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tetraene 2.51 communication with each other. In other word, one conformation in the right side 
would affect the conformation in the left side to adopt predominantly a specific conformation 
and vice versa. 
 
Figure 2.10 Conformation transduction of cis-decalin41 and perhydroanthracene42.  
2.4.2.1 Conformation of tetraene 2.51 in crystal and solution 
We first examine the X-ray structure of tetraene 2.51 shown in Figure 2.11. It is a low 
energy conformation of the molecule in crystalline form. Conformations of B, C, and D rings are 
shown in different views. B ring and D ring clearly adopt pseudo-chair conformations with a C2 
symmetry instead of CS symmetry, which can be explained based on an assumption that a rigid 
o-benzono-bridged 1,4-cyclohexadiene (C ring) responds to ring strain from one side by slightly 
adjusting conformation of the other side to minimize its total strain energy. In other words, 
conformations of B and D ring communicate with each other via the C ring. If B ring adopts the 
pseudo-chair conformation shown in Figure 2.11, it causes a clockwise twist in the right side of 
C ring with 13a-carbon atom, a tendency of moving downwards, and 5a-carbon atom, a tendency 
of moving upwards, and because of rigidity of C ring, the other side of C ring adjusts its twist in 
opposite direction to release ring strain with 6a-carbon atom moving downwards and 12a-carbon 
moving upwards. D ring “feels” this movement and adjust its conformation to adopt 
corresponding pseudo-chair conformation. 
Based on X-ray structure, groups in axial positions and equatorial positions should show 
different NMR signals. However, 1H NMR spectrum of tetraene 2.51 taken at room temperature 
showed no splitting of diastereomeric hydrogens. A rapid conformation interconversion in 
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solution may have taken place, in which axial groups in one pseudo-chair conformation become 
equatorial groups and vice versa (Figure 2.12). During conformation interconversion of tetraene 
2.51 from conformation (I) to conformation (II) or vice versa, transformations of BD rings keep 
communicating with each other. So when the conformation of B ring changes from one pseudo-
chair conformation to the other, the conformation of D ring changes accordingly. 
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Figure 2.11 BCD ring conformations in X-ray structure of tetraene 2.51. 
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Figure 2.12 Conformation communications of B&D rings during conformation change of 2.51.  
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2.4.2.2 Conformation lock by bulky TBS group: 1HNMR analysis of protected tetraene 2.50  
At room temperature, conformation (I) and conformation (II) of tetraene 2.51 undergo 
rapid interconversion in the NMR time scale.  However, if a bulky group is introduced and 
prefers an equatorial position, it would “lock” the molecule to one conformation. In this case, 
hydrogens in axial position and equatorial position shall show different chemical shifts.  
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Figure 2.13 Predicted ABCDE ring conformations of protected tetraene 2.50 in solution. 
 According to the above model, two bulky OTBS groups in compound 2.50 can only 
occupy equatorial position (7 and 14). The predicted conformation of 2.50 is shown in Figure 
2.13. Protons in AE rings should have different chemical shifts and a total of six different sets of 
peaks would be observed. The splitting pattern of each proton can be predicted from coupling 
constants with its neighboring protons. For example, axial proton in carbon-1 has two 
neighboring protons; one is an axial proton on carbon-14a with a large coupling constant about 
8~14 Hz; the other is an equatorial proton on the same carbon with a geminal coupling constant 
about 12~18 Hz.  It shows a triplet with an average J = 13.6 Hz in the spectrum. For equatorial 
proton on carbon-1, the coupling constant with axial proton on carbon-14a is small (2~3 Hz) and 
the geminal coupling constant with axial proton on the carbon-1 is larger (12~18 Hz). It shows a 
doublet with J = 14.8 Hz in spectrum. Similarly, all the other protons in AE ring can be assigned 
based on the predicted conformation shown in Figure 2.13. Although 2D-NMR studies of 2.50 
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are needed to further verify the assignments, the successful prediction of 1H NMR by 
conformation analysis supports the conformation communication model mentioned above.  
 
Figure 2.14 Proton assignments of protons in AE rings in 1HNMR (δ 1.7~2.8) of 2.50 
2.4.2.3 Conformation lock by furan ring formation: formation of compound 2.71. 
 Based on the above model, the diagonal feature of intramolecular furan ring formation in 
tetraene 2.51 at 150oC can be explained. When the axial hydroxyl group in B ring adds to the 
C=C at γ position because of space closeness, the conformation of B ring is locked, which causes 
D ring to adopt a preferred pseudo-chair conformation to reduce the strain of C ring. The 
preferred pseudo-chair conformation of D ring, with an axial hydroxyl group being diagonal to 
the reacted hydroxyl group in B ring, facilitates the second furan formation to form compound 
2.71 (Scheme 2.16 and Figure 2.15). 
 
Figure 2.15 Conformation lock and communication leading to formation of diagonal furan rings. 
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2.4.2.4 Conformation transduction models incorporated with an o-benzono-bridged 1,4-
cyclohexadiene ring.  
In Figure 2.10, transformation transduction models are shown in such a way that if two 
same groups (such as A) in one side are brought close to each other, the other same groups in the 
other side (such as B) are brought far away from each other. Two groups are close together 
because they both occupy equatorial positions. If they both occupy axial positions, they are far 
away from each other. Similar models can be built for ring systems incorporated with a o-
benzono-bridged 1,4-cyclohexadiene ring as shown in Figure 2.16. The first model 2.77 is 
equivalent to perhydroanthracene model shown in Figure 2.10 except for the relative 
steorochemsitry of two sides.  In the second model 2.78, conformation transduction is conducted 
unprecedentedly through five rings.  
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Figure 2.16 Conformation transduction incorporated with an o-benzono-bridged 1,4-
cyclohexadiene ring 
Although the above models of conformation conduction or communication may seem 
reasonable, they are mostly empirical and descriptive. They raised more questions to be 
answered. Currently, no detailed calculations regarding to energy differences of all possible 
conformations of tetraene 2.51 have been studied. The detailed function of o-benzono-bridged 
1,4-cyclohexadiene ring is also unclear.  
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2.5 Experimental Section 
General Methods: Nuclear magnetic resonance spectra were obtained at Varian Unity 
Plus (400 MHz) and Varian Gemini 2000 (200 MHz).  Mass spectra were taken from a Hewlett 
Packard 5890A Series II, GC-MS and a Bruker Esquire 3000 Plus electrospray ionization mass 
spectrometer. FAB spectra were taken by using Xe beam (8 KV) and m-nitrobenzyl alcohol as 
matrix. Silica gel (200~400 mesh) from Natland International Coporation was used for the flash 
chromatographic separation. THF and diethyl ether were distilled over sodium and 
benzophenone. Methylene chloride was distilled over CaH2. Toluene and benzene were distilled 
over LiAlH4. 
2.5.1 Synthesis of tetraene 2.51 
2.5.1.1) (2R,3S,4aS,5S,7R,7aR,9R,10S,11aS,12S,14R,14aR)-5,12-Di(t-butyldimethylsilan-
oxy)-7,14-dihydroxy-2,3,9,10-tetra(2-nitrophenylselenyl)methyl-1,2,3,4,4a,5,6,7,7a,8,9,10, 
11,11a,12,13,14,14a-octadecahydro-6,13-o-benzenopentacene and its enantiomer  (2.49) 
OTBS
OH
HO
TBSO
CH2SePhNO2-o
CH2SePhNO2-o
o-O2NPhESH2C
o-O2NPhSeH2C
H
H
H
H
2.49  
To a solution of 290 mg (1.28 mmol) of o-nitrophenyl selenocyanate in 4 mL of dry 
pyridine was added 319 μL (1.28 mmol) of tri-n-butylphosphine. The resulting deep red solution 
was stirred at room temperature for 5 minutes. Then a solution of 100 mg (0.128 mmol) of 
tetraol 2.48 2 in 4 mL of dry pyridine was added via cannular.  The resulting solution was heated 
to 65 oC for 3 hours.  The reaction mixture was then cooled to room temperature and diluted with 
100 ml ethyl acetate.  The organic layer was washed with water (2 ×100 mL), brine (100 mL), 
dried over anhydrous magnesium sulfate, filtered, and concentrated by a rotavapor.  The residue 
was applied to column chromatography (silica gel) using dichloromethane and hexane (3:2) as 
eluent to give 190 mg (98% yield) of the title compound, 2.49, as yellow solids:  1H NMR 
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(CDCl3, 200 MHz) δ 8.2~8.3 (m, 4 H), 7.3~7.7 (m, 12 H), 7.18 (dd, J1 = 5.1 Hz, J2 = 3.3 Hz, 2 
H), 6.98 (dd, J1 = 5.1 Hz, J2 = 3.3 Hz, 2 H), 4.93 (s, 2 H), 4.50 (d, J = 7.0 Hz, 2 H), 4.27 (m, 2 
H), 3.0~3.3 (m, 4 H), 2.91 (m, 4 H), 2.43 (m, 2 H), 2.1~1.4 (series of multiplets, 12 H) 1.00 (s, 
18 H), 0.21 (s, 6 H), 0.10 (s, 6 H). 
2.5.1.2) (4aS,5S,6S,7R,7aR,11aS,12S,13S,14R,14aR)-5,12-Di(t-butyldimethylsilanoxy)-7,14-
dihydroxy-2,3,9,10-tetramethylene-1,4,4a,5,6,7,7a,8,11,11a,12,13,14,14a-tetradecahydro-
6,13-o-benzenopentacene and its enantiomer (2.50)  
TBSOHO
OH
OTBS
H
H
H H
2.50  
To a mixture of 20 mg (0.013 mmol) of tetraselenide 2.49, 11 mg (0.13 mmol) of sodium 
bicarbonate, and 43 μL (0.53 mmol) of pyridine in 4 mL methylene chloride at room temperature, 
was added 15.6 mg (0.063 mmol) of 70% m-chloroperbenzoic acid.  The reaction mixture was 
stirred overnight at room temperature and then diluted with 50 mL methylene chloride. The 
organic layer was washed with water (50 mL×2), brine (50 mL), dried over anhydride 
magnesium sulfate, filtered, and concentrated by a rotavapor. The residue was then applied to 
column chromatography (silica gel) using a gradient of petroleum ether and methylene chloride 
(3:2, V:V) to give 6.9 mg (74% yield) of the title compound 2.50: 1H NMR (CDCl3, 400 MHz) δ 
7.18 (m, 2 H), 6.94 (m, 2 H), 5.04 (m, 4 H), 4.95 (s, 2 H), 4.73 (bs, 2 H), 4.66 (bs, 2 H), 4.46 (dd, 
2 H, J1 = 6.4 Hz, J2 = 2.0 Hz), 4.25 (d, 2 H, J = 2.7 Hz), 2.70 (d, 2 H, J = 18.8 Hz), 2.42 (m, 2 H), 
2.30 (m, 2 H), 2.12 (t, 2 H, J = 14.0 Hz), 1.96 (m, 2 H), 1.78 (m, 2 H), 1.00 (s, 18 H), 0.25 (s, 6 
H), 0.15 (s, 6 H); 13C NMR (CDCl3, 100 MHz) δ 148.6, 148.4, 147.6, 146.8, 144.8, 124.0, 122.1, 
109.2, 108.1, 71.5, 69.1, 41.3, 37.1, 36.6, 30.2, 29.9, 26.3, 18.8, -4.2, -4.4;  MS: m/z: 733.589 
(M+Na)+. 
2.5.1.3) (4aR,5R,7S,7aS,11aR,12R,14S,14aR)-5,7,12,14-Tetrahydroxy-2,3,9,10-tetramethyl-
ene-1,4,4a,5,6,7,7a,8,11,11a,12,13,14,14a-tetradecahydro-6,13-o-benzenopentacene  (2.51)  
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HOHO
OH
OH
H
H
H H
2.51  
To a solution of 16.7 mg (0.0235 mmol) of tetraene 2.51 in 2.5 mL of THF at 0 oC (ice-
water bath) was added 56.4 μL (0.0564 mmol) of 1M tetrabutylammonium fluoride (TBAF) in 
THF. The reaction mixture was stirred at room temperature for 2 hours, diluted with 20 mL 
water and extracted with ethyl acetate (25 mL×2). The organic layer was then washed with 
water (50 mL) and brine (50 mL), dried over anhydrous magnesium sulfate, filtered, and 
concentrated by a rotavapor.  The residue was then applied to column chromatography using 
hexane and ethyl acetate (1:2, V:V) as eluent to give 10.1 mg (89 % yield) of the title compound, 
2.51, as white solids:  1H NMR (CDCl3, 400 MHz)  δ 7.28 (dd, J1 = 5.1 Hz, J2 = 3.3 Hz, 2 H), 
7.01 (dd, J1 = 5.1 Hz, J2 = 3.3 Hz, 2 H), 5.17 (s, 2 H), 5.09 (s, 4 H), 4.79 (s, 4 H), 4.55 (bs, 4 H), 
2.96 (bs, 4 H), 2.43 (m, 8 H), 2.00 (m, 4 H);  13C NMR (CDCl3, 100 MHz) δ 148.5, 147.0, 146.0, 
124.3, 122.6, 110.0, 70.7, 50.0, 38.6, 34.0; MS: m/z: 505.35 (M+Na)+. 
2.5.2 Synthesis of triene 2.55 
2.5.2.1) (2R,3S,4aS,5S,6S,7R,7aR,9R,10S,11aS,12S,13S,14R,14aR)-2-(t-Butyldimethylsilan-
oxy)methyl-5,12-di(t-butyldimethylsilanoxy)-7,14-dihydroxy-3,9,10-tri(2-nitrophenylselenyl) 
methyl-1,2,3,4,4a,5,6,7,7a,8,9,10,11,11a,12,13,14,14a-octadecahydro-6,13-o-benzenopenta-
cene and its enantiomer (2.53a) 
(2S,3R,4aR,5R,6S,7S,7aS,9S,10R,11aR,12R,13S,14S,14aS)-2-(t-Butyldimethylsilanoxy)- 
methyl-7,14-di(t-butyldimethylsilanoxy)-5,12-dihydroxy-3,9,10-tri(2-nitrophenylselenyl)- 
methyl-1,2,3,4,4a,5,6,7,7a,8,9,10,11,11a,12,13,14,14a-octadecahydro-6,13-o-benzenopenta- 
cene and its enantiomer (2.53b)  
To a solution of 93 mg (0.41 mmol) of o-nitrophenyl selenocyanate in 2 mL of dry 
pyridine was added 102 μL (0.41 mmol) of tri-n-butylphosphine. The resulting deep red solution 
was stirred at room temperature for 5 minutes. Then a solution of 49 mg (0.055 mmol) of triol 
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2.52a and 2.52b in 2 mL of dry pyridine was added via cannular.  The resulting solution was 
heated to 65 oC for 3 hours.  The reaction mixture was then cooled to room temperature and 
diluted with 50 ml ethyl acetate.  The organic layer was washed with water (2 ×50 mL), brine 
(50 mL), dried over anhydrous magnesium sulfate, filtered and concentrated by a rotavapor.  The 
residue was applied to column chromatography (silica gel) using a gradient of petrol ether and 
methylene chloride (from 3:2 to 3:7) as eluent to give 50 mg (62 % yield) of a mixture of title 
compounds as a yellow solid. Two isomers were partially separated in the column. 
Less polar isomer 2.53b: 1H NMR (CDCl3, 400 MHz) δ 8.24~8.32 (m, 3 H), 7.40~7.72 
(m, 6 H), 7.30 (m, 3 H), 7.18 (m, 2 H), 6.98 (dd, J1 = 5.1 Hz, J2 = 3.3 Hz, 2 H), 4.94 (s, 1 H), 
4.92 (s, 1 H), 4.48 (m, 2 H), 4.27 (m, 2 H), 4.22 (t, J = 6.0 Hz, 1 H), 3.90 (m, 1 H), 3.62 (m, 1 H), 
2.70~3.30 (series of multiplets, 8 H), 1.60~2.50 (series of multiplets, 15 H), 1.01 (s, 9 H), 0.99 (s, 
9 H), 0.90 (s, 9 H), 0.25 (s, 3 H), 0.22 (s, 3 H), 0.12 (s, 3 H), 0.09 (s, 3 H), δ 0.06 (s, 3 H), δ 0.04 
(s, 3 H).  
More polar isomer 2.53a: 1H NMR (CDCl3, 400 MHz) δ 8.22~8.28 (m, 3 H), 7.42 ~7.71 
(m, 6 H), 7.28~7.38 (m, 3 H), 7.19 (dd, J1 = 5.1 Hz, J2 = 3.3 Hz, 2 H), 6.98 (dd, J1 = 5.1 Hz, J2 = 
3.3 Hz, 2 H), 4.98 (s, 1 H), 4.96 (s, 1 H), 4.51 (m, 2 H), 4.28 (m, 2 H), 2.80~3.30 (m, 8 H), 
1.60~2.50 (series of multiplets, 16 H), 1.06 (s, 9 H), 1.01 (s, 9 H), 0.85 (s, 9 H), 0.24 (s, 3 H), 
0.20 (s, 3 H), 0.16 (s, 3 H), 0.10 (s, 3 H), 0.05 (s, 3 H), 0.02 (s, 3 H).  
2.5.2.2) (2R,4aS,5S,6S,7R,7aR,11aS,12S,13S,14R,14aR)-2-(t-Butyldimethylsilanoxy)methyl-
5,12-di(t-butyldimethylsilanoxy)-7,14-dihydroxy-3,9,10-trimethylene-1,2,4,4a,5,6,7,7a,8,11, 
11a,12,13,14,14a-pentidecahydro-6,13-o-benzenopentacene and its enantiomer (2.54a) 
(2S,4aR,5R,6S,7S,7aS,11aR,12R,13S,14S,14aS)- 2-(t-butyldimethylsilanoxy)methyl-7,14-di- 
(t-butyldimethylsilanoxy)-5,12-dihydroxy-3,9,10-trimethylene-1,2,4a,5,6,7,7a,8,11,11a,12,13, 
14,14a-pentidecahydro-6,13-o-benzenopentacene and its enantiomer (2.53b) 
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TBSOHO
OH
OTBS
H
H
H H
2.54a
CH2OTBS
TBSOHO
OH
OTBS
H
H
H H
2.54b
CH2OTBS
 
To a mixture of 26.5 mg (0.0183 mmol) of triselenides, 59.2 mL (0.73 mmol) of pyridine 
and 15.4 mg (0.183 mmol) of sodium bicarbonate in 2 mL methylene chloride at 0 oC (ice-water 
bath) was added 23 mg (0.092 mmol) of 70% m-chloroperbenzoic acid.  The reaction mixture 
was stirred at room temperature under argon for 6 hours and diluted with 20 mL of ethyl acetate. 
The organic layer was washed with water (20 mL ×2 ) and brine (20 mL), dried over anhydrous 
magnesium sulfate, and concentrated by a rotavapor.  The residue was then applied to column 
chromatography with methylene chloride and petroleum ether (2:1,V:V) as eluent to give 5.3 mg 
of less polar isomer 2.54a and 4.9 mg of the more polar isomer 2.54b with a combination yield 
of 66%. 
The less polar isomer (2.54a): 1H NMR (CDCl3, 400 MHz) δ 7.19 (m, 2 H), δ 6.96 (m, 2 
H), 5.03 (m, 4 H), 4.93 (s, 1 H), 4.20~4.80 (series of multiplets, 7 H), 3.88 (m, 1 H), 3.53 (m,  2 
H), 3.09 (m, 2 H), 1.70~2.80 (series of multiplets, 12 H), 1.04 (s, 9 H), 1.00 (s, 9 H), 0.90 (s, 9 
H), 0.27 (s, 3 H), 0.23 (s, 3 H), 0.18 (s, 3 H), 0.14 (s, 3 H), 0.07 (s, 3 H), 0.06 (s, 3 H). 
The more polar isomer (2.54b): 1H NMR (CDCl3, 400 MHz)  δ 7.17 (m, 2 H), δ 6.93 (m, 
2 H), 5.02 (m, 2 H), 5.00 (s, 1 H), 4.96 (s, 1 H), 4.84 (bs, 1 H), 4.72 (m, 1 H), 4.66 (bs, 1 H), 4.45 
(m 2 H), 4.22 (m, 2 H), 3.60 (m, 2 H), 1.70~2.74 (series of multiplets, 13 H), 1.00 (2 s, 18 H), 
0.86 (s, 9 H), 0.25 (s, 3 H), 0.24 (s, 3 H), 0.14 (s, 6 H), 0.13 (s, 3 H), 0.10 (s, 3 H), 0.007 (s, 3 H). 
2.5.2.3) (2R,4aS,5S,6R,7R,7aR,11aS,12S,13S,14R,14aR)-2-Hydroxymethyl-3,9,10-trimethyl-
ene-5,7,12,14-tetrahydroxy-1,2,4,4a,5,6,7,7a,8,11,11a,12,13,14,14a-pentidecahydro-6,13-o-
benzenopentacene and its enantiomer (2.55)  
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2.55
HO
OH
OH
HO
OH
H
H
H
H
H
 
To a solution of 37.8 mg (0.0448 mmol) of triene 2.54a and 2.54b in 4 mL of THF at 0oC 
(ice-water bath) was added 161 μL (0.161 mmol) of 1M tetrabutylammonium fluoride (TBAF) 
in THF. The reaction mixture was stirred at room temperature for 2 hours, diluted with 20 mL 
water and extracted with ethyl acetate (25 mL×2). The organic layer was then washed with 
water (50 mL) and brine (50 mL), dried over anhydrous magnesium sulfate, filtered and 
concentrated by a rotavapor.  The residue was then applied to column chromatography using 
methylene chloride and methanol (25:1, V:V) as eluent to afford 19.3 mg (86% yield) of the title 
compound 2.55: 1H NMR (CDCl3, 400 MHz) δ 7.28 (m, 2 H), 7.00 (m, 2 H), 5.17 (s, 1 H), 5.16 
(s, 1 H), 5.09 (bs, 2 H), 4.98 (bs, 1 H), 4.82 (bs, 2 H), 4.79 (bs, 1 H), 4.50~4.60 (m, 4 H), 
3.58~3.70 (m, 3 H),  3.30 (m, 1 H), 2.88 (m, 2 H), 2.74 (m. 1 H), 1.77~2.52 (series of multiplets, 
12 H); 13C NMR (CDCl3, 100 MHz) δ 150.0, 149.2, 148.1, 147.9, 147.8, 146.1 (3 C), 145.9, 
124.4 (2 C), 122.6 (2 C), 111.0, 110.5, 109.6, 77.2, 71.0, 70.3, 69.9, 64.3, 50.1, 50.0, 44.6, 39.8, 
38.5, 37.7, 36.1, 35.5, 34.3, 32.1, 25.3.   
2.5.3 Synthesis of Diels-Alder adducts of tetraenr 2.51 and triene 2.55 
2.5.3.1) (4aR,6aS,7S,8S,9R,9aR,11R,13aS,14S,15R,16R,16aR,18S-11-Hydroxymethyl-12-
methylene-7,9,15,17-tetrahydroxy-4a,5,6,6a,7,8,9,9a,10,11,13,13a,14,16,16a,17,18,18a-
nonadecahydro-4a,18a-cis-ethylenedicarbonyl-8,15-o-benzenoheptacene-1,3-dione and its 
enantiomer (2.65)  
 A mixture of 18 mg (0.035 mmol) of triene 2.55 and 8.6 mg (0.046 mmol) of NDQ 2.64 
was stirred in 0.5 mL of 1,2-dichloroethane at 0oC, then slowly warmed up to room temperature 
and stirred at room temperature for 4 hours. Solvent was removed by a rotavapor. The residue 
was applied to column chromatography (silica gel) using methylene chloride and methanol (25:1, 
V:V) as eluent to afford 20 mg (82% yield) of the title compound: 1H NMR (CDCl3, 400 MHz) δ 
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7.30 (m, 2 H), 7.00 (m, 2 H), 6.78~6.80 (m, 4 H), 5.24 (s, 1 H), 5.18 (s, 1 H), 4.93 (bs, 1 H), 4.76 
(bs, 1 H), 4.56 (bt, 2 H, J = 8.2 Hz), 4.39 (d, J = 5.0 Hz, 2 H), 3.65 (m, 2 H), 1.60~2.90 (series of 
multipets, 17 H).  
2.65
HO
OH
OH
HO
OH
O
O
O
O
H
H
H
H
H
 
2.5.3.2) (6aS,7S,8S,9R,9aR,13aS,14S,15R,16R,16aR)-11,12-Dimethylene-7,9,14,16-tetra-
hydroxy-4a,5,6,6a,7,8,9,9a,10,13,13a,14,16,16a,17,18,18a-octadecahydro-4a,18a-cis- 
ethylenedicarbonyl-8,15-o-benzenoheptacene-1,3-dione (2.67)  
(6aS,7S,9R,9aR,17aS,18S,20R,20aR)-7,9,18,20-Tetrahydroxy-4a,5,6,6a,7,8,9,9a,10,11,11a, 
15a,16,17,17a,18,19,20,20a,21,22,22a-docosahydro-(4a,22a:11a,15a)-di(cis-ethylenedi-
carbonyl)-8,19-o-benzenononacene-1,3,12,15-tetraone (2.68) 
OHO HO
OH
OOOO
O
O
O
H
H
H
H
2.67
HO
OH
OH
HO
O
O
O
O
H
H
H
H
2.68  
 A mixture of 25 mg (0.052 mmol) of tetraene 2.51 and 5.9 mg (0.031 mmol) of NDQ 
2.64 was stirred in 10 mL of 1,2-dichloroethane at -78 oC, then slowly warmed up to 0 oC and 
stirred at 0 oC for 40 min. Solvent was removed by a rotavapor. The residue was applied to 
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column chromatography (silica gel) using methylene chloride and acetone (20:1, V:V) as eluent 
to afford 11.6 mg (33 % yield) of monoadduct 2.67 and 2.3 mg (5.0 % yield) of diadduct 2.68.  
Monoadduct 2.67: 1H NMR (CDCl3, 400 MHz) δ 7.29 (m, 2 H), 7.01 (m, 2 H), 6.81 (s, 2 
H), 6.80 (s, 2 H), 5.22 (s, 2 H), 5.07(s, 2 H), 4.76 (s, 2 H), 4.60 (bs, 2 H), 4.37 (bs, 2 H), 3.05 (bs, 
2 H), 2,74 (bs, 2 H), 1.74~2.64 (series of multiplets, 16 H); 13C NMR (CDCl3, 50 MHz) δ 193.7 
(2 C), 148.3, 147.0, 146.3, 146.1, 140.0 (2 C), 125.7, 124.4, 122.7, 110.2, 70.9, 70.0, 65.8, 49.9, 
38.7, 35.2, 34.2, 31.7, 29.9; MS: m/z 693.29 (M+Na). 
Diadduct 2.68: 1H NMR (CDCl3, 400 MHz) δ 7.28 (m, 2 H), 7.00 (m, 2 H), 6.80 (s, 4 H), 
6.73 (s, 4 H), 5.18 (s, 2 H), 4.37 (bs, 4 H), 2.50 (b, 4 H), 2.36 (bs, 4 H), 2.31 (bs, 4 H), 2.15 (bs, 4 
H), 1.89 (bs, 4 H), 1.84 (bs, 4 H); MS: m/z 881.36 (M+Na). 
2.5.3.3) (cis-4a,18a)-(6aR,7R,8R,9S,9aS,13aR,14R,15S,16S,16aS)-11,12-Dimethylene-7,9,14, 
16-tetrahydroxy-2,3,4a,18a-tetraethoxycarbonyl-4a,5,6,6a,7,8,9,9a,10,13,13a,14,16,16a,17, 
18,18a-octadecahydro-8,15-o-benzenoheptacene-1,3-dione (2.71)  
(cis-4a,18a;cis-11a,15a)-(6aR,7R,9S,9aS,17aR,18R,20S,20aS)-7,9,18,20-Tetrahydroxy-
2,3,4a,11a,13,14,15a,22a-octaethoxycarbonyl-4a,5,6,6a,7,8,9,9a,10,11,11a,15a,16,17,17a,18, 
19,20,20a,21,22,22a-docosahydro-(4a,22a:11a,15a)-8,19-o-benzenononacene-1,3,12,15-
tetraone (2.72) 
OH
OH
O
O
H
H
2.71 2.72
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 A mixture of 26.7 mg (0.0553 mmol) of tetraene 2.51 and 13 mg (0.033 mmol) of the 
double activated quinone 2.70 was stirred in 33 mL of benzene at 0 oC, then slowly warmed up 
to room temperature and stirred at room temperature for overnight. Solvent was removed by a 
rotavapor. The residue was applied to column chromatography (silica gel) using a gradient of 
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methylene chloride and acetone (25:1 to 9:1, V:V) as eluent to afford 10.4 mg (21% yield) of 
monoadduct 2.71 and 13.4 mg (19% yield) of diadduct 2.72.  
Monoadduct 2.71: 1H NMR (CDCl3, 400 MHz) δ 7.29 (m, 2 H), 7.01 (m, 2 H), 5.19 (s, 2 
H), 5.13 (bs, 2 H), 4.81 (bs, 2 H), 4.56 (bs, 2 H), 4.38 (bs, 2 H), 4.34 (m, 4 H), 4.25 (m, 4 H), 
2.99 (bs, 2 H), 2.75 (bd, 2 H), 2.00~2.70 (series of multiplets, 12 H), 1.79 (bd, 2 H), 1.33 (t, 6 H, 
J = 7.2 Hz), 1.28 (t, 6 H, J = 7.2 Hz); 13C NMR (CDCl3, 50 MHz) δ 189.3, 167.2, 162.1, 148.0, 
147.0, 146.2, 146.1, 138.5, 125.7, 124.4, 122.7, 110.4, 70.8, 70.0, 64.3, 63.5, 62.9, 49.8, 38.6, 
35.2, 34.1, 33.1, 29.9, 14.1, 14.0;  MS: m/z 901.80 (M+Na). 
Diadduct 2.72: 1H NMR (CDCl3, 400 MHz) δ 7.27 (m, 2 H), 7.00 (m, 2 H), 5.14 (s, 2 H), 
4.30~4.40 (m, 12 H), 4.22 (m, 8 H), 2.76 (bd, 4 H), 2.56 (bd, 4 H), 2.17 (bd, 4 H), 2.06 (bs, 4 H), 
1.80 (bd, 4 H), 1.32 (t, 12 H, J = 7.6 Hz), 1.25 (t, 12 H, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz) 
δ 188.9, 167.2, 162.1, 146.2 (2 C), 138.6, 125.5, 124.4, 122.6, 70.1, 64.3, 63.4, 62.8, 50.0, 35.3, 
33.3, 14.1, 14.0;  MS: m/z 1297.74 (M+Na). 
2.5.4 Isomerization of tetraene 2.51 
2.5.4.1) (3S,4aR,5R,6R,7S,7aS,11aR,12R,13R,14S,14aS)-2,9-Dimethylene-7,14-tetrahydroxy-
(3,5:10,12)-bis-oxo-1,3,4,4a,5,6,7,7a,8,10,11,11a,12,13,14,14a-hexadecahydro-6,13-o-
benzenopentacene (2.74)  
OH HO
OO H
H
H
H
2.74  
A solution of tetraene 2.51 20 mg (0.041 mmol) in 3 mL 1,2-dichloroethane under argon 
was heated in seal tube at 155 oC for five hours. The solvent was removed by a rotavapor. The 
residue was applied to column chromatography using a gradient of methylene chloride and 
acetone (100:1 to 20:1) as eluent to afford 11 mg (55% yield) of the title compound 2.74:  1H 
NMR (CDCl3, 400 MHz) δ 7.27 (m, 2 H), 6.99 (m, 2 H), 5.19 (s, 2 H), 4.67 (bs, 2 H), 4.48 (m, 6 
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H), 2.49 (bs, 2 H), 1.64~2.32 (series of multiplets, 12 H), 1.48 (s, 6 H); 13C NMR (CDCl3, 50 
MHz) δ 151.7, 148.7, 146.2, 143.4, 124.3, 122.6, 104.8, 83.1, 76.0, 71.9, 50.5, 44.7, 40.5, 38.8, 
29.1, 22.5;  MS: m/z  987.4 (2M+Na). 
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CHAPTER 3 - Towards the synthesis of new cyclododeciptycene 
based molecular gears 
3.1 Introduction 
This new project was detoured from the previous beltene project.  From knowledge 
gained in pursuing the [10]beltene derivative and literature study,  successful cyclization of a 
molecular ring structure by Diels-Alder reaction depends on both closeness and right alignment 
of the diene and dienophile ends. In order to bring the two ends close together, a reasonable route 
coming out was to extend curved backbone of triptycenebisquinone, which led to a series of 
iptycene quinones with increased curvity. For cis,cis,cis,cis-undeciptycenehexaquinone 3.59 (for 
nomenclature, see below) two quinone ends are both close enough and parallel to each other. If 
one end was transformed to diene component 1,4-dimethoxyanthracene, the two ends should be 
close and right on top of the other for intramolecular Diels-Alder cyclization as in 3.112. The 
basic idea of extension of simple triptycenebisquinone together with a goal of cyclization would 
naturally lead to a new beltene derivative cyclododeciptycenehexaquinone, a beautiful gear-
shaped molecule with D6h symmetry which was first proposed in my oral proposal in Dec. 2004.  
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Figure 3.1 From benzoquinone to cyclododeciptycenehexaquinone. 
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3.2 Background 
3.2.1 Iptycenes and iptycene quinones 
3.2.1.1 Iptycenes 
“Iptycenes”, coined by Harold Hart,  “are extended triptycenes.”1 They refer to a series of 
compounds derived from the idea of extension of triptycene in that two nearby triptycene units 
merged together by sharing a benzene ring (See Figure 3.2). The prefix (tri-, pent-, etc.) 
accounts for the number of benzene planes separated by   ring bridges.1, 2 
(top view)
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Figure 3.2 Structural correlations between triptycene and pentiptycene; 
 triptycene bisquinonone and pentiptycene trisquinone 
3.3 3.4 3.5 3.6
3.7
3.8 3.9  
Figure 3.3 Some higher iptycenes. 
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Triptycene, the simplest member in the iptycene family, was first synthesized by 
P.D.Bartlett in 1942 for mechanistic study of radicals.3 Triptycene is a rigid D3h symmetric gear-
like molecule, with three benzene rings connected by a [2.2.2] ring bridge, forming the 
fundamental structural unit for iptycenes.   
Pentiptycene, first synthesized in 1974,4 is the first member of larger iptycenes. Two 
possible pentiptycenes exist theoretically due to two possible alignments (termed here zig-zag 
and armchair respectively, for their similarity to zig-zag and armchair carbon nanotubes) when 
two triptycene “merged” together by overlapping one benzene ring (Figure 3.2). 1  Since 
quinone rings can only be overlaped in a zigzag way, iptycene quinones can only be derivatives 
of zigzag type of iptycenes. Thus only zigzag type of iptycenes will be discussed in this chapter.  
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Scheme 3.1 Synthesis of iptycenes 
It was Harold Hart who first systematically explored syntheses of higher iptycenes based 
on aryne and Diels-Alder chemistry.1, 2, 5-8 A series of building blocks were developed and 
several higher iptycenes were successfully synthesized. In some cases, several synthetic routes 
are available. Both the selection of building blocks and the reaction sequence are crucial for 
achieving good yield. But in most cases, higher iptycenes remain difficult and/or tedious to 
synthesize and purify. Cycloiptycenes, iptycenes with  ring structures, are even more challenging 
targets for synthesis (Figure 3.4).1, 2 Up to now, no successful synthesis of them or their 
derivatives have been reported in literature. Among them, cyclododeciptycene (3.11) derivatives 
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have a honeycomb structure with a dihedral angle of 120o, which minimize the strain energy and 
make them more amenable for synthesis.  
 
3.10 3.11 3.12
3.13
3.14
3.15  
Figure 3.4 Cycloiptycenes. 
3.2.1.2 Iptycene quinones 
Similarly, iptycenes quinones are extended triptycene quinones (Figure 3.2). They can 
also been seen as iptycene derivatives with one or more benzene rings being replaced by quinone 
rings. Compared with iptycenes, iptycene quinones have interesting electrochemical and 
photochemical properties with embedded quinone rings in their structure. Furthermore, they have 
better derivatization ability,9 since the quinone ring can be converted to a benzene ring with one 
position being bromo, iodo, amino, nitro, cyano, or formyl group and its para-position being a 
hydroxy or alkoxy group.10 They would be important synthetic intermediates leading to a wide 
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range of iptycene derivatives which have potential applications in supramolecular and material 
chemistry.  
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Scheme 3.2 Synthesis of iptycene quinones 
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The idea of extension of triptycene bisquinone framework was first reported by Iwamura, 
H. in 1982.11 He found that triptycene bisquinone has lower electron potential than benzoquinone 
due to a transannular interaction in triptycene framework.  An extended system would expected 
to show “higher electron affinity and therefore serve as a novel electron acceptor.” 11 He then 
synthesized a series of iptycene quinones (3.19, n = 1, 2, 3). It was found that extension of 
framework does stabilized the 1:2 complex with electron rich 2-(1,3-dithiol-2-ylidene)-1,3-
dithiole (3.20) especially for compound 3.23. However, no detailed synthetic routes or structural 
identification data were provided. Higher iptycene quinones (3.19, n = 4, 5) in all cis-
configuration have not been reported. They contain more units of triptycene bisquinone in a 
circular form and are predicted to be even better electron acceptors.  
It was not until recently a detailed synthesis of higher iptycene quinones was reported by 
Zhu et.al.9 Interestingly, their syntheses were more like replica of the simple triptycene bisquione 
since basically they follow exactly the same reaction sequences. The higher iptycene quinones 
were synthesized from simpler iptycene quinones and anthracenes just as triptycene bisquinone 
were synthesized form 1,4-benzoquinone and 1,4-dimethoxyanthracene: a two step synthesis 
started from an one-pot Diels-Alder–enolization–oxidation reaction followed by another 
oxidative demethoxylation reaction using CAN as reagent as shown in Scheme 3.2. In the first 
step, the Diels-Alder adducts formed in situ were enolized in acetic acid media to form phenols, 
which was quickly oxidized to quinone rings by p-chloroanil. However, a mixture of possible 
products was formed and it is usually difficult to separate them in this stage. This will increase 
the task of separation of different products in the final CAN oxidation. 
In our lab, we independently synthesized pentiptycene trisquinone 3.21 and 3.22 (LK-4-
064, LK-4-070) before the publication of Zhu’s paper.  We did Diels-Alder reaction in refluxing 
toluene. Adducts were first separated and then enolized and oxidized in a refluxing benzene with 
sodium hydride and silver oxide as shown in Scheme 3.2. The stepwise method in our lab may 
seem tedious because of the extra step. It gave the opportunity to separate individual Diels-Alder 
adduct and identify their structures. Later, we found Diels-Alder adducts containing inherent 
structural indicators in 1H NMR spectum, which were proved to be very useful to determine the 
structure of iptycenequinones derived from them. Besides, using a pure single Diels-Alder 
adduct for later steps would give only one iptycenequinone as product and thus reduced the 
purification demand in later steps.  
 71
3.2.1.3 Properties and applications of iptycene and iptycene quinones 
1) Intramolecular charge transfer study. 
Charge transfer is a behavior of a partial electronic charge transfer from an electron donor 
to an electron acceptor in an excited state when these two groups are close to each other. A new 
and strong band can be observed in UV-Vis spectrum due to charge transfer interaction. Iptycene 
structure provides unique alignments of electron donors and acceptors for the study of 
transannular charge transfer behavior.12-14   
 
Figure 3.6 Electron spectrum of 9, 10-dihydro-9, 10-(1,2-tropylio)anthracene  
tetrafluoroborate (3.27) in CH3CN(―) and CH2Cl2(---). 
(Taken from reference12 without permission) 
The first spectrum evidence of the existence of transannular charge-transfer interaction  
in the tripycene framework was reported by Murata et.al in 1977.12 The new broad absorption 
band at 300~450 nm was formed due to a charge-transfer interaction between tropylium ion and 
benzene rings. The red-shift of the band from solvent acetonitrile to solvent methylene chloride 
agreed with that of a charge-transfer band.   
A year later, Iwamura et al. reported a new triptycene system incorporated a p-
benzoquinone ring as the acceptor and a hydroquinone ring as the donor.13 The observed λmax of 
charge-transfer band in DMSO is 430 nm, which is almost comparable to that of quinhydrone.13   
The strong charge-transfer band could not be explained simply by the through space interaction 
between the hydroquinone and p-benzoquinone rings in a dihedral angle of 120o alone. A 
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through-bond homoconjugation model was proposed by the author as shown in Figure 3.7. The 
carbon-carbon σ orbitals in [2.2.2] bicyclic ring bridge have both high p-character and off-center 
bent bond nature, which facilitate their interaction with π orbital of nearby donor and acceptor 
rings.13  
 
Figure 3.7 Through-bond homoconjugative interaction between hydroquinone 
 and p-benzoquinone rings in a triptycene framework. 
(Taken from reference13 without permission) 
 Murata studied the other two triptycene systems in Figure 3.8 by focusing the effect of  
different substitution in the electron donating moiety to the wavelength of charge transfer band.14 
It was found that 5- or 8- substituents showed little effect to λmax of charge-transfer band, while 
electron donating 6- or 7- substituents caused a significent red-shift, which was rationalized by 
orbital symmetry analysis.  
 
Figure 3.8 Two other triptycene systems with transannular  
charger-transfer interaction studied by Murata.14 
2) Photoinduced electron transfer study. 
 Photoinduced electron transfer (PET) is the key process in photosynthesis, during which 
light energy is converted to an electronic potential energy due to the separation of charges. Many 
synthetic PET models containing an electron donor chromophore such as porphyrin linked to 
acceptor moietie such as quinones in a molecule have been reported.15  
The rigid structure of iptycene quinones together with the adjustable number of quinone 
rings and their distances to the donor chromophore make them an ideal acceptor to study the 
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influence of such factors to PET activities.16-18  Some reported PET systems with triptycene 
quinones and pentiptycene quinones are shown in Figure 3.9.  
 
Figure 3.9 Iptycenequinones as electron acceptor in photoinduced electron transfer studies.17, 18 
 3) Intermolecular charge transfer interactions of iptycene quinones with electron donors. 
 Besides the above intramolecular charge transfer interactions, iptycene quinones form 
charge-transfer complex with small organic electron donors in solution. Iwamura et al. reported 
triptycene bisquinone (3.17) and cis,cis,cis-heptiptycene tetraquinone (3.23) formed a 1:2 
complex with 2-(1,3-dithiol-2-ylidene)-1,3-dithiole (TTF, 3.20) in methylene chloride. From 
theromo-dynamic data listed in Table 3.1, compound 3.23 is a better electron acceptor. In a 
higher TTF concentration, a 1:3 or even 1:4 complexes were formed for 3.23.11  
 λCT(nm) -ΔH(KJ mol-1) -ΔS (J deg-1mol-1) -ΔG (KJ mol-1) 
3.17•2TTF 760 37.7 ± 0.4 90.0 ± 1.5 10.4 ± 0.1 
3.23•2TTF 774 45.1 ± 2.0 104.6 ± 6.5 13.5 ± 0.6 
Table 3.1 Thermodynamic constants for 3.17•2TTF and 3.23•2TTF complexes in CH2Cl2.11 
4) Iptycene-containing poly(p-phenyleneethynylene)s (PPEs) and poly(iptycene)s 
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Ipytcene-containing polymers have been mainly investigated in Swager’s group at MIT 
since 1998.19-27 Most of their work is focused on iptycene-containing PPEs, which are 
conjugated polymers with a backbone of alternating benzene rings and acetylenes. Examples of 
PPEs (3.37) and iptycene-containing PPEs are shown in Figure 3.10. In PPEs, more efficient 
electron delocalization and excition migration along polymer backbone allows amplified sensory 
responses compared with small-molecule-based sensors.28 However, the usefulness of PPEs in 
thin films is offset by low fluorescence quantum yields due to π-π stacking and interchain 
excimer/exciplex formation, which also causes a substantial red-shift relative to solution values 
in the absorption and fluorescence spectrum (3.37 in Figure 3.11). Incoporation of rigid 
iptycenes in PPEs have been found to reduce interchain interactions by spatial isolation of 
polymer backbones. Thus iptycene-containing PPEs show improved photoluminescent stability 
and quantum yields in the solid state.20 Correspondently, little or no redshifts in thin film relative 
to solution values would be found in the absorption and fluorescence spectra. In addition, the 
“internal free volume” in iptycene moieties provides additional channel-like cavities to facilitate 
rapid analytes diffusion and achieve faster signal responses (Figure 3.12).  Also, the insertion of 
iptycene units into a polymer backbone also lowers its dielectric constant,24  increases its 
solubility25 and improves mechanical properties.29  Ipytcene containing PPEs are potential 
sensory materials for detecting TNT.19, 20 
 
Figure 3.10 Iptycene-containing poly(p-phenyleneethynylene)s (PPEs)20, 22, 25, 30 
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Figure 3.11 Absorption and fluorescence spectra of 3.37, 3.38, 3.39 in methylene chloride 
and 3.41, 3.42, 3.43 in  chloroform (dash line) and thin films (solid line)19, 20, 25 
(Taken from reference19, 20, 25 without permission) 
  
Figure 3.12 Iptycene-containing poly(p-phenyleneethynylene)s (PPEs)  
show channel-like cavities 20 (Taken from reference 20 without permission) 
 Schanze’s group reported a platinum acetylide polymer (3.46) containing penticene units 
in the polymer backbone (Figure 3.13).31 Platinum acetylide polymers, such as 3.45, display 
phosphorescence at room temperature due to their high efficient intersystem crossing. The 
optical properties of two polymers 3.45 and 3.46 were studied both in solution and in the solid 
state. Similar results were drawn. Polymer 3.45 showed phosphorescence emission from an 
interchain aggregate in solid state, while dominating intrachain phosphorescence emission were 
observed for polymer 3.46. 
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Figure 3.13 Structure of a penticene containing platinum acetylide polymer 3.44 and its parent 
polymer 3.45 
 
Figure 3.14 Poly(iptycene)s 
Another type of iptycene polymers reported are poly(iptycene)s, which contain iptycene 
units in a extended ladder-like double strand structure (Figure 3.14).27, 32, 33 The unique shape-
persistent structure and high free volume inside the polymer has been utilized as a “threading” 
host for other linear polymer molecules. The polymer 3.47 was found to “align perpendicular to 
strech-aligned PVC”.33 
 
Figure 3.15 Perpendicular alignment of poly(iptycene) 3.45  
with stretch-aligned PVC molecules. 33 (Taken from reference 33 without permission)  
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 5) Other properties and applications. 
 Other properties and applications which have not mentioned above are listed below. First, 
iptycenes have high melting points and thermal stability, and they could be used in heat-resistant 
materials.1  Second,  their packing behaviors in crystal structures34-36 and self-assembly behavior 
on metal surface37 have been studied recently, which will further our understanding the 
interaction of these molecules in microscopic level. Third, their rigid structures have been used 
to design molecular gate38 or molecular probe for Cu(II) ion.39 Moreover, triptyenes have been 
used as molecular gears, which will be discussed in the coming section. Furthermore, triptycene 
bisquinone derivatives showed anticancer and antimalaial activities and other bioactivities.40-42  
  Overall, most of reported research on iptycenes were based on triptycenes and 
pentipycenes systems. There were limited reports on heptipycene and noniptycene derivatives 
and their applications. No higher iptycene derivatives and cycloiptycenes have ever been 
synthesized and reported. The synthetic effects to cyclododeciptycenehexaquinone (3.1) will 
bring a series of higher iptycene derivatives, which are expected to show interesting electronic 
and optical properties and potential applications in supramolecular chemistry and material 
chemistry due to both their unique structure and properties. 
3.2.2 Molecular Gears 
3.2.2.1 Molecular gears and their functions 
The targeted molecule cyclododeciptycenehexaquinone (3.1) forms a perfect molecular 
gear with a macropolycyclic ring incorporated six p-benzoquinonone as the shaft and six 
benzene rings as teeth. It would be expected to have a potential application as a building part in a 
molecule machine just as its macroscopic counterparts are important building parts in a machine 
such as a car or a watch in our daily life. Gears mainly play three functions: 1) transferring the 
information about the direction of rotation, 2) adjusting the speed of rotation, 3) changing 
rotational axis.43 For the first function, as illustrated in Figure 3.16, in a molecular gear system 
3.50 reported by Bryan et.al.,44 or a more complicated gear chain system 3.51 reported by 
Iwamura et.al.45  the direction of rotation of two neighboring gears are opposite. In this fashion, 
the information of the directions of rotation is transferred from one end of the gear train to the 
other end depending on the number of gears (the number of reversion). The last two functions 
are seen in a molecular bevel gear system reported by Richards et. al.46 as shown in Figure 3.17.  
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Not only the direction of rotational axis turned 90º from the small gear (triptycene) to the large 
gear, but also the speed of rotation are different. Since the number of teeth passed the joggle in a 
certain period of time are same for both gears, it takes the small gear less time to finish a round 
because it has less teeth attached to it.  In other words, small gear rotates faster and big gear 
rotates slower in a gear system with their relative speed depending on the ratio of the number of 
teeth in each gear. Currently the number of teeth in a molecular gear can be two (aromatic amide 
gears), three (triptycenene molecular gears), and four (metallocene molecular gears). The 
cyclododeciptycene based molecular gears would be first 6-teeth gears in the molecular level.  
 
Figure 3.16 Transduction of the direction of rotation in molecular gears: a) two 
neighboring molecular gears with opposite directions of rotation.(the left picture is taken from 
reference47 page 280 without permission, the right crystal structure from reference44) b) the 
transferring of the direction of rotations in a molecular train. (picture from reference47  page 280 
without permission)  
 
 Figure 3.17 A macroscopic and a molecular bevel gear (taken from reference47 page 280 
without permission). 
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3.2.2.2 Study of rotation behavior of molecular gears. 
The most important behavior associated to a molecular gear is its rotation, which is often 
studied by NMR method.  In the gear systems based on triptycene and metallocenes, rotation 
barriers are usually small. For the simple molecular gear system 3.50, both triptycene gears 
rotate very fast on the NMR timescale above 60 oC, since the aromatic region only show two 
peaks in NMR. When decreasing temperature, the rotation slows down, reflected by the 
broadening of aromatic peaks. Finally, under the temperature below -40 oC, individual sets of 
signals are seen in NMR.44 
For the tristriptycene molecular gear train 3.51, the two benzene rings on the triptycene 
outside have been labeled with Cl. Two phase isomers meso- and racemic d-/l- can be existed 
(Figure 3.18). It was calculated that the inner rotatory (gear-like rotation) barrier is no higher 
than 1 kcal/mol, whereas the gear slippage barrier was 43.2 kcal/mol by studying the conversion 
between two phase isomers in the temperature 238~332 oC.48 
 
 Figure 3.18 45        Figure 3.19 NMR of  3.52  at a) 260 K, b) 233 K, c) 220 K, d) 203 K 
(Taken form reference 45 without permission) 
In the case of the molecular bevel gear 3.52, the simplicity of the NMR peaks in the 
aromatic region shows the rotations are very fast for both gears on the NMR timescale at 260 K. 
Then in the spectrum at 203 K, the peaks are broadened a little, which means the ration is slower 
at lower temperature. (Figure 3.19) 
Han et.al reported a computer simulation study of the rotation of carbon nanotube-based 
molecular gears by molecular dynamics.49  One of the gears was first drove to rotate by charge 
separation caused by a laser in the simulation condition. The angular momentum was transferred 
to the other gear. The gears functioned well in the temperature range 600~1000 K with rotation 
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rates between 50~100 GHz.  At higher temperature, these molecular gears did not work well due 
to the inefficient conversion of input energy to rotational motion.49  
 
                             (a)                                                                       (b) 
Figure 3.20 a) Carbon [14,0]nanotube-based gears with benzyne teeth  on every two six-
membered ring. b) In-line multiple rows of teeth gears.49 (Taken form reference 49 without 
permission) 
3.3 Synthetic studies towards cyclododeciptycene based molecular gears 
3.3.1 Retrosynthetic analysis of cyclododeciptycenehexaquinone 
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Figure 3.21  
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The target cyclododeciptycenehexaquinone molecule gear can be conveniently divided as 
teeth parts and shaft part. Teeth parts are simple benzene rings with two single bonds connected 
to the shaft, a [12]cyclacene based macropolycycle. For convenience, the six quinone rings in the 
shaft are named by numbers as 1, 3, 5, 7, 9, 11 according to a clock. The teeth are labelled as  2, 
4, 6, 8, 10, 12clockwisely.  
There are many different ways to break the molecule to different sizes of fractions in 
retrosynthetic analysis. For convenience, these small fractions or intermediates are categorized 
by the number of teeth remained in them. A list of possible intermediates is shown in Figure 
3.22.  Based on these synthetic intermediates, two strategic retrosynthetic routes could be 
proposed: stepwise and convergent.  
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Figure 3.22 Synthetic intermediates for cyclododeciptycenehexaquinone with  
different number of teeth remained 
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Scheme 3.3 Proposed stepwise retrosynthetic analysis of cyclododeciptycenehexaquinone  
to iptycene quinones. 
 For the stepwise route, a retrosynthetic Diels-Alder transformation converts 3.1 to key 
synthetic intermediate 3.61 which contains a quinone end and a dimethoxyanthracene end. The 
disconnection position is between ring No.7 and ring No. 6.  From intermediate 3.61, one tooth is 
taken off to form 5-teeth intermediate 3.59 by an o-quinodimethane Diels-Alder transformation. 
Then, further teeth reduction transformation to take off either one tooth or two teeth at a time 
will convert cis,cis,cis,cis-undeciptycenehexaquinone 3.59  to lower iptycene quinones 3.57, 
3.23, 3.21, and 3.17. Triptycene bisquinone 3.17 is synthesized from 1,4-dimethoxyanthracene 
and 1,4-benzoquinone. The transformation of increased teeth number starting from 1,4-
benzoquinone to cis,cis,cis,cis-undeciptycenehexaquinone 3.59 is generalized in Scheme 3.4. 
One quinone end in an iptycenequinone or benzoquinone is first reacted with 1,4-
dimethoxyanthracene,  a one tooth intermediate, in toluene. The Diels-Alder adducts are 
separated and enolized in refluxing acetic acid (sometimes catalyzed by hydrobromic acid). The 
final oxidative demethoxylation by CAN gives a new iptycenequinone with one more tooth. For 
iptycene quinone with two quinone ends, two teeth are added if the first Diels-Alder reaction 
using excess amount of 1,4-dimethoxyanthracene. Theoretically, 5-teeth intermediate 3.59 can be 
 83
synthesized in nine steps from 1,4-dimethoxyanthracene and 1,4-benzoquinone through three 
repititive tooth expansion transformation cycles.  
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Scheme 3.4 Tooth expansion transformation 
 For the convergent route, cyclododeciptycenehexaquinone (3.1) are retrosynthetically 
split into two parts, one bisdienophile intermediate such as iptycene quinone. (3.57, 3.23, 3.21, 
3.17) and one bisdiene tweezer-like intermediate (3.55, 3.56, 3.58, 3.60) or two identical three 
teeth intermediate (3.62) which contain both quinone ring and 1,4-dimethoxyanthracene moiety 
as shown in Scheme 3.5. The bisdiene intermediate can be synthesized from corresponding 
quinone through o-quinodimethane Diels-Alder reaction as key transformation. (Scheme 3.17) 
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Scheme 3.5 Proposed convergent retrosynthetic analysis of cyclododeciptycenehexaquinone  
 84
3.3.2 Synthesis of iptycenequinones 
From retrosynthetic analysis, the key intermediates towards the cyclododeciptycene-
hexaquinone are iptycenequinones (3.17, 3.21, 3.23, 3.57, 3.59). The prior three of them are 
known compounds. The latter two have never been synthesized before. The general synthetic 
strategy follows the tooth expansion transformation outlined in Scheme 3.4.   
3.3.2.1) Synthesis of 1,4-dimethoxyanthracene  (3.54) 
 1,4-Dimethoxyanthracene (3.54) is an important one-tooth building block for 
iptycenequinones. 1,4-dimethoxyanthracene was synthesized from commercially available 
quinizarin (3.63) in three steps.41 First, quinizarin was reduced with sodium borohydride in 
methanol at 0oC for 4 hours and then quenched with hydrochloric acid to afford 95% of 1,4-
anthracenedione. The reaction mechanism was shown in Scheme 3.6. The addition of hydride to 
the quinone ring to form a tetraol intermediate, which was protonated in acidic condition and 
underwent elimination of water to form 1,4-anthracenedione (3.65).  Then 1,4-Anthracenedione 
(3.65) was treated with sodium hydrosulfite in a 1:1 mixture solvent of water and dioxane at 
room temperature for 10 hours. The 1,4-anthracenediol (3.66) was obtained in 82% yield and 
further methylated in dry DMF solution using sodium hydride as base and methyl iodide as 
methylation agent to give 1,4-dimethoxyanthracene (3.54) in 65% yield.  
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Scheme 3.6 Synthesis of 1,4-dimethoxyanthracene, an important one-tooth building block 
 The 1,4-anthracenedione (3.65) can also be synthesized starting from 1,4-dihydro-2,3-
benzoxathiin-3-oxide (3.67)  and 1,4-benzoquinone as shown in Scheme 3.7. The sultine 3.67 
was refluxed in an excess amount of 1,4-benzoquinone in dry benzene for 2 hours. The 
monoadduct 3.68 was obtained in a yield of 39% after crystallization of the crude mixture from 
methanol.50 Then 3.68 was enolized and oxidized in refluxing acetic acid with choranil to get 
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quantitative yield of 1,4-anthracenedione. This route is not economically better than the route 
mentioned above, but it shows that the 1,4-dimethoxyanthracene can be synthesized from even 
smaller building blocks 3.67  and 1,4-benzoquinone. All the iptycenequinones (3.17, 3.21, 3.23, 
3.57, 3.59) and the target cyclododeciptycenehexaquinone (3.1) are retrieved back to simple one-
tooth component (3.67) and shaft component (1,4-benzoquinone) in synthesis (Figure 3.21).  
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Scheme 3.7 Another route to 1,4-anthracenedione  
3.3.2.2) Synthesis of triptycene bisquinone (3.17) 
The synthesis of triptycene bisquinone was first reported by Iwamura in 1978 starting 
from 1,4-dimethoxyanthracene and 1,4-benzoquinone.13 We modified the procedure with 
basically the same reaction sequence described in Scheme 3.4. First, the Diels-Alder reaction of 
1,4-dimethoxyanthracene and 1,4-benzoquinone in refluxing toluene for 36 hours afforded  a 
mixture of 1:1 endo- and exo-adducts (3.69, 3.70) in a yield of 96%. The two adducts were 
partially separable in column chromatography and they can be differentiated by chemical shifts 
in 1HNMR. It was predicted the chemical shift of methoxy protons of endo-adduct should be 
larger than that of exo-adduct, since the methoxy groups in endo-adduct are closer to 
electronegative carbonyl oxygen atoms, as are protons on the 2,3-position of dimethoxybenzene 
ring. On the contrary, the chemical shift of protons in half-quinone rings of endo-adduct should 
be smaller than that of exo-adduct due to the better shielding effect of 1,4-dimethoxybenzene 
ring in endo-adduct compared to benzene ring in exo-adduct. The less polar one is believed to be 
endo-adduct 3.69 from its 1H NMR spectrum compared to that of more polar one. Some 
chemical shifts of two isomers were given in Scheme 3.8. 
The adducts (3.69, 3.70) were then treated with refluxing acetic acid with a catalytic 
amount of hydrobromic acid for 10 minutes. An offwhite solid was then precipitated. Simple 
filtration will give enolized intermediate 3.71 in 87% yield.42 The enolisation could be done in 
basic conditions using potassium hydroxide in aqueous dioxane reported by Iwamura.13 Previous 
work in our lab showed that the basic condition gave 82% yield of 3.71 after extra acidic workup. 
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(Reference51, page 88) Apparently, the acidic conditions gave better yield and an easier 
procedure. Moreover, based on mechanism, α-protons of carbonyl group were first deprotonated 
by hydroxyl anion in basic condition to form enolate. This was sometimes difficult because of 
steric hindrance of the carbonyl α-proton. In acidic condition, there would no such problem 
because the enolisation is catalyzed by the protonation of more open carbonyl group.   
 Finally, oxidative demethoxylation of intermediate 3.71 using excess amount of cerium 
ammoniuim nitrate (CAN) in a mixture of dioxane and water at room temperature for 5 hours 
gave triptycene bisquinone (3.17) in 93% yield. According to the mechanism proposed by Jacob 
et.al., a bis-methoxyhemiacetal intermediate 3.72 was formed and then methoxy groups was 
cleaved to form quinone ring.52  
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Scheme 3.8 Synthesis of triptycene bisquinone 
When 2 eq. of CAN was used instead of 6 eq. in the same reaction condition, 
dimethoxytriptycene monoquinone 3.73 was formed predominantly because of the much faster 
rate of phenol oxidation compared to the oxidative demethoxylation of the 1,4-
dimethoxybenzene ring.  The intermediate 3.73 is synthetically useful as triptycenebisquinone 
equivalence with one quinone end protected as 1,4-dimethoxybenzene. Compound 3.73 was also 
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synthesized in one pot by treating the Diels-Alder adducts 3.69 and 3.70 with sodium hydride 
and silver oxide in refluxing benzene and THF in our lab. (Reference53, page 57)   
3.3.2.3) Synthesis of cis-pentiptycene trisquinone (3.21) 
 The synthesis of cis-pentiptycene trisquinone (3.21) has been reported by two other 
groups.9, 54 In the recent Zhu and Chen’s paper,9 a modified procedure was taken as shown in 
Scheme 3.9. First, the Diels-Alder reaction of 1,4-dimethoxyanthracene and the 
dimethoxytriptycene monoquinone 3.73 in refluxing acetic acid with p-chloranil as oxidizer 
afforded a mixture of 3.74 and 3.75 in a yield of 82%. Compounds 3.74 and 3.75 were not 
separable and used as a mixture for CAN oxidation. Two pentiptycene trisquinones were formed 
in a yield of 28% and 45% for cis-isomer (3.21) and trans-isomer (3.22) respectively, which 
were separable by column chromatography. The shortcoming of their synthesis was the wanted 
cis-isomer was obtained as minor product. In the other paper by Spyroudis et al., even less yield 
of the similar synthesis was reported.54 They also reported an unusual route to compounds 3.74 
and 3.75 by reaction of dimethoxytriptycene choloquinone (3.76) with sodium methoxide in 
refluxing methanol with impractical yield of 10%. 
OMe
OMe
MeO
OMe
O
O+
3.54 3.73
O
O
MeO
OMeOMe
MeO
HOAc
O
O
Cl
Cl
Cl
Cl
reflux
3.74
O
O
MeO
OMe
OMe
MeO
+
3.75
Not Separable
CAN
CH3CN, H2O
O
O
O
OO
O
O
O
O
O
O
O
+
Separable
3.21 3.22
OMe
MeO
O
O
Cl
3.76
MeO
Na
MeO
H
 ref
lux
 
Scheme 3.9 Literature syntheses of cis-pentiptycene trisquinone 
 Before the publication of Zhu’s work, we synthesized same intermediates 3.74 and 3.75 
in two steps (Scheme 3.2).The four Diels-Alder adducts of 1,4-dimethoxyanthracene (3.54) and 
dimethoxytriptycene monoquinone (3.73) in toluene were first separated and then treated with 
sodium hydride and silver oxide in refluxing benzene to give a mixture of 3.74 and 3.75. But the 
CAN oxidation gave an approximately 2:1 ratio of pentiptycene trisquinones in favor of cis-
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pentiptycene trisquinone (more polar spot in TLC).  The only explanation was that the mixture of 
3.74 and 3.75 synthesized in our lab have a higher portion of 3.74.  
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Scheme 3.10 
 Later, we modified the synthesis of cis-pentiptycene trisquinone. The Diels-Alder 
reaction of dimethoxytriptycene monoquinone (3.73) with 3 eq. of 1,4-dimethoxyanthracene 
(3.54) underwent at 170oC (oil bath temperature) in a sealed tube using dry toluene as solvent for 
36 hours. The yellow precipitate was collected by filteration to give 44% yield of a mixture of 
only two adducts (about 7:3 ratio), which were identified as endo-cis-adduct (3.77) and exo-
trans-adduct (3.78) based on both NMR methods and derivtization. The filtrate was concentrated 
and purified by column chromatography (silica gel) to give  another 49% yield of a mixture of 
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four isomers in a ratio of approximately 1:4:7:6 (endo-cis-adduct 3.77, exo-trans-adduct 3.78, 
endo-trans-adduct 3.79, exo-cis-adduct 3.80) from integrals in 1HNMR. The calculated total 
yield of four adducts was 93% with 31% for 3.77, 25% for 3.78, 19% for 3.79, 18% for 3.80 
respectively. A mixture of two isomers 3.79 and 3.80 could be obtained from column 
chromatography followed by recrystalization. 
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Scheme 3.11 
 The 1HNMR assignments of four adducts were given in Scheme 3.10. They were both 
deduced from the derivatization results and 2D-NOESY/COSY experments. For example, the 
precipitate containing two isomers only gave more polar cis-pentiptycene trisquinone after 
enolization and oxidative demethoxylation. From the structure of four possible adducts, we knew 
only endo-cis and exo-trans-adducts would give cis-pentiptycene trisquinone. Thus we knew 
which two isomers were in the precipitate. Then from the cross peaks in 2D-COSY and 2D-
NOESY spectra, the chemical shift of each proton in two isomers could be identified. The 
upshifted chemical shift values were underlined. They are characteristic to the corresponding 
structural moiety, which were useful for identifying the structure of Diels-Alder adducts and 
their derivatized iptycenequinones.   
 With four Diels-Alder adducts identified, the synthesis of cis-pentiptycene trisquinone 
could be started either from two isomers (3.77, 3.78) or four isomers. Enolisation of adducts in 
refluxing acetic acid with a catalytic amount of hydrobromic acid gave over 90% yield of  
tetramethoxypentiptycene monophenol (3.81 or a mixture of 3.81 and 3.82). Then CAN 
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oxidation in aqueous acetonitrile gave over 80% yield of pentiptycene trisquinone (3.21 or a 
mixture of 3.21 and 3.22).  
In our synthetic route, the total yield of the three-step-synthesis of cis-pentitycene 
trisquinone was at least 40% compared to 23% yield of two-step synthesis reported by Zhu.9 
Also, pure intermediates 3.74 and 3.75 could be obtained using diacetoxyiodobenzene as oxidant 
from pure 3.81 or 3.82, which were derivatized from a mixture of two adducts [(3.77 and 3.78) 
or (3.79 and 3.80)]. The tetramethoxypentiptycene monoquinone 3.74 and 3.75 are useful 
intermediates for derivatization as the middle quinone ring can be converted to many functional 
groups.10 
3.3.2.4) Synthesis of cis,cis-heptiptycene tetraquinone (3.23) 
 cis, cis-Heptiptycene tetraquinone (3.23) was first reported in 1982,11 however, its first 
detailed synthesis was only reported recently in a yield of 11% from triptycene bisquinone (3.17) 
by Zhu et al..9  Their synthesis was a two step synthesis starting from a one-pot Diels-Alder-
enolisation-oxidation reaction of triptycene bisquinone with excess amount of 1,4-
dimethoxyanthracene in refluxing acetic acid in the presence of chloranil as oxidizer and then 
CAN oxidative demethoxylation to give a mixture of three heptiptycene tetraquinones in a ratio 
about 1:2:1 for cis,cis-(3.23), cis,trans-(3.24), trans,trans-(3.25) isomers respectively. (Scheme 
3.2) 
 We tried a Diels-Alder reaction of triptycene bisquinone and 1,4-dimethoxyanthracene at 
150 oC in a sealed tube using toluene as solvent for 2 days. To our surprise, a 1:1 ratio of two 
adducts (3.83 and 3.84) precipitated in 87% yield showed extraordinary face-selectivity in the 
Diels-Alder reaction. If we considered that two faces of triptycene bisquinone have no facial 
seletivity, there would be seven possible diadducts formed as shown in Figure 3.23. (This 
conclusion is also applied to iptycenequinone 3.21 and 3.23) 
 So what is the face-selectivity and where does it come from? One would guess that since 
the endo-face contains two electron deficient quinone rings compared to only one in the exo-face. 
Thus endo-face would attract electron-rich 1,4-dimethoxyanthracene better based on charge-
transfer interaction as discussed in the background part. Let’s suppose the first equivalent 1,4-
dimethoxyanthracene added from endo-face of anthracene bisquinone and blocked the second 
1,4-dimethoxyanthracene molecule from adding to the same face. Because methoxy groups are 
electron-donating, the dimethoxybenzene ring (C ring, Scheme 3.4) has more electron density 
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than benzene ring (A ring, Scheme 3.4) in the 1,4-dimethoxyanthracene molecule, 1,4-
dimethoxyanthracene preferred inward alignment with C ring close to the other quinone ring that 
was not reacting. The second 1,4-dimethoxyanthracene molecule then had to add from exo-face. 
The 1:1 ratio of two diadducts suggested that the addition of second 1,4-dimethoxyanthracene 
did not have inward-outward selectivity. That is reasonable since the addition of second 
molecule of 1,4-dimethoxyanthracene didn’t have a quinone ring to induce such selectivity.    
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Figure 3.23 Seven possible diadducts formed by triptycene bisquinone and 1,4-
demethoxyanthracene. (in, means the dimethoxy ring pointing inward to triptycene bisquinone; 
out, means the dimethoxy ring pointing outward to triptycene bisquinone.) 
To verify this hypothesis, one equivalent of 1,4-dimethoxyanthracene was reacted with 
triptycene bisquinone, predominantly one monoadduct was formed. The proposed structure was 
verified by 2D-NOESY experiment. 
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Scheme 3.12 Synthesis of cis,cis-heptiptycene tetraquinone (3.23). 
From structure of the monoadduct 3.90, two diadducts precipitated were deduced as 3.83 
and 3.84 respectively. The assignments of chemical shift were based on 2D-COSY and 2D-
NOESY. In careful column chromatography conditions, two isomers could be separated with 
the less polar one being 3.83.  The synthesis of heptiptycene tetraquinone 3.23 and 3.24 were 
then pretty straight-forward as shown in Scheme 3.12. Enolisation of corresponding diadducts 
3.83 in refluxing acetic acid with catalytic amount hydrobromic acid would afford 
corresponding tetramethoxyheptiptycene bisphenol (3.85) in 68% yield. Then the CAN 
oxidative demethoxylation would give the cis,cis-heptiptycene tetraquinone (3.23) in a yield of 
68%. The total yield of 3.23 in three steps was 20% , which was almost twice the yield reported 
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by Zhu.9 The structure of 3.23 was further verified by X-ray crystal diffraction as shown in 
Figure 3.24.   
 
Figure 3.24 X-ray structure of cis,cis-heptiptycene tetraquinone (3.23) 
3.3.2.5) Synthesis of cis,cis,cis-noniptycene pentaquinone (3.57) 
 Similar to the synthesis of cis,cis-heptiptycene tetraquinone, the four-teeth iptycene 
quinone 3.57 was synthesized from cis-pentiptycene trisquinone (3.21) which is two-teeth less. 
The Diels-Alder reaction of 3.21 with excess amount of 1,4-dimethoxyanthracene in a sealed 
tube at 150 oC  using toluene as solvent for 36 hours gave mainly two diadducts which were 
separated by careful column chromatography. The less polar one corresponded to the (endo-in, 
exo-out)-isomer, while the more polar was the (endo-in, exo-in)-isomer. The structural 
assignments were based on so called “structural inherent NMR indicators.” In other words, 
certain structural moieties in Diels-Alder adducts of iptycene quinone have unique patterns of 
peaks reflected in proton NMR which is inherent to the structure and can be used to identify the 
existence of this structure. As we seen in adducts 3.78, 3.83, the typical two upshift doublet-
doublet peaks around δ 6.2~6.3 and 6.7~6.8 suggest an exo-out 1,4-methoxyanthracene moiety. 
The upshift of OMe proton (singlet around 3.6) and the corresponding α aromatic proton (singlet 
around δ 5.8) in adducts 3.80 and 3.84 indicate an exo-in 1,4-dimethoxyanthracene moiety.  Here 
an even stronger upshift of OMe group (singlet around δ 3.5) and the corresponding α aromatic 
proton (singlet around δ 5.3) for both diadducts 3.92 and 3.93 indicates a common new structural 
moiety for them. It could only be endo-in 1,4-dimethoxyanthracene moiety since endo-out 
should have typical upshifted doublet-doublet peaks and the possiblity of exo-in and exo-out had 
already excluded. This is reasonable, since the first equivalent of 1,4-dimethoxyanthracene was 
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added to the more electrodeficient endo-face of cis-pentiptycene tetraquinone to form endo-in 
monoadduct 3.91 (Similar to the case of triptycene bisquinone 3.17), which was also verified 
from 2D-COSY and 2D-NOESY experiment.  Then the second equivalence of 1,4-
dimethoxyanthracene added from exo-face of the other end quinone moiety with no in-out 
selectivity without the help of the other quinone moieties.  
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Scheme 3.13 
 Then pure diadduct 3.92 was treated with refluxing acetic acid and a catalytic amount of 
hydrobromic acid for 30 minutes. After evaporation of acetic acid, an unexpected messy crude 
product was formed, and the desired enolised intermediates 3.94 were difficult to purify because 
of high polarity and are inclined to be oxidized by air. We then treated the crude enolized 
product with diacetoxyiodobenzene in acetone. The oxidation took about 10 minutes to half an 
hour. The tetramethoxynoniptycene trisquinone intermediate 3.95 was obtained in a yield of 20%. 
Final oxidative demethoxylation using CAN would give the cis, cis, cis-noniptycene 
pentiquinone(3.57) in 30% of yield. The reduced yield of oxidative demethoxylation was 
probably because of the electron withdrawing effect of middle quinone rings, which might be 
caused by through-bond homoconjugative interaction as we discussed in the background part. 
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The electron density in the terminal 1,4-dimethoxybenzene rings was reduced, as were their 
susceptiblity to oxidation reagent.  
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Scheme 3.14 Synthesis of cis,cis,cis-noniptycene pentaquinone (3.57). 
 The yield of cis,cis,cis-noniptycene pentiquinone (3.57) dropped tremendously compared 
with its one-tooth less cis,cis-heptiptycene tetraquinone (3.23). Better conditions for enolization 
and oxidative demethoxylation are needed for practical synthesis of it as a building block for 
cyclododeciptycenes. 
3.3.2.6) Synthesis of cis,cis,cis,cis-undeciptycenehexaquinone (3.59) 
 Similar to the synthesis of four-teeth iptycene quinone, the five-teeth all cis-iptycene 
quinone 3.59 was synthesized from three-teeth cis,cis-heptiptycene tetraquinone (3.23). The 
Diels-Alder reaction of 3.23 with excess amount of 1,4-dimethoxyanthracene in a sealed tube at 
150oC using toluene and tetrachloromethane as solvent for 36 hours, two diadducts were 
precipitated in a ratio of 4:1. Tetrachloromethane was used as cosolvent to increase the solubility 
of the tetraquinone (3.23). It is a nonpolar solvent like toluene and would not change the face-
selectivity of the Diels-Alder reaction. Similarly, structures of two diadducts were deduced both 
from “structural inherent NMR indicators” and predicted face-selectivity. As before, we predict 
the first equivalent of 1,4-dimethoxyanthracene added from endo-face and formed endo-in 
monoadduct 3.96 as the major isomer. The second equivalent of 1,4-dimethoxyanthracene 
reacted from exo-face of the other quinone moiety in the other end without in-out selectivity.  
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This prediction was mostly correct. The two isomers in the precipitate showed the predicted 
“structural inherent NMR patterns”. They both have a tremendous upshift OMe protons (singlet, 
δ ≈ 3.34) and corresponding α protons (singlet, δ ≈ 4.8), which means they have an endo-in 
dimethoxyanthracene moiety. The major isomer in precipitate (also less polar spot from careful 
column chromatography) has a characteristic set of two doublet-doublet peaks around δ 6.20 and 
δ 6.70, which is an indicator for exo-out configuration. The major isomer in the precipitate was 
then identified as the structure 3.97a in Scheme 3.15. The other isomer was determined as 3.97b.  
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Scheme 3.15 
 From the above discussion, one would expect the formation of 3.97a and 3.97b be equal. 
However, after combined recovered diadducts from filtrate, yields for 3.97a and 3.97b were 58% 
and 25% respectively. What was the reason for a less amount of (endo-in, exo-in)-diadduct 
formed in the reaction? We noticed an abnomal upshift of the α protons of carbonyl groups in 
the exo-site for both adducts 3.97a and 3.97b with adduct 3.97b upshifted δ 0.21 more (Scheme 
3.15, protons labeled with arrow and chemical shift). This big difference in chemical shift means 
the α protons of carbonyl groups in exo-site of 3.97b are closer to a deshielding 1,4-
dimethoxybenzene ring of the endo-in dimethoxyanthracene moiety. It may explained by a 
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“seesaw” model as shown in Figure 3.25. The exo-dimethoxyanthracene moiety together with 
the α proton of carbonyl group worked like a “seesaw” with the α carbon of carbonyl as pivot. 
Because the diemthoxybenzene ring is sterically larger than benzene ring, it is relatively 
“downward” in isomer 3.97b. So the α proton of carbonyl group is relatively “upward” and 
closer to the inner dimethoxy benzene ring, which increases the repulsion between them. The 
raised repulsion in its closely packed structure caused diadduct 3.97b being energetically less 
favorable than the desired (endo-in, exo-out)-diadduct 3.97a used for synthesis of all cis-
undeciptycenehexaquinone (3.59). It was somewhat amazing how a combination of face-
seletivity and steric effects would finally afford one out of seven possible isomers in 58% yield 
in this special case.    
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Figure 3.25 
 Similarly, pure diadduct 3.97 was treated with refluxing acetic acid with catalytic amount 
of hydrobromic acid for 30 minutes. After evaporizing acetic acid, a messy crude product was 
formed and the enolised intermediates 3.98 were difficult to purify because of high polarity and 
inclined to oxidation by air. We then oxidized the crude enolized product with 
diacetoxyiodobenzene in acetone. The tetramethoxyundeciptycene tetraquinone intermediate 
3.99 was obtained in a yield of 29%. Final oxidative demethoxylation using CAN only gave the 
cis, cis, cis, cis-undeciptycene hexaquinone (3.59) in a yield of 30%. The low yield was probably 
related to through-bond homoconjugative interaction of inner quinone moieties. Again, better 
conditions for enolization and oxidative demethoxylation are need. 
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Scheme 3.16 Synthesis of cis,cis,cis,cis-undeciptycenehexaquinone (3.59). 
3.3.3 Synthesis of bisdimethoxyanthracenes 
The bisdimethoxyanthracenes (3.56, 3.58, and 3.60) are bisdiene building blocks for 
cyclododeciptycenes. Pentacene 3.55 can also be seen as a bisdiene building block. After first 
Diels-Alder reaction with its anthracene part, the remaing three rings can be aromatized to 
generate another anthracene unit for a second Diels-Alder reaction. Currently we have only 
synthesized a 2-teeth bisdiene building block 3.55 and a 3-teeth bisdiene building block 3.56. 
The key step to them were the Diels-Alder reaction of corresponding quinone with 1,4-dihydro-
2,3-benzoxathiin-3-oxide (3.53), an “o-quinodimethane” precursor.   
“o-quinodimethane” is a useful and efficient diene intermediate for Diels-Alder 
reactions.55, 56 There are many ways to generate it, including 1,4-elimination of α,α’-dihalo-o-
xylenes,  thermolysis of benzocyclobutenes, photoenolization of o-methylbenzaldehydes,  
Hoffman elimination of (o-methylbenzy1)trimethylammonium hydroxide, decomposition of 
benzo-fused heterocyclic compounds.55 We chose 1,4-dihydro-2,3-benzoxathiin-3-oxide (3.53) 
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as precursor because it generates o-quinodimethane at mild conditions upon heating around 80 
oC and does not form other organic or inorganic byproducts except for sulfur dioxide in presence 
of a dienophile. The gereration of sulfur dioxide in situ has another advantage. Sulfer dioxide 
catalyzes the enolisation of initial formed Diels-Alder adducts, so the Diels-Alder reaction and 
enolisation can be performed in one-pot.  If there is no dienophile present, o-quinodimethane 
generated at the reaction temperature will react back with sulfur dioxide to form sideproduct 1,3-
dihydro-2-benzothiophene-2,2-dioxide (3.100) 
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Scheme 3.17 Formation of an 1,4-dimethoxyanthracene from quinone end. 
 The general reaction sequences and typical reaction conditions for transformation of a 
quinone to 1,4-dimethoxyanthracene moiety were given in Scheme 3.17.  The reaction of 
quinone with excess amount of 1,4-dihydro-2,3-benzoxathiin-3-oxide (3.53) in a sealed tube at 
temperature around 145oC would give phenol as the major product.  After methoxylation and 
oxidation, the 1,4-dimethoxyanthracene unit was installed.  
4.3.3.1) Synthesis of 1,4-dihydro-2,3-benzoxathiin-3-oxide (3.53)57 
 The sultine 3.53 was synthesized in two steps. First, o-xylene 3.101 was brominated in 
refluxing benzene using N-Bromosuccinimide (NBS) as a brominating reagent and benzoyl 
peroxide as a radical initiator for 2 hours. During concentration of the reaction mixture, 
dibromide 3.102 was precipited together with succinimide. The latter can be washed away by 
aqueous workup and the dibromide was obtained in 41% yield. The next step is treatment of 
dibiromide 3.102 with sodium hydroxymethanesulfinate (Rongalite) and a cataylic amount of 
tetrabutylammonium bromide (TBAB) in N,N-dimethylformamide (DMF) at 0 oC for 3 hours. 
The yield for 3.53 was 65% from the dibromide. 
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Scheme 3.18 
 The mechanism for the last step was proposed in Scheme 3.19. Intermolecular SN2 
reaction of Rongalite with the dibromide first formed sulfone intermediate 3.103, which 
underwent intramolecular SN2 to displace the second bromide anion. The intermediate 3.104 then 
eliminated a molecule of formaldehyde to give the sultine 3.53. 
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Scheme 3.19 
3.3.3.2) Synthesis of 6,13-dimethoxy-5,14-dihydropentacene (3.55) 
 As generalized in Scheme 3.17, synthesis of the pentacene diene component 3.55 started 
from the Diels-Alder reaction of 1,4-anthracenedione (3.65) and  the sultine (3.53). When two 
reactants were refluxed in a sealed tube using toluene as solvent at an oil bath temperature of 
150oC for 30 hours, a dark green solid 3.105 precipitated in a yield of 91%. The phenol 3.105 
was methylated by methyl iodide in DMF using sodium hydride as base to afford 62% of 3.55. 
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Scheme 3.20 
3.3.3.3) Synthesis of 6,8,15,17-tetramethoxy-7,16-dihydro-7,16-(o-benzeno)heptacene (3.56) 
 The bisdimethoxyanthracene 3.56 was the diene component used for successful 
cyclization as we would discuss later. Its synthesis basically followed the general sequence in 
Scheme 3.17, though it had some problems.  
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First, the Diels-Alder reaction of triptycene bisquinone (3.17) and an excess amount of 
3.53 in refluxing toluene gave almost exclusively monoadduct. It seemed the Diels-Alder 
reaction of the second quinone was much slower. Increasing temperature by changing to a sealed 
tube condition would certainly enhance the reaction rate, but also would increase the rate of 
decomposition of sultine 3.53 to sulfone 3.100. The right temperature was important for getting 
the diadducts. Besides, the monoadducts would cause a purification problem in later steps since 
it would be converted to monoanthracene 3.108, which was difficult to separate from 
bisanthracene 3.56 by column chromatography. It was necessary to find a reliable procedure to 
get diphenol 3.106 in good purity. A modified procedure was as following. First, Diels-Alder 
reaction of 3.17 and 4 equivalents of 3.53 was refluxed in a sealed tube at 140o for 24 hours. The 
precipitate usually contained over 70% of diadducts and partially or fully enolised phenols. An 
extra step of enolisation in refluxing acetic acid with small amount of hydrobromic acid would 
give a precipitate which contains mainly diphenol 3.106 since the monophenol derived from 
monoadduct has better solubility in acetic acid and remained in solution. This enolisation step 
served as an extra purification step. The diphenol was obtained in a yield of 51% in two steps. 
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Scheme 3.21 Synthesis of bisdimethoxyanthracene 3.56. 
 Second, the methylation of diphenol 3.106 also proved difficult at the beginning. The low 
solubility of 3.106 in DMF caused the previous methylation conditions for 3.105 not feasible 
here. A harsh methylation condition using methyl p-toluenesulfonate, potassium carbonate in 
refluxing 1,2-dichlorobenzene at around 180 oC was found and gave a tetramethoxy intermediate 
3.107 in a yield of 91%. 
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 The last step aromatization was an easy step. The tetramethoxy intermediate 3.107 was 
stirred with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) in toluene to give 
bisdimethoxyanthracene 3.56 in 89% yield. 
3.3.4 Towards the synthesis of cyclododeciptycene based molecular gears 
3.3.4.1) Unsuccessful effort starting from cis,cis,cis,cis-undeciptycenehexaquinone (3.59) 
 Since the 5-teeth iptycene quinone 3.59 was the closest building block to the target 
molecular gear 3.1, we tried to convert it to 6-tooth intermediate 3.61, which has a quinone 
moiety and an anthracene moiety ready for Diesl-Alder reaction. However, the attempted Diels-
Alder reaction of either the sultine or benzocylcobutene failed to give the expected adduct 3.110. 
The iptycene quinone 3.59 seemed to undergo fragmentation upon heating. The stepwise 
synthetic route did not work.  
O
S
O
O
O
O
O
O
O
O
OO
O
O
O
O
O
O
O
O
O
O
O
O
O O
O
H
H
H
H
3.59
3.53
3.109
3.110
O
O
O
O O
O
O
O
O
O
HO
OH
O
O
O
O O
O
O
O
O
O
MeO
OMe
O
O
O
O O
O
O
O
O
O
MeO
OMe
enolisation
methylation DDQ
3.111 3.112 3.61
 
Scheme 3.22 
3.3.4.2) Convergent synthesis: finding suitable bisdiene and dienophile components. 
 The unsuccessful synthesis of stepwise route made us resorted to convergent synthetic 
routes shown in Scheme 3.5. Among five proposed routes, route I and II have starting materials 
that have already been synthesized.  
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Route I uses the four-tooth iptycene quinone 3.57 as the dienophile and pentacene 3.55 as 
the bisdiene component. This route has an advantage over the others because most likely only 
one adduct will be formed. For a curved structure like 3.57, the endo-face is hindered.  If endo-
adducts are excluded, the remaining two possible adducts would be exo-in and exo-out-adducts. 
The transition state energy analysis shows the exo-in alignment would be more steric hindered 
(Figure 3.26). Howerver, the pentacene 3.55 turned out to be not a reactive diene component. 
Usually, the Diels-Alder reaction of 1,4-dimethoxyanthracene with simple quinone happened 
above 80 oC.  But a model Diels-Alder reaction of the dimethoxy pentacene 3.55 with simple 
1,4-benzoquinone was slow even at 150 oC in a seal tube using toluene as solvent. Since the 
pentiquinone 3.57 may not be stable in high temperature as hexaquinone 3.59 and also the 
current synthetic yield to 3.57 was low, this route was abandoned. 
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Figure 3.26 
 We then resorted to route II. Since slightly change of anthracene structure greatly 
changed its reactivity in Diels-Alder reaction as in the case of 3.55, to ensure the reactivity of 
bisdimethoxyanthracene 3.56, a model reaction with cis-pentiptycene tetraquinone 3.21 was 
carried out.  To our delight, the Diels-Alder reaction happened in refluxing benzene, which 
means bisdimethoxyanthracene 3.56 is as active as 1,4-dimethoxyanthracene. Two major 
monoadducts were separated in about 1:1 ratio (Scheme 3.23). However, as we looked for 
typical doublet-doublet peaks around δ 6.2~6.3, which is characteristic for exo-adducts as one of 
“structural inherent NMR indicators”, we did not find them. Instead, we found a pair of more 
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upshifted doublet-doublet peaks around δ 5.9 for two isomers, which could only be explained as 
endo-adducts. The endo-face is more electron-deficient and thus, it is easier to form charge-
transfer complexes with more readily accessible benzene rings in the dimethoyanthracene moiety.  
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Scheme 3.23 
From this model reaction, we would expect that cis,cis-heptiptycene tetraquinone 3.23  
react with bisdimethoxyanthracene 3.56 following the same face-seletivity and give the endo-
adducts as major products. For this reason, the direct use of 3-teeth iptycene quinone 3.23 as 
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dienophile was initially not considered.  Instead, a 3-tooth iptycene quinone equivalent 3.91 was 
chosen. Compound 3.91 was previously separated in the Diels-Alder reaction of cis-pentiptycene 
trisquinone with excess amount of 1,4-dimethoxyanthracene (Scheme 3.13) .  Its structure had 
been verified by NOESY and COSY (Figure 3.27). Since the endo-face was already blocked by 
one 1.4-dimethoxyanthracene unit, another diene moiety has to react from exo-face unless a 
retro-Diels-Alder reaction happens and the 1,4-dimethoxyanthracene moiety in endo-face was 
split out.   
 
Figure 3.27 Importane NOE correlations of 3.91 
3.3.4.3) Synthesis of (5R,5aS,7R,9S,10aS,11S,13S,22R,24R,24aR,26S,28S,29aR,30S)-5,5a7,9, 
10a,11,13,22,24,24a,26,28,29a,30-Tetradecahydro-1,4,12,14,21,23-hexamethoxy-5,30:7,28:9,26: 
11,24:13,22)-penti(o-benzeno)tridecacene-6,8,10,25,27,29-hexaone (3.117) 
 The Diels Alder reaction of endo-face blocked dienophile 3.91 with bisdimethoxyanthra-
cene 4.56 in toluene at 100 oC for 36 hours to give a 3:7 ratio of adducts 3.117 and 3.118 in a 
yield of 51% (Scheme 3.24). They were difficult to separate from each other by column 
chromatography. But they can be differentiated from 1HNMR. The typical doublet-doublet peaks 
around chemical shift δ 6.20~6.30 not only verified the addition from exo-face, but also reflect 
slight disturbance of structure due to the “flip” of bisdimethoxyanthracene moiety. Their 
chemical shifts were δ 6.30 and δ 6.25 for cis-isomer 3.117 and trans-isomer 3.118, respectively. 
From the chemical shifts, we knew the distance between benzene ring A and benzene ring B of 
cis-isomer 3.117 is longer than that of trans-isomer 3.118 (Scheme 3.24). A seasaw model 
shown in Figure 3.28 would give a simplified explaination. The barycenter of bisanthracene 
moiety for adduct 3.117 is relatively downwards compared with its isomer 3.118, so the other 
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benzene end (ring B) moves upward and the distance of  two benzene rings were increased. The 
full assignment of 1H NMR peaks were based on 2D-ROESY experiment. 
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Figure 3.28 
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3.3.4.4) Enolization of (3.117) under basic conditions to afford (5R,7R,9S,11S,13S,22R, 
24R,26S,28S,30S)-5,7,9,11,13,22,24,26,28,30- decahydro-1,4,6,8,10,12,14,21,23,25,27,29-dode-
camethoxy-5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno)tridecacene (3.119)  
 Compound 3.117 has all six teeth installed in all cis-fashion. The next step was to enolise 
two Diels-Alder reaction sites in the molecule to bring two ends closer together. The attempt of 
enolization in refluxing acetic acid with hydrobromic acid gave messy decomposed products. 
Then we tried basic conditions using sodium hydride and methyl iodide in DMF, hoping enolate 
formed in situ would be quenched by methyl iodide and give more stable products. Actually, the 
mixture of two adducts 3.117 and 3.118 was stirred with sodium hydride in dry DMF at 0oC for 
half an hour  before adding methyl iodide and letting the reaction mixture slowly warm up to 
room temperature over the course of two hours. The typical brown color of charge-transfer band 
between endo-face dimethoxybenzene and quinone rings disappeared. Two new fluorescent 
spots close to each other in TLC together with several other spots appeared. It was a little of a 
surprise that these two products might not contain a quinone moiety since if there were 
fluorescence quenching quinone moiety in the molecule, the whole molecule should show no 
fluorescent acitivity. The less polar spot was later identified as 3.119, which was clearly derived 
from adduct 3.117. The more polar spot was the corresponding product 3.120 from adduct 3.118. 
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Scheme 3.25 
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Figure 3.29 
 The circular structure of 3.119 was verified by its 2D-ROESY spectrum. From 1H NMR, 
the peaks of 2,3-H in the terminal dimethoxy benzene was easily distiguished by the big upshift 
of the chemical shift at δ 4.53. Another group of protons easy to identify are the 15,20-H (δ 8.57) 
in anthracene ring as the most downshifted protons in the molecule. In 2D-ROESY spectrum, 
spatially close protons show cross peaks. For molecule 3.119, we can check for space 
relationship of nearby protons either starting from 2,3-H or 15,20-H.  Since 2,3-H (δ 4.53) is 
close to 1,4-OMe, this two peaks should show strong crosspeak. Among six OMe peaks, only 
one (δ 3.33) shows cross peaks with 2,3-H, then we know this peaks corresponds to 1,4-OMe.  
1,4-OMe (δ 3.33) shows two crosspeaks with chemical shift δ 4.53 and δ 5.80 respectively. From 
its structure, we know 1,4-OMe group is close to 2,3-H and 5,30-bridge H. Since we already 
know δ 4.53 belongs to 2,3-H, δ 5.80 must be of 5,30-H. Then we check the crosspeaks of 5,30-
bridge-H (δ 5.80) not counting the already known 1,4-OMe, we find the chemical shift of 6,29-
OMe is δ 3.66. In this way, we assigned all the chemical shifts in the “shaft “ part of the 
molecule 3.119, from 2,3-H to 15,20-H as δ 4.53 (2,3-Ar-H), 3.33 (1,4-OMe), 5.80 (5,30-bridge-
H), 3.66 (6,29-OMe), 5.78 (7,28-bridge-H), 3.77 (8,27-OMe), 5.82 (9,26-bridge-H), 3.81 (10,25-
OMe), 5.92 (11,24-bridge-H), 3.91 (12,23-OMe), 6.14 (13,22-bridge-H), 4.03 (14,21-OMe), and 
8.57 (15,20-Ar-H). Similar crosspeaks can be found in 2D-ROESY of 3.120 for assignment of 
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chemcal shifts. Besides the nomal crosspeaks indicated by bond connections, a crosspeak of 2,3-
H and 15,20-H is found only in 2D-ROESY of 3.119 and not 3.120, indicating that 2,3-H and 
15,20-H are close to each other in space. The strong upshift of 2,3-H  is because 2,3-H are 
strongly shielded by dimethoxyanthracene ring in that close range. From the 2D-ROESY of 
3.120, cheimcal shifts of 2,3-H (δ 6.30) in 3.120 is determined by its abnormal smaller cross 
peaks with 13,22-βH (larger chemical shift) than 13,22-γH. A bridge-H should have a bigger 
crosspeak for its β-H than γ-H, because β-H is closer. Based on the 2,3-H in both 3.119 and 
3.120, an estimated 1.77 upfield shift of chemical shift due to the closeness of two ends of 3.119 
was deduced.  
3.3.4.5) Enolization of (3.117) in acidic conditions to afford (5R,7R,9S,11S,13S,22R, 
24R,26S,28S,30S)-5,7,9,11,13,22,24,26,28,30-decahydro-1,4,12,14,21,23-hexamethoxy-
(5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno)tridecacene (3.121) 
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Scheme 3.26 
 The mixture of six-teeth adduct 3.117 and 3.118 was stirred at room temperature for 36 
hours in acetic acid with a catalytic amount of hydrobromic acid. After solvent was removed 
under vacuum, the residue was dissolved in acetone and oxided with diacetoxyiodobenzene to 
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afford the enolized product 3.121 and 3.122 in a yield of 25%. Similar to 3.119, chemical shift of 
1,2-H (δ 4.81) in 3.121 is upshifted 1.46 relative to that in 3.122.   
3.3.4.6) Unsucessful effort to selectively convert 1,4-dimethoxybenzene ring of 3.119 and 3.121 
to quinone ring.  
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Scheme 3.27 
 The six-tooth intemediate 3.119 and 3.121 are circular and two ends are close to each 
other. The next goal is to selectively oxidize the 1,4-dimethoxyanthracene end to quinone and 
form 3.127 or 3.128, which are predicted to cyclize under suitable conditions. However, the 
CAN oxidative demethoxylation of 3.121 and 3.119 gave demethoxylation product at the 
anthracene ring first. Only 3.123 or 3.125 were separated. If excess amount of CAN was used, 
compound with two quinone ends, 3.124 or 3.126, were formed, which cannot be cyclized. Here 
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we met another dead synthetic route. A rational detour was to change the protecting group in the 
1,4-dimethoxybenzene end. 
3.3.4.7) Unsucessful attempt to synthesize 3.127 or 3.128 by introducing p-
methoxyphenylmethoxy protecting group. 
 Since the methoxy group on benzene ring was difficult to remove without affecting the 
methoxy groups in anthracene ring, we started to explore the possible replacement of 1,2-
dimethoxy groups in 3.119 or 3.121 by p-methoxyphenylmethoxy (MPM) group. The 
retrosynthetic analysis went back to replacement of methoxy group in 3-teeth quinone 
intermediated 3.91, which was easy to realize by reacting the 1,4-di-MPM-anthracene 3.129 with 
cis-penticene trisquinone to afford the MPM protected 3-teeth quinone intermediate 3.130 in 
36% yield. Further Diels-Alder reaction with bisdimethoxyanthracene 3.56 at 110oC gave 28% 
of 3:7 ratio of two adducts 3.131 and 3.132. 
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Scheme 3.28 
 However, when a mixture of 3.131 and 3.132 was treated in either NaH / DMF or HBr / 
HOAc conditions, no identificable enolised product was isolated. Side reaction became dominant 
in both conditions. Possible reasons might be in basic conditions, bulky MPM group blocks 
hydride attacking α-proton of carbonyl group, while in acid conditions, MPM group might come 
off and destablize the molecule.  
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    How about removing MPM groups in 3.131 and 3.132 first before enolization? The 
model reaction of deprotection of intermediate 3.130 by DDQ in toluene at 80 oC for overnight 
gave deprotected product 3.133 from crude 1H NMR. However compound 3.133 decomposed 
during workup probably due to loss of stablizing charge-transfer interactions. So, it is not a good 
idea to remove MPM group before enolization. Besides, it was predicted that deprotection of 
MPM groups in 3.131 and 3.132 might need even a higher temperature due to steric hinderance. 
At that temperature, retro-Diels-Alder reaction might also occur.  
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3.3.4.8) Diels-Alder reaction of tetraquinone and bisdimethoxyanthracene and final cyclization  
Since both previous efforts of selective demethoxylation to form one quinone end while 
leaving the other dimethoxyanthracene end intact and protecting group manipulation failed. The 
direct Diels-Alder reaction between the tetraquinone and bisdimethoxyanthracene seemed to be a 
possible route left for trying. Although this route was abandoned from previous study because of 
the formation of predominantly unwanted endo-adducts. (That was the reason why previously we 
tried to go around this face-selectivity problem by so-called endo-face blocking strategy.)  We 
hoped a small amount of exo-adducts could be separated and identified from proton NMR 
spectroscopy from their distinguishable structural units. It was predicted the exo-cis adduct 
would undergo cylization after enolization. 
When tetraquinone 3.23 and 1 eq. of bisdimethoxyanthracene 3.56 was refluxed in 
toluene under argon for 24 hours, the crude proton NMR showed predominantly two endo-
adducts were formed as expected, which was characterized by the upfield shift of newly formed 
benzene tooth proton up to δ 5.7 because of strong shielding effect of endo-face. For exo-adducts, 
the expected new formed benzene tooth proton is around δ 6.3, which was difficult to identify in 
crude 1HNMR due to overlapping with other signals. We then took a closer look at protons near 
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the Diels-Alder connection sites. Beside the major δ 4.86 peak, a minor δ 4.93 peak with integral 
only about 1/10 that of the major pear might be the evidence of forming exo-adducts. A similar 
pattern was found for δ 2.92 and 2.87 in a ratio of 10:1, which are α−protons of carbonyl groups.  
The separation of endo-adducts and exo-adducts turned out to be difficult. The four 1:1 
adducts were only partially separated in column chromatography. Pure samples of each of the 
two endo-adducts together with a mixture of two endo-adducts were obtained by PTLC methods 
using toluene-chloroform-ethyl acetate (25:25:2, V:V:V) as eluent. HPLC conditions for 
separation of these isomers are absolutely needed later for scaled-up reactions. The yield for exo-
adducts after purification in the first trial reaction was only about 2.7%. Starting from 57 mg of 
the tetraquinone and 45 mg of bisdimethoxyanthracene, only 2.8 mg of unseparable two exo-
adducts 3.136 and 3.137 in a 1:1 ratio was obtained, but, it was enough for a trial of cyclization.  
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Scheme 3.30 Diels-Alder reaction of tetraene 3.23 and bisanthracene 3.56. 
The small amount of exo-adducts was first stirred in acetic acid at room temperature over 
night for enolizing the keto α-CH. No appreciable change happened after workup. The recovered 
sample was treated with refluxing acetic acid under argon for half an hour. After aqueous 
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workup, the residue was dissolved in acetone and treated with diacetoxyiodobenzene to oxidize 
phenol to quinone.  Besides unreacted starting material, TLC showed two newly formed spots 
with higher Rf. values. After column chromatography, the less polar new spot was isolated in 0.6 
mg. 1HNMR showed the disappearance of quinone proton peak (around δ 6.6) and DA adducts 
characteristic peaks (around δ 4.9, 2.9). The single methoxy peak around δ 3.8 and 1:2:2:1 ratio 
of bridge proton peaks around δ 6.0 showed symmetry of the molecule, which perfectly matches 
the predicted cyclized product 3.138 from the exo-cis adduct 3.136. The more polar new spot 
was isolated in 1.2 mg and it was believed to be derived from the other exo-trans adduct 3.137. It 
is reasonable that circular molecule 3.138 has higher Rf. value than its open chain analoge 3.139. 
O
O
O
O
O
O
O
O
MeO
OMeMeO
OMe
H
H
O
O
O
O O
O
O
O
OMe
MeO
OMe
MeO
H
H+ 1) HOAc, reflux
2) PhI(OAc)2, acetone
O
O
O
O
OMe
MeO
O
O
O
O
MeO
OMe
O
O
O
O
O
O
OMe
MeOMeO
OMe
O
O
(inseparable, starting with mixture)
separable
+
3.136 3.137
3.138 3.139
 
Scheme 3.31 Final cyclization of Diels-Alder adduct 3.136 in refluxing acetic acid. 
 A single crystal X-ray structure of 3.138 was achieved, which shows unquestionable 
cyclized structure with a inner ring dimeter about 8.9 Å and the distance between two protons in 
the opposite teeth about 19.6 Å. However, due to low resolution of current generated structure 
from X-ray data, positions of methoxy groups are undetermined. An average structure shows a 
hybridization of one third of 1,4-dimethoxybenzene rings and two thirds of quinone rings in the 
shaft probablily because of fast  rotation of the molecule in the crystal . We also discovered each 
unit cell in a single crystal contains four 3.138 molecules. Two of them (colored red and green) 
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are almost parallel to each other and the other two molecules (colored blue and cyan) intercalate 
between them. (Figure 3.30)  
 
Figure 3.30 Stacking of cyclododeciptycene 3.318 molecules in a unit cell of a single crystal. 
Methoxy groups are omitted for clarity. (Due to low resolution of current generated structure 
from X-ray data, the relative positions of methoxy groups are undetermined.  )  
Although the cyclized cyclododeciptycene derivative was obtained, improving yields and 
reducing separation work are needed for later property study. First, the low ratio of exo- and 
endo-adducts is not acceptable. By simply changing the solvent from toluene to 1,2-
dichloroethane, the ratio was improved to about 1:2. But the reaction has to be maintained in a 
sealed tube for reaction temperature (120 oC) above boiling point of 1,2-dichloroethane. That 
was a great improvement, but not enough. How can we improve the ratio of exo- and endo-
adducts even more for favoring exo-adducts? 
The favored endo-selectivity is due to donor-acceptor interaction of electron poor endo- 
face with electron rich diene moiety. If in a reaction solution, a better electron donor was added 
to “combine” at endo-face and “block’ the reaction of bisdimethoxyanthracene 3.56 from endo-
face, this would change the facial selectivity. Based on this assumption, 1,4-dimethoxybenzene, 
which has a melting point of 54 oC and a boiling point of 213 oC, is an ideal electron rich 
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solvent with high boiling points for Diels-Alder reaction in a wide range of temperatures. Since 
it was used as a solvent, it also has population advantage over the reactant dimethoxyanthracene. 
Actually, the ratio of exo- and endo-adducts was improved to about 3:2 ratio when using 1,4-
dimethoxybenzene as solvent. The reaction time was also reduced to four hours at 140 oC. 
After successfully solving the facial selectivity problem of Diels-Alder reaction, we 
looked into the tedious separation of four Diels-Alder adducts. Since the cyclized product 3.138 
has higher Rf. value than its open analog 3.139. So there would expected similar Rf. value 
differences between 3.138 and products from endo-adducts in refluxing acetic acid condition. A 
mixture of four adducts was refluxed in acetic acid. To our delight, the introduced two new 
unwanted products from endo-adducts did not increase the task in getting pure 3.138, since they 
have almost same Rf. value as 3.139. However, better conditions for purification of cyclized 
cyclododeciptycene 3.138 are still need to be developed.  
3.3.4.9) Failed demethoxylation of 3.138 to cyclododeciptycene hexaquione 3.1 
 The methoxy group in the molecule 3.318 seemed to be quite inert. An attempted oxy-
demethoxylation of 3.138 using CAN failed even at a temperature as high as 80 oC. The 
demethoxylation using BBr3, a strong Louis acid efficient for demethoxylation in many other 
condtions, also failed to give demethoxylated product. The difficulty of demethoxylation maybe 
due to highly hindered methoxy groups surrounded by rigid o-benzeno “teeth” and carbonyl 
groups in nearby quinone rings. 
3.4 Conclusion and future work 
After a year of hardwork and going through many difficulties in synthetic efforts towards 
cyclododeciptycene hexaquinone, the first cyclododeciptycene derivative 3.318 was synthesized. 
The work showed how beautifully a complicated molecule such as 3.318 can be assembled from 
small simple building blocks as o-xylene and p-benzoquinone. We learned a lot from previous 
failed synthesis of [10]beltene derivative and literature study. Compared to the previous system 
of [10] beltene, the key Diels-Alder intemediates tetraquinone 3.23 and bisdimethoxyanthracene 
3.56 have rigid and parallel reaction ends. Also inherent NMR structure indicators within the 
molecule helps to determine structures of Diels-Alder adducts.  Besides, the synthetic route was 
much shorter and convergent. 
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The synthesis of 3.318 opens possible synthesis of a variety of cyclododeciptycene 
derivatives with various substitutions by starting from different building blocks. The target 
cyclododeciptycene hexaquinone 3.1 may be synthesized by bisanthrancene with different 
protecting groups like 2-(trimethylsilyl)ethoxymethyl (SEM) group which are easier to remove 
under milder conditions than the methoxy group. The cyclododeciptycene 3.11 would be 
synthesized from bisanthracene 3.143 and bisquinone 3.144. Similarly, dodecamethoxy 
cyclododeciptycene 3.145 would be synthesized from bisdimethoxyanthracene 3.56 and 
bisquinone 3.147.   
We may also synthesize more complicated cycloiptycene structures shown in Figure 3.4 
such as 3.148, a [36]cycloiptycene derivative. The compound 3.148 can be assembled by four 
bisanthracene 3.56, two triptycene bisquinone 3.17, and two pentiptycene trisquinone 3.21 
through eight Diels-Alder reactions.  The purification would be inevitably difficult, but the right 
intermediate for cyclization still can be figured out by inherent NMR structual indicators.  
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Scheme 3.35 
We can also synthesize cycloiptycene-containing poly(p-phenyleneethynylene)s similar 
to what Swager’s group has done.25 This new structure of polymers may have some new 
interesting properties as new materials.  
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3.5 Experimental section 
General Methods: Nuclear magnetic resonance spectra were obtained at Varian Unity 
Plus (400 MHz) and Varian Gemini 2000 (200 MHz).  Mass spectra were taken from a Hewlett 
Packard 5890A Series II, GC-MS and a Bruker Esquire 3000 Plus electrospray ionization mass 
spectrometer. FAB spectra were taken by using Xe beam (8 KV) and m-nitrobenzyl alcohol as 
matrix. Silica gel (200~400 mesh) from Natland International Coporation was used for the flash 
chromatographic separation. THF and diethyl ether were distilled over sodium and 
benzophenone. Methylene chloride was distilled over CaH2. Toluene and benzene were distilled 
over LiAlH4. 
3.5.1 Synthesis of one tooth synthons 
O
S
O
OMe
OMe
MeO
OMe
O
O
O
O
O
O
O
O
3.53 3.65 3.54 3.73 3.17  
3.5.1.1) 1,4-Dihydro-2,3-benzoxathiin-3-oxide (3.53)57 
1) 1,2-Bis(bromomethyl)benzene (3.102) 
To a solution of 10 g (94 mmol) of 1,2-dimethylbenzene in 250 mL benzene was added 
33.5 g (188 mmol) of N-bromosuccinimde and 912 mg (3.77 mmol) of benzoyl peroxide. The 
mixture was heated to reflux under argon for 2 hours, and then concentrated to about 50 mL by a 
rotavapor. The white solids precipitated were filtered and redissolved in 200 mL ethyl ether, 
washed by 150 mL water three times, and 150 mL brine once. The ether layer was dried over 
anhydrous magnesium sulfate, filtered and then concentrated to give 10.2 g (41% yield) of the 
title compound, 3.102, as white solids: m.p. 92~94 oC (literature:58 94~95 oC); 1H NMR (CDCl3, 
400 MHz) δ 7.28~7.40 (m, 4 H), 4.67 (s, 4 H); 13C NMR (CDCl3, 50 MHz) δ 136.8, 131.3, 129.7, 
30.2. 
2) 1,4-Dihydro-2,3-benzoxathiin-3-oxide (3.53)57  
A mixture of 12.4 g (80.6 mmol) of sodium hydroxymethanesulfinate, 2.60 g (8.06 mmol) 
of tetrabutylammonium bromide, and 10.6 g (40.3 mmol) of 1,2-bis(bromomethyl)benzene 
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(3.102) in 40.3 mL DMF was stirred at 0 oC for 3 hours. The reaction was worked up by adding 
200 mL of ethyl ether, washing with 150 mL water twice and 150 mL brine. The ether layer was 
dried over anhydrous magnesium sulfate, filtered, and concentrated. The residue was applied to 
column chromatography using a mixture of petrol ether and ethyl ether (1:1, V:V) as eluent to 
afford 4.34 g (65% yield) of the title compound, 3.53, as a light yellow oil: 1H NMR (CDCl3, 
400 MHz) δ 7.18~7.38 (m, 4 H), 5.28 (d, J = 13.2 Hz, 2 H), 4.95 (d, J = 13.2 Hz, 2 H), 4.40 (d, J 
= 15.6 Hz, 2 H), 3.54 (d, J = 15.6 Hz, 2 H); 13C NMR (CDCl3, 50 MHz) δ 133.8, 129.8, 128.7, 
127.9, 126.3, 125.8, 63.1, 57.0. 
3.5.1.2) 1,4-Anthracenedione (3.65)41 
 Route 1: To the solution of 24.0 g (100 mmol) of quinizarin (3.63) in 500 mL methanol 
was added 15.1 g (400 mmol, 4.0 eq.) of sodium borohydride in portions at 0 oC. The reaction 
mixture was stirred at 0 oC for 2 hours and then was added dropwisely to 350 mL of conc. HCl 
and 1 L of water. The solid precipitated was filtered, washed several times with distilled water, 
and dried under vacuum to give 19.8g (yield 95%) of the title compound, 3.65, as yellow solids: 
m.p. 214~216 oC (literature:59 218~221 oC); 1H NMR (CDCl3, 200 MHz) δ 8.64 (s, 2 H), 8.08 
(dd, J1 = 6.3 Hz, J2 = 3.5 Hz, 2 H), 7.71 (dd, J1 = 6.1 Hz, J2 = 3.3 Hz, 2 H), 7.08 (s, 2 H); 13C 
NMR (CDCl3, 100 MHz) δ 184.8, 140.2, 135.0, 130.4, 129.7, 129.0, 128.6. 
Route 2: 
1) cis-4a,9,9a,10-Tetrahydroanthracene-1,4-dione (3.68)50  
To a solution of 216 mg (2.00 mmol) of 1,4-benzoquinone in 10 mL of benzene under 
argon was added 168 mg (1 mmol) of the sultine 3.53.  The reaction mixture was refluxed for 2 
hours and benzene was removed by rotavapor. The residue was washed by petrol ether for twice 
and recrystalized from methanol to afford 83 mg (39% yield) of the title compound, 3.68, as off-
white needles: m.p. 123~125 oC (literature:50 122~123 oC); 1H NMR (CDCl3, 200 MHz) 
δ 7.08~7.14 (m, 4 H), 6.72 (s, 2 H), 3.41 (m, 2 H), 3.16~3.30 (m, 2 H), 2.83~3.00 (m, 2 H); 13C 
NMR (CDCl3, 50 MHz)  δ 199.8, 139.7, 133.0, 129.1, 126.7, 47.0, 28.6.  
2) 1,4-Anthracenedione (3.65) 
A mixture of 52 mg (0.25 mmol) of 3.68 and 181 mg (0.736 mmol) of chloranil was 
refluxed in acetic acid overnight. The acetic acid was removed by rotavapor. The residue was 
dissolved in 20 mL of ethyl acetate, washed by water (20 mL), brine (20 mL), dried over 
anhydrous mageniusm sulfate, and filtered. The filtrate was concentrated and applied to column 
 121
chromatography using petrol ether and methylene chloride as eluent to afford 46 mg (90% yield) 
of the title compound 3.65.  
3.5.1.3) 1, 4-Dimethoxyanthracene (3.54) 41 
1) 1, 4-Dihydroxyanthracene (3.66)  
To the solution of 20.1 g (100 mmol) 1,4-anthraquinone 3.65 in 625 mL 1,4-dioxane was 
added a solution of 75.0 g (366 mmol.) 85% sodium hydrosulfite in 625 mL water. The solution 
was stirred at room temperature for 10 hours and then poured into a solution of 172 mL 
concentrated HCl in 3 L water. The precipitation was filtered, washed several times with distilled 
water, and dried under vacuum to give 17.3 g (82%) of the title compound, 3.66, as green 
powder: m.p. 165~167 oC; 1H NMR (DMSO-d6, 200 MHz) δ 9.57 (s, 2 H), 8.66 (s, 2 H), 8.08 
(dd, J1 = 6.3 Hz, J2 = 3.2 Hz, 2 H), 7.46 (dd, J1 = 6.2 Hz, J2 = 3.4 Hz, 2 H), 6.61 (s, 2 H); 13C 
NMR (DMSO-d6, 50 MHz) δ 145.4, 136.2, 130.5, 128.4, 125.4, 120.7, 105.6. 
2) 1, 4-Dimethoxyanthracene (3.54) 
To a cool solution of 5.00 g (23.8 mmol) 1, 4-dihydroxyanthracene 3.66 in 25 mL DMF 
at 0o C was added 2.29 g sodium hydride (60% in oil, 57.1 mmol) in portions under argon. The 
reaction mixture was stirred at 0 oC for half an hour. Then a solution of 3.7 mL methyl iodide in 
25 mL DMF was added dropwisely at 0 oC. The reaction mixture was slowly warmed up to room 
temperature and stirred in room temperature for 2 hours. The salts precipitated out were filtered 
and washed with 200 mL ethyl ether. The filtrated was washed with water (150 mL × 2), brine 
(150 mL), dried over anhydrous magnesium sulfate, concentrated, and applied to column 
chromatography (silica gel) using a mixture of petroleum ether and methylene chloride (1:1, V:V) 
as eluent to afford 3.69 g (yield 65%) of the title compound, 3.54, as yellow crystals: m.p. 
131~133 oC (literature:60 134~136 oC); 1H NMR (CDCl3, 200 MHz) δ 8.77 (s, 2 H), 8.04 (dd, J1 
= 6.4 Hz, J2 = 3.4 Hz, 2 H), 7.47 (dd, J1 = 6.4 Hz, J2 = 3.0 Hz, 2 H), 6.60 (s, 2 H), 4.03 (s, 6 H); 
13C NMR (CDCl3, 50 MHz) δ 149.7, 131.7, 128.8, 125.7, 121.0, 101.1, 55.9. 
3.5.1.4) 9,10-Dihydro-9,10-(o-benzeno)anthracene-1,4,5,8-tetrone (triptycenebisquinone) (3.17) 
1) (4aR,9R,9aS,10S)-5,8-Dimethoxy-4a,9,9a,10-tetrahydro-9,10-(o-benzeno)anthra-
cene-1,4-dione (3.69, endo-) 
(4aR,9S,9aS,10R)-5,8-Dimethoxy-4a,9,9a,10-tetrahydro-9,10-(o-benzeno)anthracene-
1,4-dione (3.70, exo-) 
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A solution of 10.2 g (42.8 mmol) of 1,4-dimethoxyanthracene 3.54 and 6.80 g (60.6 
mmol) of 1,4-benzoquinone in 180 mL of toluene was refluxed for 36 h, then cooled to room 
temperature. The precipitate was filtered and weighted 13.4 g. The filtrate was concentrated to 
dryness, and applied to column chromatography (silica gel) using an eluent series with increasing 
polarity starting from petrol ether and methylene chloride (2:3, V:V), to (1:4, V:V),  followed by 
methylene chloride and acetone (50:1, V:V), and finally methylene chloride and acetone (25:1) 
to afford another batch of the Diels-Alder adducts 0.85  g. Total yield of two adducts 3.69 and 
3.70 (in about 1:1 ratio from 1H NMR) was 96%. 3.69 and 3.70 can be partially separated by 
silica gel column chromatography using petrol ether and methylene chloride (1:2, V:V) with 1% 
volume of ethyl ether as eluent. The less polar adduct 3.69: 1H NMR (CDCl3, 200 MHz) δ 7.21 
(dd, J1 = 5.4 Hz, J2 = 3.0 Hz, 2 H), 7.06 (dd, J1 = 5.4 Hz, J2 = 4.2 Hz, 2 H), 6.65 (s, 2 H), 6.28 (s, 
2 H), 5.31 (t, J = 1.0 Hz, 2 H), 3.82 (s, 6 H), 3.07 (t, J = 1.0 Hz, 2 H); 13C NMR (CDCl3, 50 
MHz) δ 198.6, 148.7, 140.7, 140.2, 131.4, 126.7, 125.1, 109.3, 56.2, 48.7, 42.3. More polar 
adduct 3.70: 1H NMR (CDCl3, 200 MHz) δ 7.42 (dd, J1 = 5.2 Hz, J2 = 3.1 Hz, 2 H), 7.17 (dd, J1 
= 5.3 Hz, J2 = 3.3 Hz, 2 H), 6.59 (s, 2 H), 6.31 (s, 2 H), 5.31 (t, J = 1.0 Hz, 2 H), 3.75 (s, 6 H, 
Me), 3.07(t, J = 1.0 Hz, 2 H); 13CNMR (CDCl3, 50 MHz) δ 198.3, 149.4, 142.0, 140.5, 129.7, 
126.7, 124.2, 110.0, 56.6, 49.0, 42.6.  
2) 9,10-Dihydro-1,4-dihydroxy-5,8-dimethoxy-9,10-(o-benzeno)anthracene (3.71)  
To a suspension of 14.0 g (40.4 mmol) 3.69 & 3.70 (about 1:1 ratio) in 300 mL acetic 
acid under argon was added 132 drops of hydrobromic acid (40% in water). The mixture was 
refluxed for 10 min and poured into 100 g ice. The white precipitate was filtered and dried in 
vacuum to afford 12.7 g (yield 87%) of the title compound 3.71: 1H NMR (DMSO-d6, 200 MHz) 
δ 8.86 (s, 2 H), 7.35 (dd, J1 = 4.7 Hz, J2 = 3.2 Hz, 2 H), 6.94 (dd, J1 = 5.0 Hz, J2 = 3.3 Hz, 2 H), 
6.58 (s, 2 H), 6.30 (s, 2 H), 6.13 (s, 2 H), 3.75 (s, 6 H); 13C NMR (DMSO-d6, 50 MHz) δ 148.6, 
146.2, 144.9, 135.2, 132.3, 124.6, 123.6, 112.9, 109.0, 56.2, 40.4.   
3) 9,10-Dihydro-9,10-(o-benzeno)anthracene-1,4,5,8-tetrone (3.17)  
Route 1: To a stirred solution of 1.0 g (2.9 mmol) of 3.73 in 40 mL acetonitrile and 40 
mL THF at 0 oC was added dropwisely a solution of 4.78 g (8.70 mmol) of ammonium cerium 
(IV) nitrate (CAN) in 20 mL water. After stirring at 0 oC for 30 minutes, another portion of 797 
mg (1.45 mmol) of CAN was added. The reaction was stirred at 0 oC for another 30 minutes, 
then diluted with water (200 mL), extracted with ethyl acetate (150 mL × 2). The combined ethyl 
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acetate layer was washed by water (150 mL × 2), brine (150 mL), dried over anhydrous 
magnesium sulfate, filtered and concentrated. The residue was applied to column 
chromatography (silica gel) using an eluent series with increasing polarity starting from petrol 
ether and methylene chloride (2:3, V:V), then petrol ether and methylene chloride (1:2, V:V),  
followed by petrol ether, methylene chloride and ethyl ether (1:2:0.06, V:V:V) to afford 921 mg 
(100% yield) of the title compound, 3.17, as yellow solids: m.p. 297~298 oC, decomp. 
[literature13 >220 oC(decomp.)]; 1H NMR (CDCl3, 200 MHz) δ 7.49 (dd, J1 = 5.4 Hz, J2 = 3.2 
Hz,  H), 7.08 (dd, J1 = 5.4 Hz, J2 = 3.2 Hz, 2 H), 6.65 (s, 4 H), 6.18 (s, 2 H); 13C NMR (CDCl3, 
50 MHz) δ 182.5, 151.8, 142.3, 135.7, 126.2, 125.7, 42.4. 
Route 2: 
To a suspension of 4.00 g (11.5 mmol) of 3.71 in 200 mL dioxane at 0 oC was added 
dropwisely a solution of 25.3 g (46.2 mmol)ammonium cerium (IV) nitrate in 200 mL water. The 
mixture was stirred at room temperature for 1 hour, diluted with 400 mL water, extracted with 
400 mL ethyl acetate for twice. The combined ethyl acetate layer was washed with water (400 
mL × 3) and brine (400 mL), dried over anhydrous magnesium sulfate, filtered. The yellow 
precipitate formed during concentration was filtered to afford 2.66 g of the title compound. The 
filtrate was concentrated to dryness and applied to column chromatography (silica gel) using an 
eluent series with increasing polarity starting from petrol ether and methylene chloride (2:3, 
V:V), then petrol ether and methylene chloride (1:2, V:V),  followed by petrol ether, methylene 
chloride and ethyl ether (1:2:0.06, V:V:V) to afford 698 mg of the title compound. The total 
yield calculated was 92.6%. 
3.5.1.4) 9,10-Dihydro-5,8-dimethoxy -9,10-(o-benzeno)anthracene-1,4-dione (3.73)  
To a suspension of 3.45 g (10.0 mmol) of 3.71 in 200 mL (actonitrile : H2O = 6:1, V:V) 
at 0 oC was added 10.9 g (20.0 mmol) of CAN. The reaction mixture was stirred at room 
temperature for half an hour. The red precipitate was filtered to afford 3.30 g (96% yield) of the 
title compound 3.73. m.p. 269~270 oC (literature:13 271.5~272.5 oC); 1H NMR (CDCl3, 200 
MHz) δ 7.44 (dd,  J1 = 5.3 Hz, J2 = 3.1 Hz, 2 H), 7.01 (dd, J1 = 5.3 Hz, J2 = 3.1 Hz, 2 H), 6.57 (s, 
2 H), 6.53 (s, 2 H), 6.23 (s, 2 H), 3.80 (s, 6 H); 13C NMR (CDCl3, 100 MHz) δ 183.8, 153.1, 
149.9, 144.4, 135.5, 133.8, 125.5, 124.8, 109.8, 56.6, 41.6. 
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3.5.2 Synthesis of 2-teeth synthons 
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3.5.2.1) (5R,7S,12R,14S)-5,7,12,14-Tetrahydro-5,14:7,12-di(o-benzeno)pentacene-1,4,6,8,11, 
13-hexaone (cis-pentiptycenetrisquinone) (3.21) 
1) (5R,5aS,7S,12R,14aR,14S)-1,4,8,11-Tetramethoxy-5,5a,7,12,14,14a-hexahydro-
5,14: 7,12-di(o-benzeno)pentacene-6,13-dione (3.77) 
(5R,5aR,7S,12R,14aS,14S)-1,4,8,11-Tetramethoxy-5,5a,7,12,14,14a-hexahydro-5,14: 
7,12-di(o-benzeno)pentacene-6,13-dione (3.78) 
(5R,5aR,7R,12S,14aS,14S)-1,4,8,11-Tetramethoxy-5,5a,7,12,14,14a-hexahydro-5,14: 
7,12-di(o-benzeno)pentacene-6,13-dione (3.79) 
(5R,5aS,7R,12S,14aR,14S)-1,4,8,11-Tetramethoxy-5,5a,7,12,14,14a-hexahydro-5,14: 
7,12-di(o-benzeno)pentacene-6,13-dione (3.80) 
A solution of 1,4-dimethoxyanthracene (715 mg, 3.00 mmol) and 5,8-di-methoxy-9,10-
dihydro-9,10-(o-benzeno)anthracene-1,4-dione (3.73) (689 mg, 2.00 mmol) in 12 mL dry toluene 
was heated to 170 oC (oil bath temperature) in a sealed tube for 36 hours. The reaction mixture 
was cooled to room temperature. The yellow precipitate was filtered, washed with toluene (2 mL) 
and ethyl ether (5 mL), and dried in vacuum to give 508 mg (44% yield) of a mixture of 3.77 and 
3.78 (about 7:3 from 1H NMR)  The filtrate was concentrated and purified by column 
chromatography (silica gel) using a mixture of toluene, chloroform and ethyl acetate (25:25:1, 
V:V:V) as eluent to give  570 mg (49% yield) of a mixture of four isomers in a ratio of 1:4:7:6. 
The calculated total yield of four adducts was 93% with 30% for 3.77, 24% for 3.78, 49% for 
3.79, and 18% for 3.80, respectively.  
Diels Alder adduct 3.77 (the less polar spot of 3.77 and 3.78; pure sample was available 
by careful column chromatography): m.p. 277~278 oC; 1H NMR (CDCl3, 400 MHz) δ 7.37 (dd, 
J1 = 5.6 Hz, J2 = 3.6 Hz, 2 H), 7.34 (dd, J1 = 5.4 Hz, J2 = 3.4 Hz, 2 H), 7.13 (dd, J1 = 5.6 Hz, J2 
= 3.2 Hz, 2 H), 6.92 (dd, J1 = 5.4 Hz, J2 = 3.0 Hz, 2 H), 6.50 (s, 2 H), 5.94 (s, 2 H), 5.85 (s, 2 H), 
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5.17 (t, J = 1.2 Hz, 2 H), 3.79 (s, 6 H, OMe), 3.65 (s, 6 H, OMe), 2.98 (t, J = 1.2 Hz, 2 H); 13C 
NMR (CDCl3, 100 MHz) δ 194.0 (C=O), 157.2, 149.3, 148.7, 144.3, 141.8, 133.8, 128.5, 126.6, 
125.3, 124.6, 124.2, 109.6, 109.0, 56.2 (OMe), 56.0 (OMe), 50.4, 43.5, 41.7.  
Diels-Alder adduct 3.78 (hard to separate from 3.77): 1H NMR (CDCl3, 400 MHz) 
(deduced from 1H NMR, COSY & NOESY of a 7:3 mixture of 3.77 and 3.78)  δ 7.18 (dd, J1 = 
5.2 Hz, J2 = 3.1 Hz, 2 H), 6.91 (dd, J1 = 5.6 Hz, J2 = 2.8 Hz, 2 H), 6.83 (dd, J1 = 5.2 Hz, J2 = 3.2 
Hz, 2 H), 6.61 (s, 2 H), 6.46 (s, 2 H), 6.34 (dd, J1 = 5.6 Hz, J2 = 3.2 Hz, 2 H), 5.94 (s, 2 H), 5.14 
(t, J = 1.0 Hz, 2 H), 3.80 (s, 6 H, OMe), 3.76 (s, 6 H, OMe), 3.00 (t, J = 1.2 Hz, 2 H); 13C NMR 
(CDCl3, 100 MHz) (deduced from 13C NMRs of pure 3.77 and a 7:3 mixture of 3.77 and 3.78) δ 
194.6 (C=O), 157.6, 149.9, 148.8, 143.9, 138.9, 133.6, 131.6, 126.5, 125.1, 124.4, 124.1, 110.1, 
109.4, 56.9 (OMe), 56.3 (OMe), 49.9, 43.4, 41.8. 
Diels-Alder adduct 3.79 (hard to separate from 3.80, no pure sample was available): 
1HNMR (CDCl3, 400 MHz) (deduced from 1H NMR, COSY, NOESY of a 1:1 mixture of 3.79 
and 3.80)  δ 7.35 (dd, J1 = 5.4 Hz, J2 = 3.4 Hz, 2 H), 6.93 (dd, J1 = 5.4 Hz, J2 = 3.0 Hz, 2 H), 
6.89 (dd, J1 = 5.2 Hz, J2 = 3.0 Hz, 2H), 6.61 (s, 2 H), 6.47 (s, 2 H), 6.35 (dd, J1 = 5.2 Hz, J2 = 
3.2 Hz, 2 H), 5.91 (s, 2 H), 5.13 (t, 2 H, J = 1.2 Hz), 3.82 (s, 6 H, OCH3), 3.79 (s, 6 H, OCH3), 
3.00 (t, 2 H, J = 1.2 Hz); 13C NMR (CDCl3, 100 MHz) (deduced from 13C NMR of a 1:1 mixture 
of 3.79 and 3.80 and 13C NMR of a 70% of 3.80 sample) δ 194.7 (C=O), 157.5, 149.8, 148.8, 
144.0, 139.1, 133.6, 131.5, 126.3, 125.3, 124.6, 123.9, 110.0, 109.4, 56.9, 56.3, 50.0, 43.5, 41.7. 
Diels-Alder adduct 3.80 (hard to separate from 3.79, only a 70% of 3.80 sample is 
available by careful column chromatography): 1H NMR (CDCl3, 400 MHz) (deduced from 
1HNMR, COSY, NOESY of a 1:1 mixture of 3.79 and 3.80) δ 7.37 (dd, J1 = 5.4 Hz, J2 = 3.4 Hz, 
2 H), 7.20 (dd, J1 = 5.2 Hz, J2 = 3.6 Hz, 2 H), 7.12 (dd, J1 = 5.4 Hz, J2 = 3.4 Hz, 2 H), 6.98 (dd, 
J1 = 5.4 Hz, J2 = 3.0 Hz, 2 H), 6.46 (s, 2 H), 5.98 (s, 2 H), 5.84 (s, 2 H), 5.17 (t, 2 H, J = 1.2 Hz), 
3.76 (s, 6 H, OCH3), 3.66 (s, 6 H, OCH3), 3.00 (t, 2 H, J = 1.2 Hz); 13C NMR (CDCl3, 100 MHz) 
(deduced from 13C NMR of a 1:1 mixture of 3.79 and 3.80 and 13C NMR of a 70% of 3.80 
sample) δ 194.0 (C=O), 157.6, 149.7, 148.3, 144.4, 141.9, 133.4, 128.2, 126.5, 125.1, 124.3, 
124.2, 109.9, 109.8, 56.8, 56.2, 50.1, 43.3, 41.9. 
2) (5R,7S,12R,14S)-6,13-Dihydroxy-5,7,12,14-tetrahydro-1,4,8,11-tetramethoxy-
5,14:7,12-di(o-benzeno)pentacene (3.81) 
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A suspension of 7:3 mixture of 3.77 & 3.78 (600 mg, 1.03 mmol) in acetic acid (24 mL) 
and hydrobromic acid (40% solution, 24 drops) was refluxed for 10 mins. The grey precipitate 
formed was filtered and washed with toluene (4 mL) and ethyl ether (10 mL) and dried in 
vacuum to give 564 mg (yield 94.0 %) of the title compound 3.81: 1H NMR (DMSO-d6, 400 
MHz) δ 8.64 (s, 4 H), 7.30 (dd, J1 = 4.8 Hz, J2 = 3.6 Hz, 4 H), 6.87 (dd, J1 = 4.8 Hz, J2 = 3.6 Hz, 
4 H), 6.52 (s, 4 H), 6.16 (s, 4 H), 3.72 (s, 12 H); 13C NMR (DMSO-d6, 100 MHz) δ 148.2, 146.1, 
140.1, 135.1, 131.1, 124.2, 123.4, 108.6, 55.8 (OMe), 40.4.  
3) (5R,7S,12R,14S)-5,7,12,14-Tetrahydro-5,14:7,12-di(o-benzeno)pentacene-1,4,6,8, 
11,13-hexaone (cis-pentiptycenetrisquinone) (3.21)9  
To a suspension of 3.81 (442 mg, 0.759 mmol) in 120 mL acetonitrile and 20 mL water at 
0oC was added ammonium cerium (IV) nitrate (3.74 g,  6.82 mmol). The reaction mixture was 
stirred at room temperature for 5 hours, and extracted with chloroform (300 mL), washed with 
water (200 mL×2) and brine (200 mL), dried over anhydrous magnesium sulfate, filtered and 
solvent was removed by a rotavapor. The residue was applied to column chromatography using a 
mixture of toluene, chloroform and ethyl acetate (25:25:1, V:V:V) as eluent to afford 350 mg 
(89% yield) of the title compound 3.21: m.p. >300 oC (literatue:9 >320 oC); 1H NMR (CDCl3, 
400 MHz) δ 7.42(dd, J1 = 5.4 Hz, J2 = 3.4 Hz, 4 H), 7.02 (dd, J1 = 5.4 Hz, J2 = 3.4 Hz, 4 H), 
6.61 (s, 4 H), 6.15 (s, 4 H); 13C NMR (CDCl3, 100 MHz) δ 182.3, 177.8, 151.9, 151.3, 142.3, 
135.6, 126.2, 125.7, 42.6. 
3.5.2.2) 6,13-Dimethoxy-5,14-dihydropentacene (3.55) 
1) 5,14-Dihydro-6,13-dihydroxypentacene (3.105) 
A suspension of 416 mg (2.0 mmol) of 1,4-anthracenedione (3.65) and 672 mg (4.00 
mmol) of benzosultine (3.53) in 8 mL dry toluene was heated to 150 oC in a sealed tube for 30 
hours. The reaction mixture was cooled to room temperature. The yellow precipitate was filtered, 
washed with toluene (2 mL) and ethyl ether (5 mL), dried in vacuum to give 568 mg (91% yield) 
of the title compound 3.105: 1H NMR (DMSO-d6, 400 MHz) δ 8.86 (s, 2 H), 8.74 (s, 2 H), 8.06 
(dd, J1 = 6.6 Hz, J2 = 3.4 Hz, 2 H), 7.45 (dd, J1 = 6.4 Hz, J2 = 3.2 Hz, 2 H), 7.37 (dd, J1 = 5.2 Hz, 
J2 = 3.6 Hz, 2 H), 7.21 (dd, J1 = 6.2 Hz, J2 = 3.2 Hz, 2 H), 4.12 (s, 4 H); 13C NMR (DMSO-d6, 
50 MHz) δ 140.9, 136.9, 130.2, 128.3, 127.4, 126.1, 125.0 (2 C), 120.4, 118.4, 29.9. 
2)  6,13-Dimethoxy-5,14-dihydropentacene (3.55) 
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To a solution of 100 mg (0.32 mmol) of phenol 3.105 in 2 mL DMF at 0 oC was added 
30.7 mg NaH (60% in oil). The resulting mixture was stirred at 0 oC for half an hour, then 51.8 
μL (0.83 mmol) of methyl iodide was added by syringe. The reaction mixture was stirred at 
room temperature for 2 hours and diluted with 40 mL ethyl ether. The organic layer was washed 
with ammonium chloride solution (100 mL), brine (100 mL), dried over anhydrous magnesium 
sulfate, filtered and concentrated by a rotavapor. The residue was applied to column 
chromatography using petro ether and ethyl ether (8:1, V:V) as eluent to afford 86 mg (79% 
yield) of the title compound 3.55: m.p. 147~148 oC; 1H NMR (CDCl3, 400 MHz) δ 8.65 (s, 2 H), 
8.04 (dd, J1 = 6.4 Hz, J2 = 2.8 Hz,  2 H), 7.47 (dd, J1 = 6.6 Hz, J2 = 3.0 Hz,  2 H), 7.41 (dd, J1 = 
5.4 Hz, J2 = 3.4 Hz, 2 H), 7.25 (dd, J1 = 5.8 Hz, J2 = 3.4 Hz, 2 H), 4.20 (s, 4 H), 4.06 (s, 6 H); 
13C NMR (CDCl3, 100 MHz) δ 148.5, 136.8, 131.7, 128.7, 127.8, 126.7, 126.0, 125.7, 121.1, 
62.1, 30.5. 
3.5.2.3) (5R,6aR,7S,12R,12aS,14S)-8,11-Dimethoxy-5,6a,7,12,12a,14-hexahydro-5,14:7,12-
di(o-benzeno)pentacene-6,13-dione (3.90)  
A solution of 1,4-dimethoxyanthracene (119 mg, 0.500 mmol) and triptycene bisquinone 
(3.17) (314 mg, 1.00 mmol) in 10 mL dry toluene was refluxed for 8 h under argon. The reaction 
mixture was cooled to room temperature. The red precipitate was filtered, washed with toluene 
(1 mL) and ethyl ether (2 mL), dried in vacuum to give 125 mg crude red precipitate, which was 
further purified by column chromatography over silica gel using toluene, chloroform and ethyl 
acetate (25:25:1, V:V:V) as eluent to provide 85 mg (30% yield) of the title compound, 3.90, as 
red solids: 1H NMR (CDCl3, 400 MHz) δ 7.39 (m, 4 H), 7.15 (dd, 2 H), 7.00 (dd, J1 = 5.4 Hz, J2 
= 3.0 Hz, 2 H), 6.67 (s, 2 H), 6.18 (s, 2 H), 5.87 (s, 2 H), 5.14 (bs, 2 H), 3.62 (s, 6 H), 3.05 (bs, 2 
H); 13C NMR (CDCl3, 100 MHz) δ 192.9, 188.7, 182.6, 155.6, 150.8, 149.0, 141.9, 141.4, 135.5, 
129.3, 126.8, 126.0, 125.5, 124.4, 108.6, 55.9 (OMe), 51.1, 43.5, 42.5. 
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3.5.3 Synthesis of 3-teeth synthons 
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3.5.3.1) (5R,7s,9S,14R,16s,18S)-5,7,9,14,16,18-Hexahydro-5,18:7,16:9,14-tris(o-benzeno)- 
heptacene-1,4,6,8,10,13,15,17-octaone (cis,cis-heptiptycenetetraquinone) (3.23) 
  1) (5R,5aR,7S,8aR,9S,14R,14aS,16S,17aS,18S)-5,5a,7,8a,9,14,14a,16,17a,18-Deca-
hydro-1,4,10,13-tetramethoxy-5,18:7,16:9,14-tris(o-benzeno)heptacene-6,8,15,17-tetraone 
(3.83) 
(5R,5aS,7R,8aS,9R,14S,14aR,16S,17aR,18S)-5,5a,7,8a,9,14,14a,16,17a,18-Decahydro-
1,4,10,13-tetramethoxy-5,18:7,16:9,14-tris(o-benzeno)heptacene-6,8,15,17-tetraone (3.84)  
A solution of 314 mg (1.00 mmol) of triptycenebisquinone and 715 mg (3.00 mmol) of 
1,4-dimethoxyanthracene was heated at 150 oC in a sealed tube for 2 days. The orange solids 
precipitate was filtered to afford 690 mg (87%) of 1:1 mixture of two isomers, which can be 
partially separated by column chromatography (silica gel) using petrol ether–methylene 
chloride–ether (1:2:0.12, V:V:V) as eluent. 
The less polar isomer (3.83): m.p. > 220 oC (decomp.); 1H NMR (CDCl3, 400 MHz) 
δ 7.33 (dd, J1 = 5.4 Hz, J2 = 3.4 Hz, 2 H), 7.13 (dd, J1 = 5.4 Hz, J2 = 3.0 Hz, 2 H), 7.10 (dd, J1 = 
5.4 Hz, J2 = 3.4 Hz, 2 H), 6.90 (dd, J1 = 5.4 Hz, J2 = 3.0 Hz, 2 H), 6.73 (dd, J1 = 5.2 Hz, J2 = 3.2 
Hz,  2 H), 6.65 (s, 2 H), 6.24 (dd, J1 = 5.6 Hz, J2 = 2.8 Hz, 2 H), 6.08 (s, 2 H), 5.57 (s, 2 H), 5.10 
(bs, 2 H), 5.08 (bs, 2 H), 3.83 (s, 6 H, OMe), 3.66 (s, 6 H, OMe), 3.06 (bs, 2 H), 2.95 (bs, 2 H); 
13C NMR (CDCl3, 50 MHz) δ 193.3, 192.9, 155.2, 155.0, 148.7, 148.6, 141.4, 141.3, 138.4, 
131.1, 129.1, 126.7, 126.6, 125.6, 125.1, 124.3, 124.0, 109.3, 108.2, 56.2 (OMe), 55.8 (OMe), 
50.9, 50.2, 43.6, 43.4, 42.6. 
The more polar isomer (3.84): m.p.> 220 oC (decomp.); 1H NMR (CDCl3, 200 MHz) δ 
7.40 (dd, J1 = 5.3 Hz, J2 = 3.3 Hz,  2 H), 7.34 (dd, J1 = 5.6 Hz, J2 = 3.4 Hz, 2 H), 7.16 (m, 4 H), 
7.11 (dd, J1 = 5.5 Hz, J2 = 3.1 Hz,  2 H), 6.97 (dd, J1 = 5.3 Hz, J2 = 3.2 Hz, 2 H), 6.08 (s, 2 H), 
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5.74 (s, 2 H), 5.63 (s, 2 H), 5.14 (t, J = 1.2 Hz, 2 H), 5.09 (t, J = 1.4 Hz, 2 H), 3.66 (s, 6 H, 
OMe), 3.59 (s, 6 H, OMe), 3.07 (t, J = 1.2 Hz, 2 H), 2.96 (t, J = 1.4 Hz, 2 H); 13C NMR (CDCl3, 
50 MHz) δ 192.9, 192.6, 155.4, 155.0, 148.5, 148.0, 141.8, 141.50, 141.46, 128.9, 127.7, 126.8, 
126.7, 125.6, 125.0, 124.3, 124.2, 109.6, 109.4, 108.1, 56.0 (OMe), 55.6 (OMe), 50.9, 50.5, 43.4, 
43.3, 42.7. 
2) (5R,7s,9S,14R,16s,18S)-5,7,9,14,16,18-Hexahydro-6,8,15,17-tetrahydroxy-1,4,10, 
13-tetramethoxy-5,18:7,16:9:14-tris(o-benzeno)heptacene (3.85)  
A suspension of 66 mg (0.083 mmol) of 3.83 in 2 mL acetic acid and 2 drops of 40% 
hydrobromic acid in water was refluxed under argon for half an hour, and then cooled to room 
temperature. The gray precipitate was filtered, washed with 2 mL toluene and 5 mL of diethyl 
ether, and dried in vacuum desiccator to afford 45 mg (68% yield) of the title compound 3.85: 
m.p. > 300 oC; 1H NMR (DMSO-d6, 200 MHz) δ 8.38 (s, 4 H, -OH), 7.27 (dd, J1 = 5.4 Hz, J2 = 
3.1 Hz, 4 H), 7.21 (dd, J1 = 5.2 Hz, J2 = 3.0 Hz, 2 H), 6.86 (dd, J1 = 5.2 Hz, J2 = 3.4 Hz, 4 H), 
6.79 (dd, J1 = 5.2 Hz, J2 = 3.4 Hz, 2 H), 6.47 (s, 4 H), 6.12 (s, 4 H), 5.99 (s, 2 H), 3.69 (s, 12 H, -
OMe); 13C NMR (DMSO-d6, 50 MHz) δ 148.2, 146.4, 146.2, 139.8, 135.1, 131.4, 131.1, 124.3, 
124.1, 123.4, 123.2, 108.5, 55.8, 41.0, 40.5; MS (MALDI-TOF): m/z calcd.for C52H39O8 
[(M+H)+] 791.3, found 790.6. 
3) (5R,7s,9S,14R,16s,18S)-5,7,9,14,16,18-Hexahydro-5,18:7,16:9,14-tris(o-benzeno)-
heptacene-1,4,6,8,10,13,15,17-octaone (cis,cis-heptiptycenetetraquinone) (3.23) 
To a suspension of 25 mg (0.032 mmol) of 3.85 in a mixture of 6 mL of acetonitrile and 1 
mL of water was added 208 mg (0.380 mmol) of ammonium cerium (IV) nitrate. The mixture 
was stirred at room temperature for 8 hours and then diluted with ethyl acetate (50 mL), washed 
with water (50 mL) and brine (50 mL), dried over anhydrous magnesium, filtered, and 
concentrated. The residue was applied to flash column chromatography using toluene-
chloroform-ethyl acetate (25:25:2, V:V:V) as eluent to afford 15.7 mg (68% yield) of the title 
compound 3.23: m.p. > 300 oC (literature:9 m.p. > 320 oC); 1H NMR (CDCl3, 200 MHz) δ 7.40 
(dd, J1 = 5.4 Hz, J2 = 3.0 Hz, 4 H), 7.36 (dd, J1 = 5.2 Hz, J2 = 3.2 Hz, 2 H), 7.01 (dd, J1 = 5.2 Hz, 
J2 = 2.8 Hz, 4 H), 6.96 (dd, J1 = 5.2 Hz, J2 = 3.2 Hz, 2 H), 6.58 (s, 4 H), 6.12 (s, 2 H), 6.11 (s, 4 
H); 13C NMR (CDCl3, 50 MHz) δ 182.2, 177.7, 151.8, 151.3, 151.2, 142.1, 142.0, 135.5, 126.2 
(2 peaks overlap), 125.64, 125.57, 42.5, 42.4.   
3.5.3.2) 6,8,15,17-Tetramethoxy-7,16-dihydro-7,16-(o-benzeno)heptacene (3.56) 
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1) 6,8,15,17-Tetrahydroxy-5,7,9,14,16,18-hexahydro-7,16-(o-benzeno)heptacene 
(3.106)  
i) A suspension of 467 mg (1.49 mmol) triptycene bisquinone and 1g (5.94 mmol) 
benzosultine 3.53 in 15 mL dry toluene was heated to 140 oC in a sealed tube for 24 hours. The 
reaction mixture was cooled to room temperature. The yellow precipitate was filtered, washed 
with toluene (2 mL) and ethyl ether (5 mL), and dried in vacuum to give 523 mg (67% yield) of 
a mixture of Diels-Alder adducts and their partially enolised derivatives.  
ii) A suspension of the above Diels-Alder adducts mixture (400 mg, 0.765 mmol) in 
acetic acid (10 mL) and hydrobromic acid (40% in water, 10 drops) was refluxed for 10 min. The 
reaction mixture was cooled to room temperature. The yellow precipitate was filtered, washed 
with toluene (2 mL) and ethyl ether (5 mL), dried in vacuum to give 306 mg (77% yield) the title 
compound 3.106: m.p. > 300 oC; 1H NMR (DMSO-d6, 400 MHz) δ 8.22 (s, 4 H, OH), 7.35 (dd, 
J1 = 5.2 Hz, J2 = 2.8 Hz, 2 H), 7.24 (dd, J1 = 5.4 Hz, J2 = 3.4 Hz, 4 H), 7.12 (dd, J1 = 5.6 Hz, J2 
= 3.2 Hz, 4 H), 6.92 (dd, J1 = 5.4 Hz, J2 = 3.4 Hz, 2 H), 6.28 (s, 2 H), 3.77 (s, 8 H); 13C NMR 
(DMSO-d6, 100 MHz) δ 146.5, 141.5, 135.7, 130.7, 127.4, 125.7, 124.1, 123.3, 121.5, 40.8, 30.6; 
MS (MALDI-TOF): m/z calcd.for C36H27O4 [(M+H)+] 523.2, found 522.3.   
2) 6,8,15,17-Tetramethoxy-5,7,9,14,16,18-hexahydro-7,16-(o-benzeno)heptacene 
(3.107) 
A mixture of 3.106 (300 mg, 0.570 mmol), potassium carbonate (629 mg, 4.55 mmol), 
and methyl p-toluenesulfonate (1.24 g, 6.66 mmol) in 12ml 1,2-dichlorobenzene was refluxed for 
24 hours. The reaction mixture was cooled to room temperature and diluted with 150 mL of ethyl 
acetate. The organic layer was washed with water (100 mL), 1M HCl solution (100 mL), 
saturated sodium dicarbonate water solution (100 mL), brine (100 mL); dried over anhydrous 
magnesium sulfate; filtered and ethyl acetate was removed by rotavapor. The remaining 
dichlorobenzene was removed by vacuum distillation. The residue was applied to flash column 
chromatography (silica gel) using petrol ether–ethyl ether–methylene chloride (8:2:1, V:V:V) as 
eluent to afford 299 mg (yield 91%) of the title compound 3.107: m.p. 286~288 oC; 1H NMR 
(CDCl3, 200 MHz) δ 7.44 (dd, J1 = 5.2 Hz, J2 = 3.4 Hz, 2 H), 7.25 (dd, J1 = 5.6 Hz, J2 = 3.2 Hz, 
4 H), 7.13 (dd, J1 = 5.5 Hz, J2 = 3.3 Hz, 4 H), 7.00 (dd, J1 = 5.4 Hz, J2 = 3.2 Hz, 2 H), 6.15 (s, 2 
H), 3.92 (s, 12 H, OMe), 3.86 (s, 8 H); 13C NMR (CDCl3, 50 MHz) δ 148.8, 145.5, 136.2, 128.2, 
127.7, 126.3, 125.6, 123.8, 62.4 (-OMe), 42.8, 29.7.  
 131
3) 6,8,15,17-Tetramethoxy-7,16-dihydro-7,16-(o-benzeno)heptacene (3.56)  
To a stirred solution 123 mg (0.210 mmol) of 3.107 in 10 mL toluene at 0 oC was added 
290 mg (1.28 mmol) of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone. The reaction mixture was 
stirred at room temperature for 24 hours and diluted with 100 mL of ethyl acetate. The organic 
layer was washed with water (100 mL), saturated sodium thiosulfate water solution (100 mL), 
saturated sodium bicarbonate water solution (100 mL), brine (100 mL), dried over anhydrous 
magnesium sulfate, filtered and concentrated. The residue was applied to flash column 
chromatography (silica gel) using petrol ether–diethyl ether (4:1, V:V) as eluent to afford 109 
mg (89% yield) the title compound 3.56: m.p.>300 oC; 1H NMR (CDCl3, 400 MHz)  δ 8.59 (s, 4 
H), 7.98 (dd, J1 = 6.4 Hz, J2 = 3.2 Hz, 4 H), 7.62 (dd, J1 = 5.4 Hz, J2 = 3.4 Hz, 2 H), 7.43 (dd, J1 
= 6.8 Hz, J2 = 3.2 Hz, 4 H), 7.17 (dd, J1 = 5.4 Hz, J2 = 2.8 Hz, 2 H), 6.52 (s, 2 H), 4.20 (s, 12 H, 
OMe); 13C NMR (CDCl3, 100 MHz) δ 146.7, 143.5, 131.9, 130.1, 128.6, 126.9, 126.7, 125.7, 
124.4, 121.3, 63.3 (-OMe), 41.8. 
3.5.3.3) (5R,7S,8aR,9S,14R,14aR,16R,18S)-5,7,8a,9,14,14a,16,18-Octahydro-5,18:7,16:9,14-
10,13-dimethoxy-tris(o-benzeno)-heptacene-1,4,6,8,15,17-hexaone (3.91)  
 A mixture of 556 mg (1.07 mmol) of cis-pentiptycene trisquinone (3.21) and 225 mg 
(1.07 mmol) of 1,4-dimethoxyanthracene was refluxed in 50 mL toluene under argon for 36 
hours. After cooling to room temperature, the unreacted cis-pentiptycene trisquinone was filtered. 
About 6 g of silica gel was added to the filtrate and concentrated to dryness by rotavapor. The 
dried silica gel was then applied to column chromatography (silica gel) using toluene-
chloroform-ethyl acetate (25:25:1, V:V:V) as eluent to afford 312 mg (38% yield) of the title 
compound, 3.91, as red solids: 1H NMR (CDCl3, 200 MHz) δ 7.45 (dd, J1 = 5.3 Hz, J2 = 3.3 Hz, 
2 H), 7.32~7.37 (m, 4 H), 7.13 (dd, J1 = 5.4 Hz, J2 = 3.2 Hz, 2 H), 7.05 (dd, J1 = 5.4 Hz, J2 = 3.0 
Hz, 2 H), 6.95 (dd, J1 = 5.4 Hz, J2 = 3.2 Hz, 2 H), 6.75 (s, 2 H), 6.26 (s, 2 H), 5.85 (s, 2 H), 5.37 
(s, 2 H), 5.08 (t, J = 1.3 Hz, 2 H), 3.47 (s, 6 H), 3.03 (t, 2 H, J = 1.2 Hz); 13C NMR (CDCl3, 100 
MHz) δ 192.8, 182.8, 178.0, 155.0, 152.3, 150.7, 150.1, 148.9, 141.9, 141.6, 141.4, 135.8, 129.6, 
126.8, 126.4, 126.1, 125.7, 125.5, 124.3, 106.9, 55.6, 51.1, 43.6, 42.6 (2 peaks overlap). 
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3.5.4 Synthesis of 4-teeth synthon 
O
O
O
O
O
O
O
O
O
O
3.57  
3.5.4.1) (5R,7R,9S,11S,16R,18R,20S,22S)-5,7,9,11,16,18,20,22-Octahydro-5,22:7,20:9,18:11, 
16-tetra(o-benzeno)nonacene-1,4,6,8,10,12,15,17,19,21-decaone (cis,cis,cis-noniptycene-
pentiquinone) (3.57) 
1) (5R,5aR,7R,8aR,9S,10aR,11S,16R,16aS,18R,20S,21aS,22S)-5,5a,7,9,10a,11,16,16a, 
18,20,21a,22-Dodecahydro-1,4,12,15-tetramethoxy-5,22:7,20:9,18:11,16-tetra(o-benzeno)- 
nonacene-6,8,10,17,19,21-hexaone (3.92) 
(5R,5aS,7R,9S,10aS,11R,16S,16aR,18R,20S,21aR,22R)-5,5a,7,9,10a,11,16,16a,18,20, 
21a,22-Dodecahydro-1,4,12,15-tetramethoxy-5,22:7,20:9,18:11,16-tetra(o-benzeno)nona-
cene-6,8,10,17,19,21-hexaone (3.93)  
 A mixture of 567 mg (1.09 mmol) of cis-pentiptycene trisquinone (3.21) and 650 mg 
(2.73 mmol) of 1,4-dimethoxyanthracene was refluxed in 57 mL toluene under argon for 24 
hours. After cooling to room temperature, about 6 g of silica gel was added to the filtrate and 
concentrated to dryness by rotavapor. The dried silica gel was then applied to column 
chromatography (silica gel) using toluene-chloroform-ethyl acetate (25:25:2, V:V:V) as eluent to 
afford 275 mg (25% yield) of the title compound 3.92 (less polar spot) and 315 mg (29% yield) 
of the title compound 3.93 (more polar spot).  
The less polar isomer 3.92: 1H NMR (CDCl3, 200 MHz) δ 7.33 (dd, J1 = 5.6 Hz, J2 = 3.4 
Hz, 2 H), 7.30 (dd, J1 = 5.2 Hz, J2 = 3.0 Hz, 2 H), 7.18 (dd, J1 = 5.5 Hz, J2 = 3.1 Hz, 2 H), 7.11 
(dd, J1 = 5.5 Hz, J2 = 3.1 Hz, 2 H), 6.97 (dd, J1 = 5.5 Hz, J2 = 3.1 Hz, 2 H), 6.91 (dd, J1 = 5.4 Hz, 
J2 = 3.3 Hz, 2 H), 6.83 (dd, J1 = 5.3 Hz, J2 = 3.1 Hz, 2 H), 6.59 (s, 2 H), 6.31 (dd, J1 = 5.4 Hz, J2 
= 3.2 Hz, 2 H), 5.93 (s, 2 H), 5.77 (s, 2 H), 5.27 (s, 2 H), 5.13 (bs, 2 H), 5.04 (bs, 2 H), 3.78 (s, 6 
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H), 3.48 (s, 6 H), 3.15 (bs, 2 H), 2.98 (bs, 2 H)；13C NMR (CDCl3, 100 MHz) δ 194.4, 192.9, 
177.9, 156.7, 155.7, 150.3, 149.9, 148.9, 148.8, 141.6 (2 peaks overlap), 141.4, 138.5, 131.0, 
129.3, 126.9, 126.8, 126.0, 125.9, 125.4, 125.3, 124.3, 124.1, 109.5, 107.1, 56.2, 55.7, 51.1, 50.3, 
43.6 (2 peaks), 42.8, 42.6. 
The more polar isomer 3.93: 1H NMR (CDCl3, 200 MHz) δ 7.26~7.40 (m, 6 H), 7.21 (dd, 
J1 = 5.4 Hz, J2 = 3.2 Hz, 2 H), 7.10 (dd, J1 = 5.1 Hz, J2 = 3.1 Hz, 4 H), 7.02 (dd, J1 = 5.4 Hz, J2 
= 3.2 Hz, 2 H), 6.91 (dd, J1 = 5.5 Hz, J2 = 3.1 Hz, 2 H), 5.98 (s, 2 H), 5.81 (s, 2 H), 5.78 (s, 2 H), 
5.23 (s, 2 H), 5.16 (bs, 2 H), 5.04 (bs, 2 H), 3.65 (s, 6 H), 3,59 (s, 6 H), 3.15 (bs, 2 H), 2.98 (bs, 2 
H); 13C NMR (CDCl3, 100 MHz) δ 193.8, 192.9, 177.9, 156.8, 155.7, 150.4, 149.9, 148.9, 148.3, 
142.2, 141.7, 141.4 (2 peaks overlap), 129.3, 127.9, 126.9, 126.7, 125.9 (2 peaks), 125.4, 125.2, 
124.3, 124.2, 109.9, 107.0, 56.2, 55.7, 51.1, 50.6, 43.5, 43.3, 42.9, 42.5; MS (MALDI-TOF): m/z 
calcd.for C66H44O10Na[(M+Na)+] 1019.3, found 1019.4. 
2) (5R,7R,9S,11S,16R,18R,20S,22S)-5,7,9,11,16,18,20,22-Octahydro-1,4,12,15-tetra-
methoxy-5,22:7,20:9,18:11,16-tetra(o-benzeno)nonacene-6,8,10,17,19,21-hexaone (3.95)  
A solution of 37 mg (0.037 mmol) of 3.92 in 5 mL acetic acid and 5 drops of 40% 
hydrobromic acid was refluxed for 10 minutes under argon.  The solvent was removed by a 
rotavapor. The residue was dissolved in 5 mL of acetone. Diacetoxyiodobenzene (36 mg, 0.11 
mmol) was added and the reaction mixture was stirred at room temperature for half an hour. 
Then acetone was removed by a rotapavor. The residue was appled to column chromatography 
(silica gel) using petrol ether, methylene chloride and ethyl ether (1:1:0.02, V:V:V) as eluent to 
afford 7.4 mg (20% yield) of the title compound 3.95: 1H NMR (CDCl3, 200 MHz) δ 7.35 (m, 8 
H), 7.32 (dd, J1 = 5.2 Hz, J2 = 3.0 Hz, 4 H), 6.41 (s, 4 H), 6.12 (s, 4 H), 6.05 (s, 4 H), 3.72 (s, 12 
H); 13C NMR (CDCl3, 100 MHz) δ 178.8, 177.9, 152.3, 151.4, 150.9, 149.8, 144.2, 142.3, 133.9, 
126.0, 125.5, 125.4, 124.7, 109.8, 50.7, 42.5, 41.6.  
3)5R,7R,9S,11S,16R,18R,20S,22S)-5,7,9,11,16,18,20,22-Octahydro-5,22:7,20:9,18:11, 
16-tetra(o-benzeno)nonacene-1,4,6,8,10,12,15,17,19,21-decaone (cis,cis,cis-noniptycene-
pentiquinone) (3.57)  
To a suspension of 55 mg (0.055 mmol) of 3.95 in 12 mL acetonitrile and 2 mL water 
was added 182 mg (0.330 mmol) of CAN. The reaction mixture was stirred at room temperature 
for overnight and diluted with 40 mL of chloroform. The organic layer was washed by water (50 
mL ×2), brine (50 mL), dried over anhydrous magnesium sulfate, filtered and concentrated. The 
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residue was applied to column chromatography using petrol ether, methylene chloride and ethyl 
ether (1:1:0.04, V:V:V) as eluent to afford 4.8 mg (9.3% yield) of the title compound 3.57: 1H 
NMR (CDCl3, 400 MHz) δ 7.38 (dd, J1 = 5.4 Hz, J2 = 3.4 Hz, 4 H), 7.34 (dd, J1 = 5.6 Hz, J2 = 
3.6 Hz, 4 H), 7.00 (dd, J1 = 5.4 Hz, J2 = 3.2 Hz, 4 H), 6.95 (dd, J1 = 5.4 Hz, J2 = 3.2 Hz, 4 H), 
6.55 (s, 4 H), 6.08 (s, 8 H); 13C NMR (CDCl3, 50 MHz) δ 182.2, 177.6 (2 C), 151.8, 151.3 (2 C), 
151.1, 142.1, 141.9, 135.5, 126.1 (2 C), 125.7, 125.6, 42.5, 42.4.  
3.5.5 Synthesis of 5-teeth synthon 
O
O
O
O
O
O
O
OO
O
O
O
3.59
 
3.5.5.1) (5R,7R,9s,11S,13S,18R,20R,22s,24S,26S)-5,7,9,11,13,18,20,22,24,26-Decahydro-
5,26:7,24:9,22:11,20:13,18-penti(o-benzeno)undecacene-1,4,6,8,10,12,14,17,19,21,23,25-
dodecaone (cis,cis,cis,cis-undeciptycenehexaquinone) (3.59) 
1) (5R,5aR,7R,9S,11S,12aR,13S,18R,18aS,20R,22R,24S,25aS,26S)-5,5a,7,9,11,12a, 
13,18,18a,20,22,24,25a,26-Tetradecahydro-1,4,14,17-tetramethoxy-5,26:7,24:9,22:11,20:13, 
18-penti(o-benzeno)undecacene-6,8,10,12,19,21,23,25-octaone (3.97) 
(5R,5aS,7R,9R,11S,12aS,13R,18S,18aR,20R,22S,24S,25aR,26S)-5,5a,7,9,11,12a,13,18, 
18a,20,22,24,25a,26-Tetradecahydro-1,4,14,17-tetramethoxy-5,26:7,24:9,22:11,20:13,18-
penti(o-benzeno)undecacene-6,8,10,12,19,21,23,25-octaone (3.98)  
A mixture of 100 mg (0.138 mmol) of cis,cis-heptiptycenetetraquinone (3.23) and 131 
mg (0.550 mmol) of 1,4-dimethoxyanthracene in 10 ml toluene and 2 ml carbon tetrachloride 
was heated to 170 oC (oil bath) in a sealed tube under argon for 24 hours. The precipitation was 
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filtered to give 80 mg of a mixture of 3.97 and 3.98 in a ratio of 8:1. The filtrate was absorbed in 
1 g of silica gel and applied to column chromatography using toluene, chloroform and ethyl 
acetate (25:25:2, V:V:V) as eluent to give 27 mg of a mixture of 3.97 and 3.98 in a ratio of 3:7. 
The calculated yield of two isomers is 83% with 58% for 3.97 and 25% for 3.98.  
The less polar isomer 3.97: m.p. > 240 oC decomp.; 1H NMR (CDCl3, 200 MHz) δ 7.20 
~7.38 (m, 6 H), 7.16 (dd, J1 = 5.6 Hz, J2 = 3.3 Hz, 2 H), 6.84~7.04 (m, 8 H), 6.69 (dd, J1 = 5.3 
Hz, J2 = 3.1 Hz, 2 H), 6.47 (s, 2 H), 6.21 (dd, 2 H), 6.15 (s, 2 H), 5.87 (s, 2 H), 5.79 (s, 2 H), 5.00 
(bs, 2 H), 4.86 (bs, 2 H), 4.84 (s, 2 H), 3.69 (s, 6 H), 3.34 (s, 6 H), 2.93 (bs, 2 H), 2.39 (bs, 2 H).  
The more polar isomer 3.98: m.p. >240 oC decomp.; 1H NMR (CDCl3, 200 MHz): δ 7.35 
(dd, J1 = 5.4 Hz, J2 = 3.2 Hz, 2 H), 7.30 (dd, J1 = 5.4 Hz, J2 = 3.0 Hz, 2 H), 7.19 (dd, J1 = 5.2 Hz, 
J2 = 3.4 Hz, 4 H), 7.10 (dd, J1 = 5.2 Hz, J2 = 3.4 Hz, 2 H), 6.88~7.04 (m, 10 H), 6.17 (s, 2H), 
5.92 (s, 2 H), 5.78 (s, 2 H), 5.71 (s, 2 H), 4.98 (bs, 2 H), 4.85 (bs, 2 H), 4.77 (s, 2 H), 3.55 (s, 6 
H), 3.35 (s, 6 H), 2.93 (bs, 2 H), 2.18 (bs, 2 H); MALDI-TOF MS: m/z= 1225.4 [(M+Na)+], 
1241.4 [(M+K)+] 
2) (5R,7R,9s,11S,13S,18R,20R,22s,24S,26S)-5,7,9,11,16,18,20,22-Octahydro-1,4,14,17-
tetramethoxy-5,26:7,24:9,22:11,20:13,18-penti(o-benzeno)undecacene-6,8,10,12,19,21,23,25-
Octaone (3.99)  
A solution of 50 mg (0.042 mmol) was suspended and heated to reflux in 30 mL acetic 
acid with 30 drops of HBr (40% water solution) under argon for 45 mins. The acetic acid was 
removed by a rotavapor. Toluene (25 mL) was added and was removed by the rotavapor for the 
purpose of further removing remaining acetic acid. The residue was vacuumed for 10 mins 
before was dissolved in 20 mL acetone. 60 mg (0.186 mmol) of PhI(OAc)2 was added and the 
reaction mixture was stirred at room temperature for overnight. Silica gel (500 mg)was added 
and solvent was removed under vacuum. The crude product absorbed in silica gel was applied to 
column chromatography (Silica gel) using petrol ether, methylene chloride and ethyl ether 
(1:2:0.03, V:V:V) as eluent to give 14.5 mg (29% yield) of the title compound, 3.99, as orange 
solids: 1H NMR (CDCl3, 400 MHz) δ 7.28~7.38 (m, 10 H), 6.88~6.98 (m, 10 H), 6.28 (s, 4 H), 
6.13 (s, 4 H), 6.03 (s, 6 H); 13C NMR (CDCl3, 50 MHz) δ 178.7, 177.7, 152.1, 152.3, 151.1, 
150.8, 149.6, 144.1, 142.3, 142.2, 134.1, 126.0 (2 peaks), 125.5, 125.4 (2 peaks overlap), 124.7, 
109.4, 56.5, 42.4 (2 peaks overlap), 41.5; MS (MALDI-TOF): m/z (M+H)+ 1200.2561 (Cal. 
1199.3068), (M+Na)+ 1221.2578 (Cal. 1221.2887), (M+K)+ 1237.1980 (Cal. 1237.2626). 
 136
3) (5R,7R,9s,11S,13S,18R,20R,22s,24S,26S)-5,7,9,11,13,18,20,22,24,26-Decahydro-
5,26:7,24:9,22:11,20:13,18-penti(o-benzeno)undecacene-1,4,6,8,10,12,14,17,19,21,23,25-
dodecaone (cis,cis,cis,cis-undeciptycenehexaquinone) (3.59)  
A suspension of 15.0 mg (0.0125 mmol) of 3.99 was suspended in 3 mL acetonitrile. The 
mixture was sonicated for 30 mins, 0.5 mL water and 41 mg (0.075 mmol) of CAN was added, 
and the mixture was stirred at room temperature for 2 hours. 40 mL of methylene chloride was 
added. The organic layer was then washed by water (20 mL × 2) and brine (20 mL), dried over 
anhydrous magnesium sulfate, filtered, and concentrated by a rotavapor. The residue was 
purified via column chromatography (silic gel) using a mixture of petrol ether, methylene 
chloride and ethyl ether (1:2:0.12, V/V/V) to give 4.2 mg (yield 30%) of the title compound, 
3.59, as yellow solids. 1H NMR (CDCl3, 200 MHz) δ 7.39 (dd, J1 = 5.4 Hz, J2 = 3.2 Hz, 4 H), 
7.28~7.35 (m, 6 H), 7.00 (dd, J1 = 5.3 Hz, J2 = 3.3 Hz, 4 H), 6.88~6.96 (m, 6 H), 6.55 (s, 4 H), 
6.07 (s, 4 H), 6.05 (s, 4 H), 6.04 (s, 2 H); 13C NMR (CDCl3, 50 MHz) δ 182.1, 177.5 (2 peaks), 
151.8, 151.1 (3 peaks overlap), 151.0, 142.1 (2 peaks overlap), 141.6, 135.4, 126.2, 126.1 (2 
peaks overlap), 125.7, 125.6 (2 peaks overlap), 42.4 (3 peaks overlap); MS (MALDI-TOF): 
M+Na+: 1162.3230 (Cal. 1161.1948). 
3.5.6 Synthesis of 6-teeth “molecular roll”   
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3.5.6.1) (5R,7R,9S,11S,13S,22R,24R,26S,28S,30S)-5,7,9,11,13,22,24,26,28,30-Decahydro-
1,4,6,8,10,12,14,21,23,25,27,29-dodecamethoxy-(5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno) 
tridecacene (3.119) 
1) (5R,5aS,7R,9S,10aS,11S,13S,22R,24R,24aR,26S,28S,29aR,30S)-5,5a7,9,10a,11,13, 
22,24,24a,26,28,29a,30-Tetradecahydro-1,4,12,14,21,23-hexamethoxy-(5,30:7,28:9,26:11,24: 
13,22)-penti(o-benzeno)tridecacene-6,8,10,25,27,29-hexaone (3.117) 
(5R,5aS,7R,9S,10aS,11S,13R,22S,24R,24aR,26S,28S,29aR,30S)-5,5a7,9,10a,11,13,22, 
24,24a,26,28,29a,30-Tetradecahydro-1,4,12,14,21,23-hexamethoxy-(5,30:7,28:9,26:11,24:13, 
22)-penti(o-benzeno)tridecacene-6,8,10,25,27,29-hexaone (3.118)  
A mixture of 142 mg (0.187 mmol) of 3.91 and 107 mg (0.197 mmol) of bisdimethoxy-
anthracene 3.56 in 10 mL of toluene under argon was heated at 100 oC for 36 hours. Toluene was 
removed by a rotavapor. The residue was applied to column chromatography (silica gel) using a 
mixture of toluene, chloroform and ethyl acetate (25:25:2, V:V:V) as eluent to give 126 mg 
(51% yield) of a mixture of 3.117 and 3.118 in a ratio of 3:7.  
Isomer 3.117 (the minor isomer): 1H NMR (CDCl3, 200 MHz) (deduced from 1H NMR, 
ROESY of a 3:7 mixture of 3.117 and 3.118) δ 8.50 (s, 2 H), 7.93 (m, 2 H), 7.49 (m, 2 H), 
6.86~7.46 (m, 16 H), 6.79 (m, 2 H), 6.30 (m, 2 H), 6.24 (s, 2 H), 6.89 (s, 2 H), 5.74 (s, 2 H), 5.17 
(s, 2 H), 4.98 (bs, 2 H), 4.95 (bs, 2 H), 4.10 (s, 6 H), 3.93 (s, 6 H), 3.41 (s, 6 H), 3.09 (bs, 2 H), 
2.94 (bs, 2 H); 13C NMR (CDCl3, 50 MHz) (deduced from 13C NMR of a 3:7 mixture of 3.117 
and 3.118) δ 194.0, 192.9, 177.8, 156.7, 155.6, 150.0, 149.8, 148.7, 146.9, 146.5, 144.0, 141.5, 
141.4, 141.2, 138.1, 136.7, 132.7, 131.7, 130.2, 129.5~125.0 (m, 11 C), 124.2, 123.0, 123.9, 
121.2, 106.7, 63.5, 63.2, 55.5, 51.0, 50.3, 44.4, 43.4, 42.6, 42.4, 42.0; MS (MALDI-TOF): m/z 
calcd. for C90H61O12[(M+H)+] 1333.4, found 1333.5; MS (MALDI-TOF) m/z calcd.for 
C90H61O12[(M+H)+] 1333.4, found 1333.5. 
Isomer 3.118 (the major isomer): 1H NMR (CDCl3, 200 MHz) (deduced from 1H NMR, 
ROESY of a 3:7 mixture of 3.117 and 3.118) δ 8.45 (s, 2 H), 7.92 (m, 2 H), 7.49 (m, 2 H), 
6.86~7.46 (m, 16 H), 6.76 (m, 2 H), 6.25 (m, 2 H), 6.24 (s, 2 H), 6.90 (s, 2 H), 5.76 (s, 2 H), 5.23 
(s, 2 H), 5.03 (bs, 2 H), 4.96 (bs, 2 H), 4.06 (s, 6 H), 3.95 (s, 6 H), 3.46 (s, 6 H), 3.09 (bs, 2 H), 
2.97 (bs, 2 H); 13C NMR (CDCl3, 50 MHz) (deduced from 13C NMR of a 3:7 mixture of 3.117 
and 3.118) δ 194.0, 192.9, 177.8, 156.7, 155.6, 150.0, 149.8, 148.8, 146.9, 146.4, 144.1, 141.5, 
141.4, 141.3, 138.0, 136.6, 132.7, 131.7, 130.2, 129.5~125.0 (m, 11 C), 124.3, 124.1, 123.9, 
 138
121.2, 106.8, 63.5, 63.1, 55.6, 51.0, 50.4, 44.4, 43.4, 42.6, 42.4, 42.0; MS (MALDI-TOF): m/z 
calcd. for C90H61O12[(M+H)+] 1333.4, found 1333.5. 
2) (5R,7R,9S,11S,13S,22R,24R,26S,28S,30S)-5,7,9,11,13,22,24,26,28,30-Decahydro-
1,4,6,8,10,12,14,21,23,25,27,29-dodecamethoxy-(5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno) 
tridecacene (3.119) 
 (5R,7R,9S,11S,13R,22S,24R,26R,28S,30S)-5,7,9,11,13,22,24,26,28,30-Decahydro-1,4, 
6,8,10,12,14,21,23,25,27,29-dodecamethoxy-(5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno)- 
tridecacene (3.120) 
 To a solution of 87 mg (0.065 mmol) of a mixture of 3.117 and 3.118 in 5 mL DMF at 
0oC was added 26 mg (60% NaH in oil). The reaction mixture was stirred at 0 oC for half an hour. 
Then 162 μL (2.60 mmol) of methyl iodide was added by a syringe. The reaction mixture was 
then stirred at room temperature for 3 hours, diluted with 30 mL water, and extracted with ethyl 
acetate (30 mL×2). The organic layer was washed with 30 mL 1M HCl, conc. sodium 
bicarbonate solution (30 mL), and brine (30 mL), dried over anhydrous magnesium sulfate, 
filtered and concentrated by a rotavapor. The residue was appled to column chromatography 
using toluene, chloroform and ethyl acetate (5:5:1 to 5:5:2, V:V:V) as eluent to afford 23 mg (a 
mixture of two isomers 3.119 and 3.120 in a ratio of about 1:1. The two isomers are partial 
separated with the less polar isomer being 3.120 and the more polar isomer being 3.119. 
 The more polar isomer 3.119 (not enough materials for 13C NMR): 1H NMR (CDCl3, 400 
MHz) δ 8.57 (s, 2 H), 7.92 (m, 2 H), 7.36 (m, 2 H), 7.30 (m, 2 H), 7.12~7.26 (m, 8 H), 6.95 (m, 2 
H), 6.76~6.88 (m, 8 H), 6.14 (s, 2 H), 5.92 (s, 2 H), 5.82 (s, 2 H), 5.80 (s, 2 H), 5.78 (s, 2 H), 
4.53 (s, 2 H), 4.03 (s, 6 H), 3.91 (s, 6 H), 3.81 (s, 6 H), 3.77 (s, 6 H), 3.66 (s, 6 H), 3.33 (s, 6 H).  
 The less polar isomer 3.120 (not enough materials for 13C NMR): 1H NMR (CDCl3, 200 
MHz) δ 8.46 (s, 2 H), 7.92 (m, 2 H), 7.12~7.50 (m, 12 H), 7.08 (m, 2 H), 6.75~6.95 (m, 8 H), 
6.30 (s, 2 H), 6.15 (s, 2 H), 6.03 (s, 2 H), 5.92 (s, 2 H), 5,86 (2s overlap, 4 H), 4.05 (s, 6 H), 3.91 
(s, 6 H), 3.82 (2s overlap, 12 H), 3.78 (s, 6 H), 3.72 (s, 6 H); MS (MALDI-TOF): m/z calcd.for 
C96H75O12 [(M+H)+] 1419.5, found 1418.7. 
3.5.6.2) (7R,9R,11R,13R,15R,20S,22S,24S,26S,28S)-7,9,11,13,15,20,22,24,26,28-Decahydro-
8,10,12,14,16,19,21,23,25,27-decamethoxy-(7,28:9,26:11,24:13,22)-penti(o-benzeno)-trideca-
cene-6,29-dione (3.125)  
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 To a stirred solution of 7.6 mg (5.4 μmol) of 3.119 in 1 mL of CH3CN and water (6:1) 
was added 3.0 mg (5.5 μmol) of CAN. The reaction was stirred at room temperature for 5 hours 
and diluted with 20 mL of ethyl acetate, washed by water (20 mL), brine, dried over anhydrous 
magnesium sulfate, filtered and concentrated by a rotavapor. The residue was applied to column 
chromatography using toluene, chloroform and ethyal acetate (5:5:2, V:V:V) as eluent to afford 
2.4 mg (32% yield) of the title compound 3.125 (not enough materials for 13C NMR): 1H NMR 
(CDCl3, 200 MHz) δ 8.64 (s, 2 H), 7.98 (m,  2 H), 7.55 (m, 2 H), 7.38 (m, 2 H), 7.12~7.30 (m, 8 
H), 6.94 (m, 2 H), 6.76~6.90 (m, 8 H), 6.23 (s, 2 H), 5.91 (s, 2 H), 5.85 (2s overlap, 4 H), 5.81 (s, 
2 H), 4.70 (s, 2 H), 3.89 (s, 6 H), 3.82 (s, 6 H), 3.80 (s, 6 H), 3.68 (s, 6 H), 3.36 (s, 6 H); MS 
(MALDI-TOF): m/z calcd.for C94H68O12Na [(M+Na)+] 1411.5, found 1411.6. 
3.5.6.3) (5R,7R,9S,11S,13S,22R,24R,26S,28S,30S)-5,7,9,11,13,22,24,26,28,30-Decahydro-
6,8,10,12,23,25,27,29-octamethoxy-(5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno)tridecacene-
1,4,14,21-tetraone (3.126)  
 To a stirred solution of 2.4 mg (1.7 μmol) of 3.119 in 0.5 mL of CH3CN and water (6:1, 
V:V) was added 0.8 mg (1.5 μmol) of CAN. The reaction was stirred at room temperature for 5 
hours and diluted with 20 mL of ethyl acetate, washed by water (20 mL), brine, dried over 
anhydrous magnesium sulfate, filtered and concentrated by a rotavapor. The residue was applied 
to column chromatography using toluene, chloroform and ethyal acetate (5:5:2, V:V:V) as eluent 
to afford 1.0 mg (43% yield) of the title compound 3.126 (not enough materials for 13C NMR): 
1H NMR (CDCl3, 200 MHz) δ 8.60 (s, 2 H), 8.01 (m, 2 H), 7.57 (m, 2 H), 7.37 (m, 2 H), 
7.18~7.34 (m, 8 H), 6.80~6.98 (m, 10 H), 6.25 (s, 2 H), 5.91 (s, 2 H), 5.86 (s, 2 H), 5.81 (s, 2 H), 
5.76 (s, 2 H), 4.67 (s, 2 H), 3.89 (s, 6 H), 3.84 (s, 6 H), 3.80 (s, 6 H), 3.67 (s, 6 H); MS (MALDI-
TOF): m/z calcd.for C92H62O12Na[(M+Na)+] 1381.4, found 1381.7. 
3.5.6.4) (5R,7R,9S,11S,13S,22R,24R,26R,28S,30S)-5,7,9,11,13,22,24,26,28,30-Decahydro-1,4, 
12,14,21,23-hexamethoxy-(5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno)tridecacene-6,8,10, 
25,27,29-hexaone (3.121) 
 (5R,7R,9S,11S,13R,22S,24R,26R,28S,30S)-5,7,9,11,13,22,24,26,28,30-Decahydro-1,4, 
12,14,21,23-hexamethoxy-(5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno)tridecacene-6,8,10, 
25,27,29-hexaone (3.122)  
 A suspension of 40 mg (0.030 mmol) of 3.117 and 3.118 in 6 mL of acetic acid and 6 
drops of 40% hydrobromic acid was stirred at room temperature for 36 hours. The solvent was 
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removed under reduced pressure. The residue was dissolved in 5 mL of acetone followed by 
adding 29 mg (0.090 mmol) of diacetoxyiodobenzene. The resulting solution was stirred at room 
temperature for 5 minutes. 400 mg of silica gel was added and solvent was removed by a 
rotavapor. The dried silica gel was applied to column chromatography (silica gel) using toluene, 
chloroform and ethyl acetate (25:25:1, V:V:V) as eluent to afford 10 mg (25% yield) of  the 
mixture of title compounds 3.121 and 3.122, which could be separated by PTLC using petrol 
ether, methylene chloride and ethyl ether (1:2:0.06, V:V:V) as eluent.  
 Compound 3.121 (more polar isomer) (not enough materials for 13C NMR): 1H NMR 
(CDCl3, 200 MHz) δ 8.57 (s, 2 H), 7.94 (m, 2 H), 7.18~7.42 (m, 12 H), 6.82~7.00 (m, 10 H), 
6.16 (s, 2 H), 6.00 (s, 2 H), 5.98 (s, 2 H), 5.96 (s, 2 H), 5.89 (s, 2 H), 4.81 (s, 2 H), 4.07 (s, 6 H), 
3.90 (s, 6H), 3.31 (s, 6 H). 
 Compound 3.122 (less polar isomer) (not enough materials for 13C NMR): 1H NMR 
(CDCl3, 200 MHz) δ 8.46 (s, 2 H), 7.93 (m, 2 H), 7.18~7.48 (m, 12 H), 6.82~7.00 (m, 10 H), 
6.27 (s, 2 H), 6.16 (s, 2 H), 6.11 (s, 2 H), 6.02 (2 s overlap, 4 H), 5.98 (s,2 H), 4.05 (s, 6 H), 3.87 
(s, 6 H), 3.73 (s, 6 H). 
3.5.6.5) (7R,9R,11R,13R,15R,20S,22S,24S,26S,28S)-7,9,11,13,15,20,22,24,26,28-Decahydro-
8,10,12,14,16,19,21,23,25,27-decamethoxy-(7,28:9,26:11,24:13,22)-penti(o-benzeno)-trideca-
cene-6,29-dione (3.123)  
 To a stirred solution of 3 mg (2.3 μmol) of 3.121 in 0.25 mL of CH3CN and water (6:1, 
V:V) was added 2.0 mg (3.6 μmol) of CAN. The reaction was stirred at room temperature 
overnight and diluted with 20 mL of ethyl acetate, washed by water (20 mL), brine, dried over 
anhydrous magnesium sulfate, filtered and concentrated by a rotavapor. The residue was applied 
to column chromatography using toluene, chloroform and ethyal acetate (25:25:1, V:V:V) as 
eluent to afford 1.6 mg (54 % yield) of the title compound 3.123 (not enough materials for 13C 
NMR): 1H NMR (CDCl3, 200 MHz) δ 8.63 (s, 2 H), 7.12~7.64 (m, 12 H), 6.80~7.04 (m, 10 H), 
6.26 (s, 2 H), 6.01 (s, 2 H), 5.98 (s, 2 H), 5.97 (s, 2 H), 5.93 (s, 2 H), 4.95 (s, 2 H), 3.86 (s, 6 H), 
3.34 (s, 6 H). 
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3.5.7 Synthesis of new cyclododeciptycene based molecular gear 3.318 
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3.5.7.1) 2,4,6,8,10,12,14,16,18,20,22,24-Dodecahydro-9,11,21,23-tetramethoxy-(2,14:4,16:6, 
18:8,20:10,22:12,24)-hexa(o-benzeno)-[12]cyclacene-1,3,5,7,13,14,17,19-octaone (3.318) 
1) (5R,7R,9S,10aR,11S,13S,22R,24R,24aS,26R,28S,30S)-5,7,9,10a,11,13,22,24,24a,26, 
28,30-Dodecahydro-12,14,21,23-tetramethoxy-(5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno) 
tridecacene-1,4,6,8,10,25,27,29-octaone (endo-cis adduct) (3.314) 
(5R,7R,9S,10aR,11S,13R,22S,24R,24aS,26R,28S,30S)-5,7,9,10a,11,13,22,24,24a,26,28, 
30-Dodecahydro-12,14,21,23-tetramethoxy-(5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno)-
tridecacene-1,4,6,8,10,25,27,29-octaone (endo-trans adduct) (3.315) 
(5R,7R,9S,10aS,11S,13R,22S,24R,24aR,26R,28S,30S)-5,7,9,10a,11,13,22,24,24a,26,28, 
30-Dodecahydro-12,14,21,23-tetramethoxy-(5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno)- 
tridecacene-1,4,6,8,10,25,27,29-octaone (exo-cis adduct) (3.316) 
(5R,7R,9S,10aS,11S,13S,22R,24R,24aR,26R,28S,30S)-5,7,9,10a,11,13,22,24,24a,26,28, 
30-Dodecahydro-12,14,21,23-tetramethoxy-(5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno)- 
tridecacene-1,4,6,8,10,25,27,29-octaone (exo-trans adduct) (3.317)  
 A mixture of the tetraquinone 3.23 (116 mg, 0.160 mmol) and bisdimethoxyanthracene 
3.56 (110 mg, 0.190 mmol) was heated in 1,2-dichloroethane at 120 oC in a sealed tube for 24 
hours. The solvent was removed by a rotavapor. The residue left was applied to column 
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chromatography (silica gel) using toluene-chloroform-ethyl acetate (25:25:2, V:V:V) as eluent to 
afford 117 mg (56% yield) of four monoadducts in a ratio about 2:2:1:1 based on 1H NMR.  
 Endo-cis adduct 3.314 (a small amount of pure sample was obtained by PTLC method 
using toluene-chloroform-ethyl acetate (25:25:2, V:V:V) as eluent, not enough materials for 13C 
NMR: 1H NMR (CDCl3, 200 MHz) δ 8.54 (s, 2 H), 7.97 (m, 2 H), 7.20~7.50 (m, 10 H), 
6.87~7.04 (m, 8 H), 6.80 (m, 2 H), 6.33 (s, 2 H), 6.26 (s, 2H), 6.15 (s, 2 H), 6.13 (s, 2 H), 5.74 (s 
& dd, 4 H), 4.86 (bs, 2 H), 4.14 (s, 6 H, OMe), 3.90 (s, 6 H, OMe), 2.92 (bs, 2 H).  
Endo-anti adduct 3.315 (a small amount of pure sample was obtained by PTLC method 
using toluene-chloroform-ethyl acetate (25:25:2, V:V:V) as eluent, not enough materials for 13C 
NMR): 1H NMR (CDCl3, 200 MHz) δ 8.47 (s, 2 H), 7.94 (dd, J1 = 6.4 Hz, J2 = 3.4 Hz, 2 H), 
7.53 (dd, J1 = 5.3 Hz, J2 = 3.1 Hz, 2 H), 7.20~7.44 (m, 8 H), 7.11 (dd, J1 = 5.2 Hz, J2 = 3.0 Hz,  
2 H), 6.89~7.00 (m, 6 H), 6.77 (dd, J1 = 5.3 Hz, J2 = 3.3 Hz, 2 H), 6.26 (s, 2 H), 6.14 (s, 2 H), 
6.11 (s, 2 H), 6.08 (s, 2 H), 5.73 (s, 2 H), 5.70 (dd, 2 H), 4.86 (bs, 2 H), 4.07 (s, 6 H, OMe), 3.91 
(s, 6 H, OMe), 2.93 (bs, 2 H). 
 Exo-cis adduct 3.316 (hard to separate from 3.317, no pure sample was available): 1H 
NMR (CDCl3, 200 MHz) (deduced from 1H NMR of a 4:6 mixture of 3.316 and 3.317) δ 8.55 (s, 
2 H), 7.98 (m, 2 H), 7.53 (m, 2 H), 6.80~7.48 (m, 10 H), 6.70 (m, 2 H), 6.43 (s, 2 H), 6.29 (m, 2 
H), 6.25 (s, 2 H), 6.04 (s, 2 H), 6.03 (s, 2 H), 5.79 (s, 2 H), 4.93 (bs, 2 H), 4.14 (s, 6 H, OMe), 
3.91 (s, 6 H, OMe), 2.87 (bs, 2 H).  
 Exo-trans adduct 3.317 (hard to separate from 3.316, no pure sample was available): 1H 
NMR (CDCl3, 200 MHz) (deduced from 1H NMR of a 4:6 mixture of 3.316 and 3.317) δ  8.45 (s, 
2 H), 7.92 (m, 2 H), 6.80~7.48 (m, 12 H), 6.74 (m, 2 H), 6.54 (s, 2 H), 6.26 (s, 2 H), 6.23 (m, 2 
H), 6.08 (s, 2 H), 6.04 (s, 2 H), 5.80 (s, 2 H), 4.93 (bs, 2 H), 4.06 (s, 6 H, OMe), 3.93 (s, 6 H, 
OMe), 2.87 (bs, 2 H).  
2) 2,4,6,8,10,12,14,16,18,20,22,24-Dodecahydro-9,11,21,23-tetramethoxy-(2,14:4,16: 
6,18:8,20:10,22:12,24)-hexa(o-benzeno)-[12]cyclacene-1,3,5,7,13,14,17,19-octaone (3.138) 
(5R,7R,9S,11S,13R,22S,24R,26R,28S,30S)-5,7,9,11,13,22,24,26,28,30-Decahydro-
12,14,21,23-tetramethoxy-(5,30:7,28:9,26:11,24:13,22)-penti(o-benzeno)tridecacene-1,4,6,8, 
10,25,27,29-octaone (3.139)  
A 1:1 mixture of two Diels-Alder adducts (2.8 mg, 2.2 μmol) was refluxed in 2 mL of 
acetic acid under argon for 30 min. The reaction mixture was poured into 50 mL of water and 
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extracted with 20 mL of ethyl acetate. The ethyl acetate layer was then washed with water (50 
mL×2), concentrated sodium bicarbonate water solution (20 mL×2), brine (20 mL × 2), dried 
over anhydrous magnesium sulfate, filtered and concentrated. The residue was dissolved in 2 mL 
acetone. Diacetoxyiodobenzene (2.0 mg, 6.2 μmol) was added and shaked well. Then the 
solution was applied to PTLC using a mixture of toluene, chloroform, ethyl acetate (25:25:2, 
V:V:V) as eluent. The Rf. = 0.29 band was cut and eluented with the same eluent [toluene, 
chloroform, ethyl acetate (25:25:2, V:V:V)], concentrated and was further purified by column 
chromatography using a mixture of petrol ether, methylene chloride, diethyl ether (1:2:0.12, 
V:V:V) to give 0.6 mg (43% yield) of the title compound, 3.318, as orange solids: m.p. > 300 oC; 
1H NMR (CDCl3, 200 MHz) δ 7.25~7.36 (m, 12 H), 6.85~6.98 (m, 12 H), 6.05 (s, 2 H), 6.04 (s, 
4 H), 5.95 (s, 4 H), 5.89 (s, 2 H), 3.82 (s, 12 H, OMe); 13C NMR (CDCl3, 50 MHz) δ 178.6, 
177.6, 152.0, 151.4, 151.3, 151.0, 147.8, 145.0, 143.5, 141.9, 141.8, 137.4, 135.0, 126.1 (2 peaks 
overlap), 125.9, 125.7, 125.5(2 peaks overlap), 124.5, 123.8, 63.4 (OMe), 42.4 (3 peaks overlap), 
42.2.  
 The band just below the cyclized product (Rf. = 0.26) was cut and eluented with toluene-
chloroform-ethyl acetate (25:25:2, V:V:V), concentrated to afford 1.2 mg (86% yield) of 
compound 3.139 (not enough materials for 13C NMR): 1H NMR (CDCl3, 200 MHz) δ 8.47 (s, 2 
H), 7.93 (m, 2 H), 7.20~7.70 (m, 12 H), 6.80~7.00 (m, 12 H), 6.63 (s, 2 H), 6.14 (s, 2 H), 6.07 (s, 
2 H), 6.04 (s, 2 H), 6.03 (s, 2 H), 5.99 (s, 2 H), 4.05 (s, 6 H), 3.88 (s. 6 H).  
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Appendix 
1H-NMR SPECTRA, 13C-NMR SPECTRA AND MASS SPECTRA 
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LK-8-073-precipitate
C52H39O8
C52H38O8Na
C52H38O8K
(M+H)+:
(M+Na)+:
(M+K)+:
Exact Mass: 791.2645
m/z: 791.26 (100.0%), 792.27 (57.0%), 793.27 (17.6%), 794.27 (3.7%)
Exact Mass: 813.2464
m/z: 813.25 (100.0%), 814.25 (57.0%), 815.25 (17.3%), 816.26 (2.9%)
Exact Mass: 829.2204
m/z: 829.22 (100.0%), 830.22 (56.6%), 831.23 (15.9%), 831.22 (8.9%), 832.22 (4.1%), 832.23 (3.9%), 
833.23 (1.8%)
HO
OH
HO
OH
OMe
MeO MeO
OMe
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LK-10-043-dp
C36H27O4
C36H26O4Na
C36H26O4K
(M+H)+:
(M+Na)+:
(M+K)+:
Exact Mass: 523.1909
m/z: 523.19 (100.0%), 524.19 (38.9%), 525.20 (8.4%), 526.20 (1.3%)
Exact Mass: 545.1729
m/z: 545.17 (100.0%), 546.18 (39.4%), 547.18 (8.4%), 548.18 (1.2%)
Exact Mass: 561.1468
m/z: 561.15 (100.0%), 562.15 (39.4%), 563.15 (8.3%), 563.14 (7.2%), 564.15 (3.2%)
OH
HO
OH
HO
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C66H44O10Na(M+Na)+:
Exact Mass: 1019.2832
m/z: 1019.28 (100.0%), 1020.29 (72.3%), 1021.29 (27.8%), 1022.29 (7.4%), 1023.30 (1.0%)
C66H44O10K(M+K)+:
Exact Mass: 1035.2572
m/z: 1035.26 (100.0%), 1036.26 (72.3%), 1037.26 (34.6%), 1038.26 (6.7%), 1038.27 (6.0%), 1039.26
(2.0%), 1039.27 (1.6%)
LK-9-033-dp-isomer
 
 
 
 
 
  264
 
  265
 
  266
 
  267
 
  268
 
  269
 
 
\  
  270
 
  271
O
O
O
O
O
O
O
O OMe
MeO
OMe
MeO
H
H
H
H
C80H50O12Na(M+Na)+:
Exact Mass: 1225.3200
m/z: 1225.32 (100.0%), 1226.32 (87.0%), 1227.33 (37.9%), 1228.33 (12.9%), 1229.33 (3.2%), 1227.32
(2.5%)
(M+K)+: C80H50O12K
Exact Mass: 1241.2939
m/z: 1241.29 (100.0%), 1242.30 (87.6%), 1243.30 (40.3%), 1244.30 (19.0%), 1243.29 (7.2%), 1245.30
(3.9%), 1245.31 (2.3%)
LK-9-047-f10
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C90H61O12
Exact Mass: 1333.4163
m/z: 1333.42 (100.0%), 1334.42 (98.5%), 1335.
42 (49.8%), 1336.43 (15.4%), 1337.43 (4.8%), 1336.42 (2.4%), 1338.43 (1.1%)
(M+H)+:
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LK-9-042-dp
 
 
 
 
 
  279
 
 
 
  280
  281
 
  282
 
  283
 
  284
 
LK
-9
-0
80
-2
-R
O
ES
Y MeO
OMe
MeO
OMe
MeO
OMe
MeO
OMe
OMe
MeO
MeO
OMe
 
  285
 
  286
 
MeO
OMe
MeO
OMe
MeO
OMe
MeO
OMe OMe
MeO
OMe
MeO
LK
-9
-0
82
-is
om
er
-R
O
ES
Y
 
  287
 
OMe
MeO
OMe
MeO
OMe
MeO
OMe
MeO
MeO
OMe
MeO
OMe
LK-9-080-1
C96H75O12(M+H)+:
C96H74O12Na(M+Na)+:
C96H74O12K(M+K)+:
Exact Mass: 1419.5259
m/z: 1420.53 (100.0%), 1419.53 (95.1%), 1421.53 (53.5%), 1422.54 (17.9%), 1423.54 (5.8%), 1422.53 
(2.4%), 1424.54 (1.3%)
Exact Mass: 1441.5078
m/z: 1442.51 (100.0%), 1441.51 (95.1%), 1443.51 (53.1%), 1444.52 (20.3%), 1445.52 (5.8%), 1446.52 
(1.3%), 1443.52 (1.3%)
Exact Mass: 1457.4817
m/z: 1458.49 (100.0%), 1457.48 (95.1%), 1459.49 (54.4%), 1460.49 (20.4%), 1460.48 (7.2%), 1459.48 
(6.9%), 1461.49 (5.0%), 1461.50 (4.6%), 1462.49 (1.5%), 1462.50 (1.3%)  
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LK-9-097-f6
C94H69O12(M+H)+:
C94H68O12Na(M+Na)+:
C94H68O12K(M+K)+:
Exact Mass: 1389.4789
m/z: 1390.48 (100.0%), 1389.48 (97.9%), 1391.49 (51.3%), 1392.49 (19.7%), 1393.49 (5.5%), 1391.48 
(2.4%)
Exact Mass: 1411.4608
m/z: 1412.46 (100.0%), 1411.46 (98.4%), 1413.47 (54.0%), 1414.47 (19.8%), 1415.47 
(5.4%), 1416.48 (1.3%), 1412.47 (1.2%)
Exact Mass: 1427.4348
m/z: 1428.44 (100.0%), 1427.43 (97.2%), 1429.44 (53.3%), 1430.44 (26.1%), 1429.43 (7.0%), 1431.45 
(5.5%), 1431.44 (3.9%), 1432.44 (1.4%), 1432.45 (1.3%)  
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LK-9-098-dp
C92H63O12(M+H)+:
C92H62O12Na(M+Na)+:
C92H62O12K(M+K)+:
Exact Mass: 1359.432
m/z: 1360.44 (100.0%), 1359.43 (99.3%), 1361.44 (52.3%), 1362.44 (18.8%), 1363.45 (4.0%), 1363.44 
(1.2%), 1364.45 (1.2%)
Exact Mass: 1381.4139
m/z: 1382.42 (100.0%), 1381.41 (99.3%), 1383.42 (52.2%), 1384.42 (18.5%), 1385.43 (4.0%), 1385.42 
(1.2%), 1386.43 (1.2%)
Exact Mass: 1397.3878
m/z: 1398.39 (100.0%), 1397.39 (99.3%), 1399.39 (58.3%), 1400.40 (18.8%), 1400.39 (7.2%), 1401.40 
(5.3%), 1401.39 (3.7%), 1402.40 (2.3%), 1399.40 (1.2%)  
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